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Abstract 
2,5-Cyclohexadienones are versatile synthetic building blocks that are currently 
underutilized in natural product synthesis. The desymmetrization of symmetrically 
substituted cyclohexadienones is a strategy for the asymmetric synthesis of complex 
frameworks that has been rapidly gaining popularity. Two desymmetrization 
methodologies developed by our group are described herein. 
The first is a phase-transfer catalyzed intramolecular Michael addition of 
malonate-tethered cyclohexadienones mediated by Cinchona alkaloid-derived ammonium 
salts. Under these conditions, bicyclic lactones are formed in enantiomeric ratios of up to 
91:9. For unsymmetrically substituted substrates, the regioselectivity of the reaction is 
governed by a combination of steric and electronic affects: cyclization occurs away from 
sterically bulky substituents and towards electron-withdrawing substituents. In the case of 
brominated substrates, unique tricyclic cyclopropanes are obtained. 
The second methodology is a Pd-catalyzed intramolecular enyne reaction of 
alkyne-tethered cyclohexadienones. This cyclization occurs with enantiomeric ratios of 
up to 81:19 in the presence of bipyridine-based chiral ligands. Substituents on the 
cyclohexadienone core were found to have a great influence on the both the selectivity 
and the efficiency of the reaction, which can likely be attributed to steric effects. 
Finally, the use of the phase-transfer catalysis methodology in the total synthesis 
of the briarane family of natural products was explored. In the pursuit of a key 
intermediate containing the briarane core, it was discovered that the enolates of the 
bicyclic lactone products are particularly unstable, and are not amenable to 
functionalization. Further studies toward this goal are underway. 
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Chapter 1  
Introduction to Cyclohexadienones 
Cyclohexadienones are a synthetically versatile class of molecules derived from 
phenols.
1
 These compounds are present in two varieties: 2,4-cyclohexadienones (1.1) and 
2,5-cyclohexadienones (1.2). Both of these motifs can undergo a large array of 
transformations, a few examples of which are shown in Figure 1.1. Additionally, the 
products of these transformations often retain a synthetic handle, such as an enone, useful 
for further elaboration. As a result, these molecules are attractive intermediates for 
natural product synthesis.
1,2
 
 
Figure 1.1. Structure and reactivity of cyclohexadienones. 
The greatest practical difference between the two varieties relates to stability. 
2,4-Cyclohexadienones have a propensity to dimerize via [4+2] cycloaddition
1
 (1.1→1.3, 
Scheme 1.1); in many cases, this dimerization is so rapid that the monomeric products 
cannot be isolated. In contrast, 2,5-cyclohexadienones are usually isolable and generally 
stable over the time periods required for use as a synthetic intermediate. For this reason, 
our research has focused on 2,5-cyclohexadienones and all discussion in the remainder of 
this dissertation pertains to this variety, unless otherwise specified. 
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Scheme 1.1. Dimerization of 2,4-cyclohexadienones. 
 
1.1 Dearomatization of phenols 
The most straightforward synthetic route to cyclohexadienones is through the 
direct oxidative dearomatization of phenols. There are many notable procedures for 
accomplishing this transformation, including the use of transition-metal complexes,
3–10
 
singlet-oxygen species,
11–13
 or electrochemical systems.
14–16
 More recently, the use of 
hypervalent iodine reagents has become a popular approach.
17–24
 The simplicity of the 
reactions and the commercial availability of reagents such as phenyliodine diacetate 
(PIDA, 1.4) and phenyliodine bis(trifluoroacetate) (PIFA, 1.5) (Figure 1.2) have made 
hypervalent iodine oxidation the dearomatization method of choice in our group. 
 
Figure 1.2. Hypervalent iodine reagents PIDA and PIFA. 
The reaction begins with ligand exchange on the iodine center, with the phenolic 
substrate 1.6 displacing one of the original ligands (e.g., acetate in 1.14) to provide iodine 
phenolate 1.7. At this point, the reaction likely proceeds through a substrate- and solvent- 
dependent mechanism, the exact nature of which lies somewhere between two 
extremes.
25
 The first (pathway A, Scheme 1.2) is an SN1-like mechanism in which the 
aryl iodide dissociates completely (1.7A), leaving behind a highly reactive phenoxenium 
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ion intermediate (1.8).
26–28
 The nucleophile then adds into the ring, providing the 
cyclohexadienone product. The second (pathway B) is SN2'-like: nucleophilic attack and 
aryl iodide dissociation occur simultaneously (1.7B or 1.7C), directly providing the 
cyclohexadienone. 
Scheme 1.2. Mechanism of hypervalent iodine mediated oxidative dearomatization. 
 
These reactions can produce either 2,5- (1.9 via para addition) or 2,4-
cyclohexadienones (1.10 via ortho addition). Generally, addition will only occur at a 
substituted position on the phenol, providing an opportunity for substrate control. 
Additionally, reagent choice can have a significant influence on regioselectivity: many 
hypervalent iodine reagents, including PIDA and PIFA, favor para addition. In most 
cases the nucleophile must either be tethered to the phenol, or be available in solvent 
quantities. 
Most natural product synthetic targets in the literature are chiral and generally 
exist as a single enantiomer. As a result, the development of synthetic methodologies that 
provide enantioenriched products is highly desirable. One way to accomplish this goal 
would be through the investigation of direct enantioselective syntheses of chiral 
cyclohexadienones. Unfortunately, the enantioselective dearomatization of 
unsymmetrically substituted phenols has proven to be a very difficult problem However, 
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some recent advances have been made.
29–34
 When successful, this approach affords 
enantioenriched cyclohexadienones 1.9 directly from phenols 1.6 (Scheme 1.3), 
providing a framework for the construction of asymmetric complex molecules. 
Scheme 1.3. Enantioselective dearomatization of phenols. 
 
1.2 Enantioselective desymmetrization of cyclohexadienones 
An alternative, and complementary, approach to using these molecules in 
asymmetric synthesis is the enantioselective desymmetrization of symmetrically 
substituted cyclohexadienones. Enantioselective desymmetrization
35,36
 involves the 
differentiation of two enantiotopic functional groups (in this case, the two enones) 
through selective reactivity, thus breaking the symmetry of the molecule. This strategy is 
extremely versatile, as many of the reactions applicable to cyclohexadienones have the 
potential provide chiral products through desymmetrization under the appropriate 
conditions. For example, nucleophilic conjugate addition into cyclohexadienone 1.11 
could generate the chiral enone 1.12 in the presence of a chiral catalyst (Scheme 1.4). 
Scheme 1.4. Example cyclohexadienone desymmetrization. 
 
Although the specific challenges of this approach depend on the exact 
transformation at hand, the general stereochemical considerations are the same. Any 
reaction that involves the enone double bond has four possible stereochemical outcomes: 
specifically, the four stereoisomers (1.12a–d) shown in Figure 1.3. The distribution of 
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these isomers depends on selective approach to one face of the dienone (1.13, 
diastereoselectivity) and preferential reaction with one of the two olefins (1.14, 
enantioselectivity). 
 
Figure 1.3. Potential stereochemical outcomes of cyclohexadienone desymmetrization. 
Designing a catalyst or ligand to control the reaction both diastereoselectively and 
enantioselectively can be challenging. While many methodologies will necessarily be 
affected by both issues, there are strategies available to simplify the problem. A common 
approach is to utilize a reaction with an inherent diastereoselective bias, such as a 
cyclization reaction that preferentially forms a cis-fused bicyclic system (1.15→1.16, 
Scheme 1.5A). Alternatively, the issue of diastereoselectivity can be avoided completely 
with transformations that ultimately retain the double bond (e.g., the intramolecular Heck 
reaction of compound 1.17 to provide bicyclic cyclohexadienone 1.18, Scheme 1.5B). In 
both cases, only the enantioselective aspect of the problem remains. 
Chapter 1 – Introduction to Cyclohexadienones | 6 
 
Scheme 1.5. Diastereochemical considerations in the desymmetrization of cyclohexadienones. 
 
No comprehensive review of these desymmetrization reactions has been 
performed. Recently, Wang and Li reviewed the asymmetric organocatalytic construction 
of chiral cyclohexenones.
37
 Although a section of this review did highlight one class of 
cyclohexadienone desymmetrization reactions (specifically, organocatalytic Michael 
additions), a large body of work remains to be covered. The remainder of this chapter 
aims to address this deficiency by reviewing previous examples of enantioselective 
cyclohexadienone desymmetrization. 
1.3 Transition-metal catalyzed cyclizations 
1.3.1 Heck reactions 
The first example of enantioselective cyclohexadienone desymmetrization was 
reported by Shibasaki and coworkers in 1993.
38,39
 The authors’ primary interest was in 
the development of an intramolecular Heck reaction of bisallylic alcohol 1.19 to provide 
cyclohexenone 1.20 in the presence of (R)-BINAP (1.22) (Scheme 1.6A). Interestingly, 
cyclohexadienone 1.21 was observed as a side product in significant amounts. The 
authors postulated that this product might arise from oxidized intermediate 1.23. To 
further investigate this observation, 1.23 was subjected to the cyclization conditions. The 
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reaction proceeded efficiently, providing the desymmetrized product 1.21 in 66% yield 
and an enantiomeric ratio of 92:8 (Scheme 1.6B). 
Scheme 1.6. Shibasaki's asymmetric Heck cyclization. 
  
Although this result theoretically would serve as a strong preliminary result for 
developing a cyclohexadienone desymmetrization methodology, the Heck reaction was 
not investigated in this context again for nearly ten years. In 2002, Feringa reported the 
Heck cyclization of cyclohexadienone-tethered aryl iodides 1.24 to provide bicyclic 
dienones 1.26 (Scheme 1.7A).
40,41
 A variety of TADDOL-derived monodentate 
phosphoramidite ligands were screened, with 1.26 providing the highest level of 
enantioselectivity. Variation of substitution on the substrate had a slight negative effect 
on both conversion and selective, as the parent substrate (R
1
 = Me, R
2
,R
3
,R
4
 = H) 
provided the best results (100% conversion, 98:2 er). Additionally, carbon-tethered 
substrate 1.27 successfully underwent cyclization to provide product 1.28 with an 
enantiomeric ratio of 90:10 (Scheme 1.7B). 
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Scheme 1.7. Feringa's asymmetric Heck cyclization. 
 
1.3.2 Conjugate additions 
In addition to the Heck cyclization example above, Feringa also performed a 
serious of studies on the conjugate addition of alkylzinc reagents to cyclohexadienones. 
A preliminary report in 1997
42
 showed the successful Cu-catalyzed addition of Et2Zn to 
dienone 1.29 in the presence of phosphoramidite ligand 1.31, providing enone 1.30 in 
very good yield and enantiomeric ratio of 97:3 (Scheme 1.8A). This specific example is 
not a desymmetrization as defined above: because the two substituents at the 4 position of 
the cyclohexadienone are identical, the two enones are homotopic, not enantiotopic. 
Feringa and coworkers later expanded on this result, performing conjugate additions into 
substrates 1.32 to provide desymmetrized enones 1.33 with high levels of 
enantioselectivity (Scheme 1.8B).
43
 Notably, spirocyclic substrate 1.34 exhibited a 
drastically reduced level of selectivity upon cyclization to 1.35 (Scheme 1.8C). 
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Scheme 1.8. Feringa's Cu-catalyzed asymmetric conjugate addition. 
 
The authors also found that the diastereoselectivity of the reaction was dictated by 
a directing effect of alkoxy substitutents in the 4 position, as monoalkoxides 1.32 
exhibited excellent stereocontrol, whereas mixed dialkoxide 1.36 was converted to 
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product 1.37 as a 1:1 mixture of diastereomers (Scheme 1.8D). In an additional report,
44
 
products 1.38 were subjected to a second conjugate addition, providing 3,5-disubstituted 
cyclohexenones 1.39 and 1.40 (Scheme 1.8E). Interestingly, the authors were able to 
control the diastereoselectivity of this second addition by utilizing either enantiomer of 
the phosphoramidite ligand 1.31, indicating that the selectivity of this addition is 
completely under catalyst control. 
1.3.3 Enyne cyclizations 
Recently, a variety of enyne cyclizations of cyclohexadienones have been 
reported. These reactions are of immediate interest to our group: we reported initial 
investigations into Pd-catalyzed cyclization in 2009
45
 and published the results of our 
efforts towards an enantioselective version of the reaction in 2013.
46
 These findings are 
discussed in detail in Chapter 3. 
In 2013, Lautens and coworkers developed a Rh-catalyzed cyclization of alkyne-
tethered cyclohexadienones.
47
 Subjecting substrates 1.41 and aryl boronic acids 1.42 to 
catalytic [Rh(coe)2Cl]2 in the presence of diene ligand 1.44 provided bicyclic enones 1.43 
in moderate yields with good stereocontrol (Scheme 1.9). The authors found that the 
stereoselectivity of the reaction was generally insensitive to the nature of the aryl boronic 
acid, and also to variations of the alkyne tether (products 1.45–1.48). The 
enantioselectivity of the reaction decreased significantly only when a sterically crowded 
tether was utilized, providing product 1.45. Product 1.47 is particularly notable, as it 
demonstrates that this methodology is also applicable to internal alkynes. The choice of 
ligand was found to play a large role in both the efficiency and the selectivity of the 
reaction. Diene ligands were found to be necessary, as phosphine ligands generally lead 
to decomposition of the starting material. The substitution pattern on the ligand was also 
found to be very important in suppressing the formation of dimeric side products 1.49. 
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Scheme 1.9. Lautens' Rh-catalyzed asymmetric arylative cyclization. 
 
Around the same time as the Lautens report, Tian and Lin published a similar Rh-
catalyzed arylative cyclization.
48
 In this case, catalytic [Rh(C2H4)2Cl]2 was utilized with 
(R)-BINAP as the chiral ligand to provide products 1.52 from internal alkynes 1.50 and 
aryl boronic acids 1.51 in excellent yields with high levels of stereocontrol (Scheme 
1.10). Once again, the efficiency and selectivity of the reaction were found to be largely 
insensitive to both substrate substitution and aryl boronic acid identity. 
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Scheme 1.10. Tian and Lin's Rh-catalyzed asymmetric arylative cyclization. 
  
Recently, Ding and coworkers utilized a Pd-catalyzed reductive enyne cyclization 
in their synthesis of indoxamycins A, C, and F (1.57–1.59, Scheme 1.11).49 Alkyne-
tethered cyclohexadienone 1.53 was treated with a cationic Pd catalyst in the presence of 
(R)-SEGPHOS (1.56) to provide epimeric products 1.54 and 1.55 with enantiomeric 
ratios of 97:3 and 90:10, respectively. 
Scheme 1.11. Ding's Pd-catalyzed asymmetric cyclization in the synthesis of indoxamycins A, C, and F. 
 
Although this reaction would typically be viewed in terms of diastereoselectivity 
(and is technically not a desymmetrization reaction as defined above), the stereocenter 
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already present in substrate 1.53 appears to have little to no influence on selectivity. As a 
result, the overall transformation is essentially an enantioselective desymmetrization of 
the cyclohexadienone core. 
Two other asymmetric enyne cyclizations of cyclohexadienone substrates have 
recently been published.
50,51
 The products provided in these reactions are very similar to 
those provided by our methodology and a discussion of these studies can be found in 
Chapter 3. 
1.3.4 Cycloadditions 
Wang and coworkers utilized a Ag-catalyzed [3+2] cycloaddition to provide 
tricyclic products 1.62 from spiro cyclohexadienones 1.60 and imino esters 1.61 (Scheme 
1.12A).
52
 These products contain five contiguous stereocenters and are formed with 
impressive stereocontrol (>20:1 dr, up to 99:1 er) in the presence of TF-BiphamPhos
53
 
ligand 1.63. Modifications to the catalyst largely resulted in lower efficiency or 
selectivity, especially for examples with increased steric bulk near the phosphorus atom. 
Additional complexity could be incorporated by the use of α-substituted imino esters 
1.65, which yields products 1.66 containing two quaternary stereogenic centers after 
cyclization with unsubstituted cyclohexadienone substrate 1.64. These reactions also 
proceeded in good yields and with high selectivity. 
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Scheme 1.12. Wang's Ag-catalyzed [3+2] cyclization. 
 
1.4 Organocatalytic reactions 
1.4.1 Michael additions 
Organocatalytic Michael additions have provided the basis for a large number of 
desymmetrization methodologies, including our own. This work, published in 2011,
54
 
will be discussed in Chapter 2. 
The earliest example of cyclohexadienone desymmetrization through an 
asymmetric Michael addition was reported by Hayashi in 2005.
55
 After a brief catalyst 
screening, it was found that cysteine-derived catalyst 1.69 promoted the cyclization of 
aldehydes 1.67, providing bicyclic products 1.68 with an enantiomeric ratio of up 98:2 
(Scheme 1.13). The alkyl substituent at the 4 position of the cyclohexadienone could be 
varied with very little effect on yield or selectivity. Excellent diastereocontrol was also 
observed: only cis-ring fusion was observed and the endo-aldehyde was observed in only 
minor amounts. 
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Scheme 1.13. Hiyashi's organocatalytic asymmetric Michael addition. 
 
In 2007, Gaunt and coworkers demonstrated a one-pot dearomatization/Michael 
addition sequence.
56
 By subjecting aldehyde-tethered phenol 1.70 to PIDA and proline-
derived catalyst 1.72, bicyclic product 1.71 was obtained in modest yield and good 
selectivity (Scheme 1.14A). The steric bulk of catalyst 1.72 was not only required to 
obtain high levels of enantioselectivity, but also to protect the amine functional group in 
the catalyst from oxidation by excess PIDA. To further investigate the 
diastereoselectivity of the reaction, the authors isolated the intermediate 
cyclohexadienone 1.73. When this intermediate was subjected to the Michael addition 
conditions, the selectivity of the reaction was found to have a strong solvent dependence. 
Methanol was found to be particularly effective, providing 1.74 in 91% yield and >20:1 
dr (Scheme 1.14B). This discovery was then applied to the one-pot reaction, in which 
enones were produced via intermediate methyl quinols using methanol as the solvent. 
The cyclization of a variety of aldehyde tethers (1.75) was examined, producing enones 
1.76 in consistently high yields and enantiomeric ratios (Scheme 1.14C). However, 
diastereoselectivity was highly substrate dependent, both in the level of selectivity and 
the identity of the major diastereomer. Finally, α,α-disubstituted substrate 1.77 was 
cyclized, affording the product 1.78 with poor selectivity, indicating that α substitution is 
not well tolerated by this reaction (Scheme 1.14D). 
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Scheme 1.14. Gaunt's one-pot asymmetric dearomatization/Michael addition sequence. 
 
Gaunt continued to work in the area of dearomatization and desymmetrization, 
publishing a report of a second conjugate addition methodology in 2011.
57
 In this work, 
alkynamide-tethered cyclohexadienones 1.79 are dearomatized using ICl to provide 
spirocycles 1.80 (Scheme 1.15A).
58
 These intermediates are used without purification in 
the next step, in which the benzoic acid salt of pyrrolidine catalyst 1.82 promotes the 
Michael addition of the aldehyde side chain into the dienone core. This reaction provides 
tricyclic products 1.81, which contain three contiguous stereocenters and a variety of 
synthetically useful functional groups. The reaction generally proceeds with high yields 
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and selectivity – the only notable exception is the cyclization of substrate 1.83, 
containing a shortened carbon chain between the amide and aldehyde. In this case, 
tricyclic lactone 1.84 is obtained as a single diastereomer, but low levels of 
enantioselectivity are observed (Scheme 1.15B). 
Scheme 1.15. Gaunt's asymmetric I-Cl dearomatization/Michael addition sequence. 
 
In 2011, You and coworkers reported an asymmetric bifunctional-urea catalyzed 
Michael addition.
59
 Substrates 1.85 contain a bisphenylsulfonyl methylene group, which 
is highly activated for use as a Michael donor. Treatment with the Cinchona alkaloid-
derived catalyst 1.87 provides bicyclic enones 1.86 in high yields with good 
enantioselectivity (Scheme 1.16A). Substrates with an aryl group internal to the 
bisphenylsulfonyl tether were also viable in the reaction (1.88→1.89, Scheme 1.16B). A 
key feature of these products is the potential to remove the bisphenylsulfonyl groups, 
which was demonstrated by the conversion bisphenylsulfonyl product 1.90 to the 
unsubstituted tricyclic enone 1.91 using a three step procedure (Scheme 1.16C). 
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Scheme 1.16. You's asymmetric bifunctional-urea catalyzed Michael addition. 
 
1.4.2 Stetter reactions 
In 2006, Rovis and coworkers demonstrated the desymmetrization of 
cyclohexadienones using an intramolecular Stetter reaction.
60
 Aminoindanol-derived 
triazolium catalyst 1.94 promoted the cyclization of aldehyde substrates 1.92, providing 
bicyclic diketones 1.93 in good yield with excellent stereocontrol (Scheme 1.17A).  
Chapter 1 – Introduction to Cyclohexadienones | 19 
 
Scheme 1.17. Rovis' asymmetric intramolecular Stetter reaction. 
  
Substitution around the cyclohexadienone ring was well tolerated: 
α,α-disubstituted substrates 1.95 provided products 1.96 as a single diastereomer 
(Scheme 1.17B) and β,β-disubstituted substrates 1.97 cyclized efficiently to give products 
1.98 containing an additional quaternary stereocenter (Scheme 1.17C). Substrate 1.99 
with an all-carbon aldehyde tether also successfully underwent cyclization, providing 
bicyclic enone 1.100 (Scheme 1.17D), although the use of free carbene catalyst 1.101 
was required in this case. Interestingly, the efficiency and selectivity of this reaction were 
highly dependent on concentration, with dilute conditions (0.008 M) found to be optimal. 
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The authors suggest that this effect is caused by the increased potential for hydrogen 
bonding at higher concentrations. In addition to the preliminary report, a detailed account 
of the development of the methodology, including conditions for gram-scale reactions, 
has been published.
61
 
In 2012, You and coworkers reported the asymmetric intramolecular Stetter 
reaction of spirocyclic cyclohexadienones.
62
 Aldehydes 1.102, reminiscent of the starting 
materials used by Gaunt described above, were treated with camphor-derived triazolium 
catalyst 1.104 to induce cyclization (Scheme 1.18A). Tricyclic products 1.103 were 
obtained as a single diastereomer in moderate yields with good stereocontrol. In a 
separate study, the authors extended this methodology to α,α-disubstituted 
cyclohexadienones.
63
 The cyclization of these substrates (1.105→1.106) required altered 
conditions, including the use of aminoindanol-derived triazolium catalyst 1.107. 
Scheme 1.18. You's asymmetric intramolecular Stetter reaction of spirocyclic cyclohexadienones. 
 
Continuing their investigation of desymmetrizations via Stetter reactions, You and 
coworkers also developed the cyclization of aryl-substituted cyclohexadienones 1.108.
64
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Using the camphor-derived catalyst 1.104 from their previous study, products 1.109 were 
obtained in very good yield with high enantioselectivity. 
Scheme 1.19. You's asymmetric intramolecular Stetter reaction of 4-aryl substituted cyclohexadienones. 
 
1.4.3 Other conjugate additions 
You and coworkers also investigated desymmetrizations involving other 
conjugate addition reactions. In 2010, they reported the Brønsted acid-catalyzed 
intramolecular oxo-Michael addition of cyclohexadienones 1.110.
65
 Cyclization to afford 
bicyclic products 1.111 in the presence of chiral phosphoric acid 1.112 proceeded in good 
yields with high levels of stereocontrol (Scheme 1.20A). Aryl-substitution at the 4 
position of the cyclohexadienone was well tolerated; however, the use of alkyl groups 
larger than methyl resulted in decreased enantioselectivity. The utility of this 
methodology was demonstrated in the synthesis of cleroindicins C, D, and F (1.115–
1.117, Scheme 1.20B). 
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Scheme 1.20. You's asymmetric intramolecular oxo-Michael addition. 
 
In a separate study, You also described an aza-Michael addition catalyzed by 
Cinchona alkaloid-derived thioureas.
66
 Catalyst 1.120 promoted the cyclization of 
sulfonamide-tethered cyclohexadienones 1.118, providing bicyclic enones 1.119 
(Scheme 1.21A) in good yields with high levels of enantioselectivity. Interestingly, 
substrates capable of undergoing oxo-Michael addition (1.118, R = O(CH2)nOH) 
preferentially cyclize through sulfonamide addition. The cyclization of oxygen-tethered 
substrates 1.121 to afford morpholine derivatives 1.122 was also investigated (Scheme 
1.21B). The efficiency of this reaction followed the same trend as the oxo-Michael 
addition: high yields and enantiomeric ratios were obtained for most 4-substituted 
substrates, but isopropyl substitution caused a drop in yield and t-butyl substitution shut 
down the reaction completely. Finally, the authors applied this methodology in the total 
synthesis of (–)-mesembrine (1.125), obtaining key intermediate 1.124 from the 
cyclization of cyclohexadienone 1.123 (Scheme 1.21C). 
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Scheme 1.21. You's asymmetric intramolecular aza-Michael addition. 
 
Doyle and coworkers reported a one-pot tandem dearomatization/conjugate 
addition procedure.
67
 While the desired reaction did occur with excellent 
diastereocontrol, an efficient enantioselective version was elusive. As a part of their 
investigation, the authors attempted the asymmetric cyclization of cyclohexadienones 
1.126 using chiral phosphoric acid catalysts 1.128. Bicyclic ethers and carbamates 1.127 
were afforded in good yields, but with modest enantioselectivity (Scheme 1.22). 
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Scheme 1.22. Doyle's assymetric intramolecular conjugate additions. 
 
Ye and coworkers developed a chiral diamine-catalyzed version of oxo-Michael 
addition, published in 2013.
68
 (R,R)-DPEN (1.131) mediated cyclization of 
cyclohexadienones 1.129 provided byclic ethers 1.130 in good yields with very good 
stereocontrol (Scheme 1.23A). The authors were also able to access the enantiomeric 
series of products (ent-1.130) through the use of diamine catalyst 1.132 (Scheme 1.23B). 
In both cases, an amino acid additive was required for the reaction to proceed. 
Substitution at the 4 position of the cyclohexadienone was well tolerated, as a variety of 
alkyl-, aryl-, and oxo-substituted substrates cyclized efficiently. However, variation of the 
alcohol tether length was not well tolerated: both increasing and decreasing the chain 
length resulted in the formation of nearly racemic products. 
Scheme 1.23. Ye's asymmetric intramolecular oxo-Michael addition. 
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Later in 2013, Wang and coworkers reported the desymmetrization of 
cyclohexadienones via an asymmetric sulfa-Michael addition.
69
 Spirocyclic oxindole 
substrates 1.133 were treated with aryl sulfides 1.134 in the presence of bifunctional 
thiourea catalyst 1.136 (Scheme 1.24). Products 1.135 were obtained in high yields and 
with high levels of enantiocontrol. The reaction is very tolerant of substitution on both 
the aryl sulfide as well as the arene ring of the oxindole. 
Scheme 1.24. Wang's asymmetric intramolecular sulfa-Michael addition. 
 
The potential utility of desymmetrizing conjugate additions was demonstrated by 
Fan and coworkers in their formal synthesis of (±)-morphine (1.141).
70
 Although the 
overall synthesis accesses racemic material, the authors did investigate a potential 
asymmetric desymmetrization reaction for the formation of the morphine E ring. 
Specifically, spirolactone 1.137 was treated with various alcohols in the presence of 
bifunctional thiourea catalyst 1.140 to induce a tandem alcoholysis/oxa-Michael addition. 
Although the reaction did proceed in good yield, the authors were unable to attain high 
levels of enantioselectivity despite extensive optimization. The best conditions, shown in 
Scheme 1.25, provided 1.138 through intermediate 1.139 with in an enantiomeric ratio of 
74:26. 
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Scheme 1.25. Asymmetric alcoholysis/oxo-Michael addition in Fan's synthetic investigations of morphine. 
 
1.4.4 Rauhut–Currier reactions 
In 2012, Sasai and coworkers reported the asymmetric Rauhut–Currier reaction71 
of cyclohexadienones bearing unsaturated esters.
72,73
 Substrates 1.142 were efficiently 
converted to bicyclic lactones 1.143 in good yields and high levels of enantioselectivity 
(Scheme 1.26A). Lewis basic catalysts (e.g., PPh3) could be employed in the reaction, but 
only with an accompanying Brønsted acid catalyst (e.g., phenol). The authors identified 
bifunctional catalyst 1.144, which satisfied both catalytic requirements and provided 
excellent stereocontrol. The cyclization of β,β-disubstituted substrate 1.145 was also 
investigated (Scheme 1.26B). In this case, the reaction provided lactone 1.146 with a low 
level of stereoselectivity. The use of a Brønsted acid catalyst in addition to catalyst 1.144 
provided higher levels of selectivity, but also lower yields. This inverse relationship was 
observed with a variety of phenolic Brønsted acids, with the extreme example being the 
use of phenol (50 mol%) to afford 1.146 in 5% yield and an enantiomeric ratio of 98:2. 
Unfortunately, the authors were unable to find conditions that provided both high yields 
and high levels of selectivity. 
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Scheme 1.26. Sasai's asymmetric intramolecular Rauhut–Currier reaction. 
 
1.5 Desymmetrization using internal asymmetric induction 
There have been a few examples of internal asymmetric induction being used to 
achieve formal enantioselective transformations of cyclohexadienones. These sequences 
allow the relevant stereocenters to be installed in a diastereoselective manner, greatly 
simplifying the challenges associated with cyclohexadienone desymmetrization. 
In 1995, Winterfeldt and coworkers reported the formal enantioselective 
epoxidation of spirolactone 1.148 through the use of a chiral Diels–Alder adduct.74 The 
cycloaddition of 1.148 and cyclopentadiene 1.147 provided adduct 1.149, which 
underwent diastereoselective epoxidation when treated with H2O2 and K2CO3 to afford 
1.150 (Scheme 1.27A). Release of the enone core was accomplished by flash vacuum 
pyrolysis, affording the formal desymmetrization product 1.151 after a three step 
sequence. In a later report, the Winterfeldt group described an in depth investigation of 
the Diels–Alder reaction.75 This study also included a cycloaddition/reduction sequence 
(1.152→1.153, Scheme 1.27B) that upon release of enone 1.154 would correspond to a 
formal enantioselective hydrogenation of a cyclohexadienone; however, the authors did 
not perform the cycloreversion reaction on this particular substrate. 
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Scheme 1.27. Winterfeldt's use of a Diels–Alder adduct as a chiral auxiliary. 
 
Also in 1995, Carreño and coworkers reported the synthesis of chiral sulfoxide 
1.155.
76
 Shortly thereafter, the group described the diastereoselective addition of AlMe3 
into the cyclohexadienone core
77,78
 (1.155→1.156, Scheme 1.28). Oxidation of the 
sulfoxide with mCPBA provides sulfone 1.157, the formal result of an enantioselective 
AlMe3 conjugate addition. The Carreño group has demonstrated this methodology 
numerous times in the synthesis of natural products.
79–82
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Scheme 1.28. Carreño's use of a chiral sulfoxide for internal asymmetric induction. 
 
1.6 Summary 
Over the past 20 years, there have been numerous advances in techniques for the 
enantioselective desymmetrization of cyclohexadienones. Although a few of these 
techniques have been applied in the total synthesis of relatively simple natural products, 
the widespread use of cyclohexadienone desymmetrization has yet to be realized. Given 
the rapidly growing interest in this field, this trend is likely to change in the coming 
years. The remainder of this dissertation describes our contributions in this area, as well 
as progress towards the application of our methodologies to natural product synthesis. 
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Chapter 2  
Phase-Transfer Catalyzed Cyclization of 
Cyclohexadienones Tethered to Active 
Methylene Groups† 
2.1 Background 
In 2009, our group began work on the total synthesis of sorbicillactone A (2.3, 
Scheme 2.1).
83
 This natural product, isolated in 2003, is a member of the sorbicillinoid 
family
84
 and has shown antileukemia, anti-HIV and neuroprotective activity.
85,86
 A key 
sequence in the synthesis involved the cyclization of cyclohexadienone 2.1. The base 
sensitivity that cyclohexadienones exhibit necessitated the use of a mild base for the 
reaction. Therefore, an electron-withdrawing group was required in order to activate the 
methylene protons in 2.1 for deprotonation. Successful intramolecular Michael addition 
would provide compound 2.2, which contains the bicyclic core of sorbicillactone A. 
                                                 
†
 This work was performed in collaboration with Rodolfo Tello-Aburto and Kelly Volp. A significant 
portion of these results have been published previously.
54
 Relevant sections reproduced by 
permission of The Royal Society of Chemistry (RSC). 
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Scheme 2.1. Intramolecular Michael addition in the synthesis of sorbicillactone A. 
 
A similar cyclization was achieved by Nicolaou in his synthetic studies of various 
bisorbicillinoid analogues
87
 (2.6, Scheme 2.2). In this case, the Michael acceptor was 
activated by the sorbyl sidechain in 2.4. This activation allowed for the use of KHMDS to 
deprotonate the unactivated acetate, providing 2.5 after cyclization. While the use of a 
strong base was successful in this case, the authors did specify that Lewis acids caused 
decomposition of the starting material, emphasizing the sensitivity of these substrates. 
Scheme 2.2. Nicolaou's intramolecular cyclization of acetate 2.4. 
 
2.2 Objective 
While our initial motivation for developing this reaction arose in the context of 
synthesizing sorbicillactone A, we realized that this methodology could prove to be of 
general use. Therefore, we sought to investigate the transformation of a wide variety of 
cyclohexadienones 2.6–2.10 to bicyclic lactones 2.11–2.15 (Scheme 2.3) in order to 
determine the scope of the reaction, observe any trends in regioselectivity, and ultimately 
develop conditions for enantioselective cyclization. We hypothesized that selective 
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desymmetrization could be achieved using a suitable chiral phase-transfer catalyst 
(PTC)
88–90
. 
Scheme 2.3. Desymmetrization of cyclohexadienones via phase-transfer catalyzed cyclization. 
 
2.3 Substrate synthesis 
All substrates (2.6–2.10) used for this study were prepared in two steps from the 
corresponding phenols 2.16: oxidative dearomatization was followed by coupling of the 
resulting quinols 2.17 to malonic acid monoesters 2.18–2.22 or other activated methylene 
compounds (Scheme 2.4). Coupling was initially accomplished with a trifluoroacetic 
anhydride-mediated coupling of the tertiary alcohol with the malonic acid mono ester;
91
 
however, the use of DCC was later found to be more convenient and cost effective, 
particularly on larger scales. 
Scheme 2.4. Synthesis of substrates through dearomatization and ester coupling 
 
These reactions are applicable to a wide range of substrates. Various malonic 
esters are tolerated (Table 2.1, entries 1, 2, 3), as are other electron-withdrawing groups 
such as amides (entry 4) and sulfones (entry 5). 
Chapter 2 – Phase-Transfer Catalyzed Cyclization of Cyclohexadienones | 33 
 
Table 2.1. Synthesis of substrates with varied electron-withdrawing groups. 
 
Entry Ester Acid EWG Method Yield (%) 
1 2.6 2.18 CO2allyl A 66 
2 2.7 2.19 CO2Bn A 63 
3 2.8a 2.20 CO2t-Bu A 43 
4 2.9 2.21 morpholine amide B 96 
5 2.10 2.22
a 
4-toluenesulfonyl B 57
b 
a
 Acid 2.22 is the corresponding aryl sulfide. 
b
 After oxidation of the aryl sulfide to the aryl sulfone. 
As discussed below (Section 2.6), the majority of our substrates were derived 
from mono-t-butyl malonate (2.20). Two series of substrates were synthesized: the first 
(Table 2.2) was derived from symmetrically substituted phenols 2.16a–m for use in our 
initial studies (Section 2.4) and in our enantioselectivity studies (Section 2.6), while the 
second (Table 2.3) was derived from unsymmetrically substituted phenols 2.16n–t and 
was designed to be utilized in our regioselectivity studies (Section 2.5). 
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Table 2.2. Synthesis of substrates derived from symmetrically substituted phenols. 
 
Entry Quinol R
1
 R
2
 
Yield (%) 
of quinol 
Ester Method 
Yield (%) 
of ester 
1 2.17a H Me known
13
 2.8a A 43 
2 2.17b H Ph known
92
 2.8b A 36 
3 2.17c H i-Pr 73 2.8c A 56 
4 2.17d H CH2CO2Me 40 2.8d A 38 
5 2.17e H CH2t-Bu 31 2.8e B >99 
6 2.17f H CH2CH2OTBS known
93
 2.8f B 74 
7 2.17g H 
 
37 2.8g B 50 
8 2.17h Me Me 78 2.8h B >99 
9 2.17i TMS Me 67 2.8i B 86 
10 2.17j Br Me known
21
 2.8j B >99 
11 2.17k Br i-Pr 78 2.8k B 95 
12 2.17l Br 
 
74 2.8l B 81 
13 2.17m Br CH2CH2OTBS 42 2.8m B 96 
Chapter 2 – Phase-Transfer Catalyzed Cyclization of Cyclohexadienones | 35 
 
Table 2.3. Synthesis of substrates derived from unsymmetrically substituted phenols. 
 
Entry Quinol R
1
 R
2
 R
3
 
Yield (%) 
of quinol 
Ester Method 
Yield (%) 
of ester 
1 2.17n Me OMe H 80 2.8n B 98 
2 2.17o Me H H known
13
 2.8o B 95 
3 2.17p H Me H 48 2.8p B 73 
4 2.17q TMS H H 51 2.8q B 82 
5 2.17r H H Br 76 2.8r A 69 
6 2.17s H Me Br 74 2.8s B 96 
7 2.17t Me OMe Br 51 2.8t B 55 
 
2.4 Initial studies 
Despite the base sensitivity that cyclohexadienones generally exhibit,
1
 the 
cyclization of dienones 2.6–2.10 proceeded well with Cs2CO3 in acetonitrile, providing 
bicyclic products 2.11–2.15 (Scheme 2.5). Cyclization occurred efficiently even for 
sterically hindered systems (e.g., 2.8c, 2.8e, and 2.8g). Substrate 2.8d is also notable, as 
the potential problem of tertiary carboxylate elimination was not observed. In all cases, 
the bicyclic lactone product was isolated as a single diastereomer. The cis-fused ring 
system was confirmed by NOE experiments on 2.11 and 2.13h, while the configuration 
of the stereocenter bearing the electron-withdrawing group was assigned through 
coupling constant analysis. At this time, it is not clear if a second diastereomer also forms 
during the reaction and then epimerizes under either the reaction or isolation conditions. 
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Scheme 2.5. Cyclization of symmetric substrates. 
 
α-Disubstituted cyclohexadienones also underwent cyclization successfully, albeit 
with much longer reaction times (1–4 days). In the case of 2.8h, the product 2.13h 
contains four contiguous stereocenters and was formed as a single diastereomer (Scheme 
2.6A). Although disilane 2.8i did cyclize successfully (Scheme 2.6B), the product (2.13i) 
contained only one trimethylsilyl group, resulting from protodesilylation of the α-silyl 
ketone.
94–96
 The region- and stereochemical features of this reaction are discussed in the 
following sections (Sections 2.5 and 2.6). 
Scheme 2.6. Cyclization of α-substituted symmetric substrates. 
 
2.5 Regioselectivity studies 
We were interested in examining the influence of various substituents on the 
regioselectivity of these anionic reactions. The cyclization of vinylogous ester substrate 
2.8n (Scheme 2.7) was completely regioselective and afforded 2.13n (the intermediate 
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used in our groups synthesis of sorbicillactone A,
83
 see Section 2.1) in high yield. This 
result can most simply be explained by electronic effects, as one olefin of the 
cyclohexadienone can be considered to be a vinylogous ester and, consequently, less 
electrophilic. 
Scheme 2.7. Regioselective cyclization of vinylogous ester substrate 2.8n. 
  
The methylated substrates 2.8o and 2.8p cyclized with very good regioselectivity. 
Compound 2.8o, with the methyl group in the α position, cyclized with a 9:1 ratio of 
regioisomers 2.13o and 2.13o' (Scheme 2.8A). This result is in agreement with an 
observation made by Giomi and co-workers concerning the addition of diethyl malonate 
to a α-methyl substituted dienone.97 Higher regioselectivity (12:1) was observed in the 
cyclization of β-methyl substrates 2.8p to 2.13p and 2.13p' (Scheme 2.8B). This 
dependence could easily be attributed to steric effects; however, an electronic argument 
involving the weakly electron-donating nature of methyl substituents should not be 
discounted. 
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Scheme 2.8. Regioselective cyclizations of methyl-substituted substrates. 
 
Finally, the cyclization of vinyl silane 2.8q (Scheme 2.9) was investigated. 
Considering a purely steric model, the increased bulk of the trimethylsilyl group in 2.8q 
as compared to the methyl group in 2.8o should increase selectivity. Similarly, the lower 
group electronegativity of a TMS group (2.06 eV)
98
 relative to a methyl group 
(~2.3 eV)
99
 would also be expected to give rise to higher regioselectivity. In practice, 
however, the cyclization of 2.8q afforded 2.13a as the major product (6.6:1 ratio of 2.13a 
and 2.13i). In this case, compound 2.13a is the product of conjugate addition onto the 
silicon-bearing olefin, followed by protodesilylation. This reversal in selectivity can be 
attributed to silicon’s ability to stabilize an adjacent negative charge,100,101 while the 
aforementioned electronegativity difference likely explains why complete selectivity is 
not observed. These findings imply that electronic effects are the major factor that 
determines the selectivity of these cyclizations. 
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Scheme 2.9. Regioselective cyclization of trimethylsilyl-substituted substrate 2.8q. 
 
2.5.1 Brominated substrates 
If the regioselectivity observed during the cyclizations described in the previous 
section was indeed due primarily to electronic effects, the presence of an electron-
withdrawing group on the cyclohexadienone should reverse the observed regioselectivity. 
In other words, an anionic nucleophile should preferentially attack the olefin bearing the 
electron-withdrawing group. Bromine is particularly attractive in that it is easily installed, 
usually has a positive impact in terms of chemical yield on the oxidative dearomatization 
step, and serves as a useful handle for further synthetic transformations.  
When the bromine-containing substrate 2.8r was subjected to the cyclization 
conditions, the tricyclic cyclopropane 2.23r was obtained (Scheme 2.10A). While this 
outcome was unexpected, there have been numerous examples in the literature of similar 
cyclopropanations.
102–105
 Importantly, the conjugate addition required to initiate the 
cyclopropanation pathway occurred with complete regioselectivity: no products arising 
from addition into the less substituted double bond in 2.8r were observed. Similarly, 
substrate 2.8s cyclized to give cyclopropane 2.13s exclusively (Scheme 2.10B). This 
cyclopropanation could also be extended to the symmetric dibromides 2.8j–m (Scheme 
2.10C). 
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Scheme 2.10. Cyclization of bromine-substituted substrates. 
 
Interestingly, while the cyclization of 2.8t proceeded well, it was noticeably 
slower than the reactions of 2.8r and 2.8s. If the reaction of 2.8t was terminated early, 
bromide 2.13t could be isolated as a single diastereomer (Scheme 2.11). The 
configuration of the bromine-bearing stereocenter in 2.13t does not allow for backside 
attack by the malonate. By resubjecting bromide 2.13t to the reaction conditions (or 
allowing 2.8t to react overnight), the complete reaction can be realized. Presumably, the 
reaction proceeds through epimerization of the relevant stereocenter, affording epi-2.13t, 
which does have the correct configuration for SN2 substitution. The slow epimerization of 
2.13t might be related to the pKa difference between the α'-bromoenones (e.g., 2.13r) 
formed during the reactions in Scheme 2.10 and the α'-bromovinylogous ester contained 
in 2.13t. 
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Scheme 2.11. Cyclization of substrate 2.8t. 
 
2.6 Enantioselectivity studies 
Recognizing that the symmetric dienones discussed above contain enantiotopic 
olefins, we hypothesized that a chiral phase-transfer catalyst might be able to 
desymmetrize these prochiral compounds. Asymmetric phase-transfer catalysis has 
proven to be a valuable tool for constructing enantioenriched products.
88–90
 However, to 
the best of our knowledge, there have been no examples of enantioselective phase-
transfer catalyzed desymmetrization reactions. While we were confident that the desired 
cyclization would occur on only one face of the dienone, we expected the discrimination 
of the two enantiotopic olefins based solely on non-bonding interactions to be a 
significant challenge. 
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Scheme 2.12. Enantioselective cyclization via phase-transfer catalysis. 
 
Cinchona alkaloid-based phase-transfer catalysts are particularly attractive 
because of their ready availability and ease of modification. Efforts toward optimization
†
 
included variation of the electronic and steric properties of the catalyst; modification of 
the base, temperature, and solvent; and a brief survey of the malonate ester (substrates 
2.6–2.8a). The best catalyst was found to be 2.24, using the conditions shown in Scheme 
2.12. Importantly, when using catalyst 2.25, the pseudo-enantiomer of catalyst 2.24, the 
opposite enantiomer, ent-2.13c was obtained with similar levels of enantioinduction 
(Scheme 2.11). 
                                                 
†
 This optimization was performed by Rodolfo Tello-Aburto. Details can be found in the supplementary 
information for reference 
45
. 
Chapter 2 – Phase-Transfer Catalyzed Cyclization of Cyclohexadienones | 43 
 
Scheme 2.13. Enantioselective cyclization using catalyst 2.25. 
 
There was concern that the background reaction might be a competing process, 
which would lead to the diminished selectivity relative to other asymmetric phase-
transfer reactions. Importantly, under otherwise identical conditions (1 equiv Cs2CO3, 
CH2Cl2, 0 ºC, 4 h), no conversion of 2.8a to 2.13a was observed. Another potential 
problem was that the reaction might be reversible, again leading to lower selectivity. 
When enantioenriched 2.13a (71:29 er) was resubmitted to the asymmetric reaction 
conditions over an extended time (12 h), the product was isolated with an enantiomeric 
ratio of 67:33. In a separate experiment, substrate 2.8a was cyclized in the absence of 
catalyst (1 equiv Cs2CO3) to give racemic 2.13a. Catalyst 2.24 was then added and the 
reaction continued for another 12 h. In this case, racemic product was isolated. While 
these experiments do not conclusively rule out the possibility of a reversible reaction, 
such a process is unlikely to be important with short reaction times (1–3 h). 
Interestingly, increased enantioselectivity was observed with substrates bearing 
more sterically demanding substituents at the γ position of the cyclohexadienone ring 
(compounds 2.8b to 2.8g). We speculated that substituents in the α positions of the 
cyclohexadienone might offer similar steric benefits; in practice, however, substrates 
2.8h and 2.8i were poor candidates for this desymmetrization reaction, affording 2.13h 
and 2.13i in enantiomeric ratios of 69:31 and 65:35, respectively (Figure 2.1). These 
reactions were significantly slower than those performed previously and required 1.5 to 4 
days to reach complete conversion. At this point, it is not clear if the decreased 
enantioselectivity is caused by catalyst decomposition over the prolonged reaction times 
or to poor interaction with the catalyst. 
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Figure 2.1. α-Substituted asymmetric cyclization products. 
Gratifyingly, desymmetrization of the dibrominated compounds 2.8j–m produced 
enantioenriched cyclopropanes 2.23j–m (Figure 2.2) with enantioselectivity that was 
improved relative to their desbromo counterparts, with the exception of 2.23l, which 
exhibited reduced enantioselectivity after extended reaction time that was needed for 
complete conversion. Additionally, the absolute configuration of 2.23k was determined 
by X-ray crystallography.
†
 
 
Figure 2.2. Asymmetric cyclization products from dibrominated substrates. 
We also speculated that we might not be achieving optimal selectivity as a result 
of the capability of the malonate substrates to form two different reactive intermediates 
(i.e., the enolate could form on the carbonyl of either ester). These two intermediates 
might have different interactions with the catalyst and therefore lead to different levels of 
enantioinduction. In an attempt to address this problem, the cyclization of substrates 
containing electron-withdrawing groups other than esters (compounds 2.9 and 2.10) was 
                                                 
†
 X-ray analysis was performed by Diane Quern. 
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performed. By introducing additional electronic differentiation, using amides or sulfones, 
we had hoped to favor the formation of only one reactive intermediate that could proceed 
to the cyclization event. Unfortunately, a decreased level of enantioselectivity was 
observed and products 2.14 and 2.15 (Figure 2.3) were both obtained with a modest 
enantiomeric ratio of 68:32. 
 
Figure 2.3. Asymmetric cyclization products containing varied electron-withdrawing groups. 
To further interrogate this problem, we were also interested in testing 
cyclohexadienone-tethered β-ketoesters, which would also be useful in the syntheses of 
natural products. However, we were unable to obtain these compounds as a result of the 
facile decarboxylation of acetoacetic acid and its derivatives, as well as the propensity of 
the desired substrates to undergo rearomatization via Carroll rearrangement (Scheme 
2.14).
106
 In this process, the substrate 2.26 undergoes a Cope rearrangement to give β-
ketoacid 2.27. This intermediate rapidly decarboxylates to enol 2.28, which provides 
phenol 2.29 upon tautomerization. 
Scheme 2.14. Carroll rearrangement of β-ketoester substrates. 
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2.7 Elaboration of products 
We have already begun to explore the utility of these bicyclic lactones as 
synthetic intermediates (Scheme 2.15). The electron-deficient tricyclic cyclopropanes 
appear to be unknown in the literature and might prove to be valuable synthetic scaffolds 
as well.
107
 For example, heating cyclopropane 2.23s with toluenethiol in toluene 
produced the sulfide 2.30 as a ~2:1 mixture of epimers (Scheme 2.15). Alternatively, the 
cyclopropane ring of 2.23k can be reductively cleaved
108–110
 with SmI2 to form 2.31. 
Notably, the bromoenone moiety was left intact. Enone 2.31 is interesting in that it is 
formally the product of an enantioselective dearomatization/conjugate addition sequence. 
However, the occurrence of such a conjugate addition is at this point hypothetical, as our 
earlier results have shown that cyclization would occur preferentially on the olefin 
bearing the bromine (see Section 2.5.1). 
Scheme 2.15. Elaboration of cyclopropane products. 
 
2.8 Conclusions 
We have shown that intramolecular conjugate additions of cyclohexadienones can 
proceed regioselectively. The selectivity of these cyclizations appears to be governed 
largely by electronic factors, although steric effects cannot be completely ruled out in 
some cases. This result is in contrast to that observed with our previously reported Pd-
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catalyzed cyclizations, which were controlled mainly by steric factors. Together, these 
observations will be important for synthetic planning and might prove to be a useful tool 
for elucidating the mechanisms of future reactions.  
We have also shown that chiral phase-transfer catalysts can be used to 
desymmetrize prochiral cyclohexadienones. The capability of the Cinchona alkaloid 
catalysts to differentiate the two enantiotopic olefins solely on the basis of non-bonding 
interactions is remarkable. 
2.9 Future work 
Further efforts to improve the enantioselectivity of this reaction will require the 
screening of a larger number of phase-transfer catalysts. While additional variants of the 
Cinchona alkaloid-based catalysts would represent the most straightforward extension of 
this work, exploration of other catalyst classes, such as those derived from tartaric acid, 
might prove to be more fruitful. 
As discussed in Section 2.7, we believe that the products provided by this 
methodology have potential use in natural product synthesis. Our preliminary 
investigations into this utility are presented in Chapter 4. 
Chapter 3 – Pd-Catalyzed Cyclization of Alkyne-Tethered Cyclohexadienones | 48 
 
Chapter 3  
Pd-Catalyzed Cyclization of Alkyne-
Tethered Cyclohexadienones† 
3.1 Background 
3.1.1 Alkyne acetoxypalladation 
Alkyne acetoxypalladation (Scheme 3.1) is the addition of an acetoxy ligand to an 
alkyne (3.1) that is coordinated to a Pd complex. This process produces vinyl-Pd 
intermediate 3.2, in which the Pd center is situated in a trans relationship to the acetoxy 
substituent. This intermediate can either undergo protonolysis to provide alkene 3.3, or 
proceed through any of a large number of transformations common to Pd-catalysis (e.g., 
migratory insertion) to provide more complex products (3.4). 
Scheme 3.1. Alkyne acetoxypalladation. 
 
In 1984, Nozaki and coworkers reported the first example of alkyne 
acetoxypalladation, utilizing the strategy in the cyclization of alkynoic acids to 
                                                 
†
 This work was performed in collaboration with Rodolfo Tello-Aburto and a significant portion of these 
results have been published previously.
46
 Relevant sections reproduced by permission of The 
Royal Society of Chemistry (RSC). 
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unsaturated lactones (Scheme 3.2).
111
 They observed excellent regioselectivity: 
homopropargylic acids (3.5) undergo 5-endo-dig cyclization to afford endocyclic alkenes 
(3.6), while substrates with longer tethers (3.7) proceed through a 5-exo-dig reaction to 
provide exocyclic alkenes (3.8). 
Scheme 3.2. Pd(II)-catalyzed acetoxylation and cyclization of alkynoic acids. 
 
An intermolecular version of the reaction was demonstrated by Lu in 1992 
through the use of acetate salts as external nucleophile in converting alkynoic esters 3.9 
to vinyl esters 3.10 (Scheme 3.3A).
112
 This report was followed by Hidai’s use of a 
Pd/Mo sulfide cluster complex (3.11, Scheme 3.3B) to perform similar transformations 
with a variety of carboxylic acid nucleophiles (3.12), providing a series of substituted 
products (3.13).
113
 
Scheme 3.3. (A) Lu and (B) Hidai's examples of intermolecular acetoxylation. 
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3.1.2 Enyne coupling triggered by alkyne acetoxypalladation 
Lu and coworkers continued to investigate the reaction, showing that the vinyl-Pd 
intermediate that is produced can be used for further reactions. Specifically, they reported 
an acetoxypalladation initiated cyclization of alkene-tethered alkynoic esters (3.14) in 
which the vinyl-Pd species undergoes syn-migratory insertion across the tethered alkene 
(Scheme 3.4).
114,115
 The final product (3.15) results from β-acetoxy elimination. 
Interestingly, the authors noted that higher yields were obtained when the acetic acid 
solvent was used as a nucleophile and acetate salts were omitted. A variety of alkyl and 
aryl alkynes were shown to successfully undergo cyclization; however, terminal alkynes 
were not suitable substrates for this transformation. 
Scheme 3.4. Pd-catalyzed cyclization of alkene-tethered alkynoic esters. 
 
It was found that the bipyridine ligand (bipy, 3.16) was vital for both initiation of 
the migratory insertion and suppression of β-hydride elimination. With the goal of 
developing an enantioselective version of the reaction, a ligand screen was performed. 
While a variety of pyridine and oxazoline ligands did promote the reaction, phosphine 
ligands were found to be ineffective, potentially resulting from the formation of a Pd(0) 
species. Additionally, tridentate amine ligands were similarly unsuitable. A screen of 
bidentate amines revealed bisoxazoline 3.19 and pymox 3.20 as the best ligands for 
inducing enantioselectivity in the cyclization of 3.17 to 3.18, producing enantiomeric 
ratios of 96:4 and 91:9, respectively (Scheme 3.5). 
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Scheme 3.5. Asymmetric cyclization of alkene-tethered alkynoic esters. 
 
The presence of the acetate as a leaving group is also crucial to this reaction, as 
the β-acetoxy elimination step is necessary to regenerate the Pd(II) catalyst (without the 
acetate, the alkyl-Pd intermediate is quenched by β-hydride elimination, eventually 
forming Pd(0)). Looking to expand the usefulness of this strategy, the Lu group explored 
substrates that would allow for protonolysis as to regenerate Pd(II) as the final step in the 
catalytic cycle. They found success using unsaturated esters and ketones (3.21) as 
partners in an intermolecular reaction with electron-deficient alkynes 3.22 to give the 
coupled products 3.23 (Scheme 3.6).
116
 
Scheme 3.6. Intermolecular enyne coupling terminated by protonolysis. 
 
When the analogous intramolecular reaction was attempted with enyne 3.34,
117
 
only the alkyne hydroacetoxylation product 3.35 was observed (Scheme 3.7A). This 
outcome was in direct contrast to previous results published by the group,
118,119
 in which 
the use of LiBr as the nucleophile did induce the desired cyclization, providing lactone 
3.36 (Scheme 3.7B). The authors attribute this difference to the electron-donating nature 
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of vinyl acetates versus the electron-withdrawing nature of vinyl halides. They also 
speculated that the electronic influence of the ester moiety in 3.34 contributes to the 
propensity for protonolysis. This hypothesis was supported by the successful, albeit low-
yielding, cyclization of alkynoic amide 3.37 to lactone 3.38 (Scheme 3.7C).  
Scheme 3.7. Attempted intramolecular enyne couplings. 
 
With these results in hand, the authors decided to change the electronic nature of 
the alkyne by removing the carbonyl functionality and using a variety of oxygen, 
nitrogen, and carbon based tethers in its place. These new substrates (3.39) readily 
cyclized under the acetoxypalladation conditions to provide tetrahydrofurans, 
pyrrolidines, and cyclopentanes (3.40, Scheme 3.8). Terminal alkynes were again found 
to be unsuitable substrates. 
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Scheme 3.8. Cyclization of tethered enynes. 
 
They also sought to perform the reaction enantioselectively. Employing the most 
successful ligands from their previous work
114,115
 (see above), they attempted the 
cyclization of the ether-tethered enyne 3.41 to tetrahydrofuran 3.42 (Scheme 3.9). 
Surprisingly, they found that when bisoxazoline ligands were used, the “reaction turned 
to a disordered reaction,” presumably meaning the desired product was not observed. 
However, phenyl-substituted pymox ligand 3.43 did promote the cyclization with an 
enantiomeric ratio of 83:17. The highest selectivity observed (89:11) was obtained with 
isopropyl-substituted ligand 3.44. 
Scheme 3.9. Enantioselective cyclization of tethered enynes. 
 
The presence of enones in the substrate scope (3.39, R
2
 = Me, Ph) piqued our 
interest. We recognized that performing this cyclization on an alkyne-tethered 
2,5-cyclohexadienone would rapidly build molecular complexity. Additionally, the use of 
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symmetrically substituted substrates would offer an opportunity to generate 
enantioenrichment through desymmetrization. 
3.1.3 Cyclization of alkyne-tethered 2,5-cyclohexadienones 
Early efforts by our group
45
 confirmed that 2,5-cyclohexadienones are acceptable 
substrates for enyne coupling, and that the reaction is subject to the same catalyst, ligand, 
and temperature constraints as described by Lu and coworkers. Additionally, 
regioselectivity was determined to be primarily governed by a steric model in which 
cyclization preferentially occurs away from cyclohexadienone substitution. This effect is 
most notable for α-substituted substrates in which 3.45 and 3.47 cyclized to provide 3.46 
and 3.48 as single isomers, respectively (Scheme 3.10A and B). Selectivity is also 
observable with β substitution, albeit at a much lower level (3.49 → 3.50 and 3.51, 
Scheme 3.10C). The greater influence of α substitution was confirmed by the preferential 
cyclization of disubstituted substrate 3.52 to give bicyclic enone 3.53 (Scheme 3.10D) as 
a single regioisomer. 
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Scheme 3.10. Regioselective cyclization of cyclohexadienone-tethered alkynes. 
 
A plausible mechanism for this transformation similar to that previously proposed 
by Lu (see above) is shown in Scheme 3.11. The Pd catalyst initially coordinates to the 
alkyne in 3.54, forming complex 3.55. This complex undergoes acetoxypalladation to 
provide vinyl-Pd intermediate 3.56. Migratory insertion occurs across the less hindered 
enone, affording Pd-enolate 3.57. Finally, protonolysis provides the product 3.58 and 
regenerates the Pd(II) catalyst. 
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Scheme 3.11. Mechanism for the Pd-catalyzed cyclization of alkyne-tethered cyclohexadienones. 
 
3.1.4 NF-κB inhibition 
The products provided by this cyclization reaction are structurally similar to the 
natural product cryptocaryone
120,121
 (3.59, Figure 3.1). Cyptocaryone displays a 
promising level of activity as an inhibitor of NF-κB signaling,122 a process that is 
essential in cellular immune response.
123–125
 NF-κB inhibitors have potential as 
anticancer agents,
126
 as excessive NF-κB activation has been implicated in a variety of 
human cancers.
127–131
 
 
Figure 3.1. Structural similarity between cryptocaryone and Pd-catalyzed cyclization products. 
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The similarity between the Pd-catalyzed cyclization products and cryptocaryone 
prompted our group to collaborate with Prof. Daniel Harki in the University of Minnesota 
Department of Medicinal Chemistry to investigate the cyclization products’ potential as 
NF-κB inhibitors.132 A series of bicyclic enones were screened using an NF-κB luciferase 
reporter assay (Figure 3.2). Unfortunately, many of the compounds did not exhibit 
inhibitory activity; however, at 50 µM concentration, compounds 3.60 and 3.61 did 
display 38% and 64% NF-κB inhibition, respectively. Interestingly, enantioenriched 3.61 
(81:19 er, obtained in preliminary phases of the work described below) exhibited 82% 
inhibition, representing a twofold increase in potency over the racemic sample. 
 
Figure 3.2. NF-κB inhibition levels of Pd-catalyzed cyclization products. 
3.2 Objective 
Encouraged by the successful application of the enyne coupling to 
cyclohexadienone systems, and also by the observed potential for the products to act as 
NF-κB inhibitors, we decided to pursue an enantioselective version of the reaction 
(Scheme 3.12). Many of the substrates used in our group’s previous work were derived 
from unsymmetrically substituted phenols and were therefore already chiral (and in this 
case, racemic). For our desymmetrization studies, we required a new series of substrates 
(3.62) derived from symmetrically substituted phenols. These achiral substrates would 
then be cyclized in the presence of a series of chiral ligands in order to identify optimal 
conditions for the enantioselective synthesis of bicyclic enones (3.63). 
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Scheme 3.12. Desymmetrization of cyclohexadienones via Pd-catalyzed cyclization. 
 
3.3 Substrate synthesis 
Three classes of substrates were synthesized based on the composition of the 
tether between the alkyne and the cyclohexadienone (oxygen, nitrogen, or carbon). Each 
of these classes presented unique challenges and required a specialized approach. 
3.3.1 Oxygen-tethered substrates 
Oxygen-tethered substrates were prepared through hypervalent iodine-mediated 
dearomatization using propargylic alcohols as nucleophiles (Scheme 3.13A). This 
procedure allowed the variation of substitution around the cyclohexadienone core in 3.62 
through the choice of phenol 3.64, and substitution on the alkyne tether through the 
choice of nucleophile 3.65. Unfortunately, this route imposes a significant constraint in 
that the nucleophile must be present in solvent quantities. As a result, the options were 
limited to 2-butyn-1-ol and propargyl alcohol itself, as more complex alkynes were either 
solid at room temperature or prohibitively expensive for use as a solvent. Attachment of 
the tether was also attempted by alkylation of quinol 2.8a
13
 with propargylic iodide 3.66; 
however, these efforts were unsuccessful (Scheme 3.13B). 
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Scheme 3.13. Synthesis of oxygen-tethered substrates. 
 
Varied substitution around the cyclohexadienone core was straightforward given 
the large variety of commercially available phenols. Focusing on variation of the required 
R
1
 substituent, cyclohexadienones were successfully obtained from both alkyl- and 
arylphenols. 4-Acyl and 4-halophenols, however, were not amenable to dearomatization; 
we attribute this result to instability of the positive charge necessarily developing in the 
aromatic ring. 
For the alkyne tether, further derivatization of terminal alkyne 3.62a would in 
theory provide access to a large variety of substrates. This strategy was applied with 
mixed results. Attempted alkylation to substrate 3.62b resulted only in decomposition of 
the starting material (Scheme 3.14A), which was unsurprising given the general 
incompatibility of cyclohexadienones with the bases required, such as LDA and NaH.
1
 
However, Sonogashira coupling with aryl halides to access 3.62g,h was successful 
(Scheme 3.14B), providing one method of diversification of the alkyne substituent. 
Additionally, alkynoate substrate 3.67 was obtained through DCC coupling of 2-octynoic 
acid and quinol 2.8a (Scheme 3.14C).
†
 
                                                 
†
 See Section 2.3 for a discussion of coupling techniques. 
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Scheme 3.14. Variation of the alkyne substituent in oxygen-tethered substrates. 
 
3.3.2 Nitrogen-tethered substrates 
Nitrogen-tethered substrates were synthesized starting from N-tosyl-4-anisidine 
(3.68) via the corresponding quinone imine ketal 3.69 (Scheme 3.15).
133–136
 Grignard 
addition into the imine
137–141
 provided tertiary sulfonamides (3.70) with variation of the 
quaternary carbon substituent. Pleasingly, sulfonamide in 3.70 readily alkylated when 
treated with propargylic iodide 3.66, providing the desired alkyne tethered substrates 
3.62i and 3.62j. 
Scheme 3.15. Synthesis of nitrogen-tethered substrates. 
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3.3.3 Carbon-tethered substrates 
Carbon-tethered substrates were prepared by one of two methods, depending on 
the identity of the γ substituent on the cyclohexadienone. The first method allowed access 
to quinol methyl ethers (Scheme 3.16). Propargyl zinc addition into benzaldehyde 3.70 
provided alcohol 3.71, which was deoxygenated with triethylsilane to give alkyne 3.72. 
Alkylation of the alkyne and removal of the TBS protecting group furnished phenols 
3.73, with variation at alkyne substituent. Finally, the phenols were subjected to 
dearomatization conditions in methanol to afford the desired substrates 3.62k–m. 
Scheme 3.16. Synthesis of carbon-tethered substrates: quinol methyl ethers. 
 
Substrates containing a quaternary carbon at the γ position required a different 
strategy, as examples of carbon-based external nucleophiles in dearomatization reactions 
have been limited to allyltrimethylsilane.
142
 Alkylation of known enone 3.74
143
 with 
propargylic iodide 3.75
144
 provided alkyne 3.76. Removal of the TMS protecting group 
and isomerization with t-BuOK afforded the internal alkyne 3.77. The vinylogous ester 
was then reduced and converted to enone 3.78 under acidic conditions. Finally, oxidation 
with DDQ afforded the cyclohexadienone substrate 3.62n. Because of the length of this 
procedure and the lack of opportunities for late-stage diversification, variations of 3.62n 
were not prepared for the initial studies. 
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Scheme 3.17. Synthesis of carbon-tethered substrates: quaternary carbon centers. 
 
3.4 Enantioselectivity studies 
3.4.1 Ligand Screening 
In order to pursue the goal of performing the cyclization enantioselectively, a 
series of nitrogen-based ligands in the cyclization of 3.62b to 3.63b (Table 3.1) were 
tested. Initially, three ligands previously utilized by Lu
114,115,117
 (see Section 3.1.2) were 
screened: pymox 3.79,
145,146
 pybox 3.80,
147
 and bisoxazoline 3.81.
148
 Although the use of 
3.79 provided cyclized product 3.63b in 59% yield and an enantiomeric ratio of 54:46 
(entry 1), 3.80 and 3.81 failed to promote the reaction (entries 2 and 3). Gratifyingly, 
when the pinene-derived bipyridine ligand (−)-iso-PINDY149,150 (3.82) was employed, 
3.63b was produced in an improved yield (67%) and improved enantioselectivity 
(79:21 er) (entry 4). 
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Table 3.1. Initial ligand screening for Pd-catalyzed cyclizations. 
 
Entry Ligand Yield (%) er 
1 3.79 59 54:46 
2 3.80 – – 
3 3.81 trace
a
 – 
4 3.82 67 79:21 
5 3.83 – – 
6 3.84 85 57:43 
7 3.85 61 64:36 
a
 Determined by 
1
H NMR analysis of the crude reaction mixture. 
Bipyridine ligands exhibiting C1 symmetry were also screened; however, the 
results were discouraging: 3.84
151
 and camphor-derived 3.85
152,153
 induced enantiomeric 
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ratios of 57:43 and 64:36, respectively (entries 6 and 7), whereas the sterically 
demanding bipyridine ligand 3.83
154
 failed to promote cyclization (entry 5). Considering 
these results, ligand 3.82 was utilized in the exploration of substrate influence on 
enantioselectivity. 
3.4.2 Oxygen-tethered substrates 
Encouraged by the selectivity afforded with substrate 3.62b, we sought to 
investigate the effect of substrate substitution on enantiocontrol. We began by altering the 
R
1
 substituent (Table 3.2). Substrates 3.62c–f (entries 2–5) behaved similarly to the 
parent substrate (3.62b, entry 1), exhibiting fair yields and moderate enantioselectivity. 
This outcome indicates that the reaction is not sensitive to changes in R
1
 substitution. 
Table 3.2. Pd-catalyzed cyclization of oxygen-tethered substrates. 
 
Entry Alkyne R
1
 R
2
 Yield (%) er 
1 3.62b Me Me 67 79:21 
2 3.62c Ph Me 72 81:19 
3 3.62d Et Me 70 75:25 
4 3.62e i-Pr Me 29 75:25 
5 3.62f CH2CO2Me Me 59 76:24 
6 3.62g Me Ph 89 52:48 
7 3.62h Me 2-Py – – 
 
We then turned our attention to the alkyne substituent (R
2
). When phenyl-
substituted substrate 3.62g was subjected to the cyclization conditions, essentially no 
enantioselectivity was observed (entry 6). Additionally, pyridyl-substituted substrate 
3.62h completely failed to undergo cyclization, which can potentially be attributed to 
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incompatibility of the catalyst with the basic nitrogen atom. Although we expected the 
alkyne substituent to have some influence on stereoselectivity, we were quite surprised 
by the magnitude of this effect. We were deterred from further exploration of the 
influence of the alkyne substituent by the significant drop in selectivity and the 
difficulties associated with varying the R
2
 substituent (see Section 3.3.1). Furthermore, 
the use of an alkynoate tether was unsuccessful (Scheme 3.18): consistent with earlier 
observations by Lu
117
 (see Section 3.1.2), only the alkyne acetoxylation product 3.86 was 
obtained from substrate 3.67. 
Scheme 3.18. Attempted Pd-catalyzed cyclization of alkynoate-tethered substrate 3.67. 
 
We also attempted to probe the effect of enone substituents on the reaction. 
However, when mesitol-derived cyclohexadienone 3.87 was subjected to the reaction 
conditions, only acetoxylation of the alkyne (providing alkene 3.88) was observed 
(Scheme 3.19). The reluctance of the vinyl-Pd intermediate to cyclize onto either 
substituted enone fits well with our previous observations of regioselectivity in this 
reaction (see Section 3.1.3). 
Scheme 3.19. Attempted Pd-catalyzed cyclization of mesitol-derived substrate 3.88. 
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3.4.3 Nitrogen-tethered substrates 
Switching the ether linkage to a sulfonamide had a pronounced influence on the 
efficiency of these transformations. The cyclizations of substrates 3.62i–j to bicyclic 
enones 3.63i–j were first attempted using the achiral bipy as the ligand (Table 3.3, entries 
1 and 5). In both cases, the reaction proceeded smoothly to give the bicyclic product in 
moderate to good yield. However, in the presence of ligand 3.82, the cyclizations were 
very sluggish, requiring extended reaction times to reach even modest levels of 
conversion (entries 2 and 6). Even after these efforts, the enantioselectivity was quite low 
(entry 6). Speculating that the increased bulk of the sulfonamide was responsible for this 
lack of reactivity, we examined the use of modified ligands with decreased steric 
demands (3.79, 3.84, and 3.85). While these ligands did improve the overall reactivity, 
the enantioselectivity remained poor (entries 3–4, 7–9). 
Table 3.3. Pd-catalyzed cyclization of nitrogen-tethered substrates. 
 
Entry Alkyne R
1
 Ligand Yield (%) er 
1 3.62i Me bipy 49 – 
2 3.62i Me 3.82 <15
a
 – 
3 3.62i Me 3.84 39 40:60 
4 3.62i Me 3.85 52 39:61 
5 3.62j Ph bipy 78 – 
6 3.62j Ph 3.82 26
b
 62:38 
7 3.62j Ph 3.79 66 35:65 
8 3.62j Ph 3.84 85 47:53 
9 3.62j Ph 3.85 45 58:42 
a
 Determined by 
1
H NMR analysis of the crude reaction mixture. 
b
 After 6 days. 
Chapter 3 – Pd-Catalyzed Cyclization of Alkyne-Tethered Cyclohexadienones | 67 
 
 
3.5 Regioselectivity studies 
In order to continue exploring these ligand effects, the use of an all-carbon tether 
was investigated. The first such compound to be evaluated was quinol methyl ether 3.62k 
(Scheme 3.20A). Cyclization of this substrate using bipy as the ligand resulted in a 2.3:1 
mixture of the expected 5,6-fused bicyclic product 3.63k and new product, determined to 
be the regioisomeric 6,6-fused bicyclic 3.89k after extensive NMR analysis. The 
cyclization of compound 3.62n (Scheme 3.20B) also produced a mixture of regioisomers, 
with the 6,6-fused bicyclic product 3.89n present in an even greater proportion than that 
observed with substrate 3.62k. Unfortunately, in both cases the regioisomeric products 
were inseparable, complicating characterization and precluding our ability to separate the 
individual enantiomers. This separation is also necessary for conducting 
enantioselectivity studies on these substrates. As a result, these cyclizations were not 
attempted in the presence of a chiral ligand. 
Scheme 3.20. Pd-catalyzed cyclization of carbon-tethered substrates. 
 
The presence of the regioisomeric products 3.63 and 3.89 in these reactions was 
surprising given the high level of selectivity observed in the cyclizations of oxygen- and 
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nitrogen-tethered substrates to the 5,6-fused bicyclic products. Indeed, examination of the 
crude reaction mixture of the cyclization of oxygen-tethered substrate 3.62b in closer 
detail revealed that the 6,6-fused bicycle 3.89b was present in only minor amounts (7.6:1 
ratio of 3.63b and 3.89b) (Scheme 3.21). 
Scheme 3.21. Regioselectivity in the cyclization of oxygen-tethered substrate 3.62b. 
 
Considering these results, it is clear that the presence of an electronegative atom 
(O or N) in or near the alkyne tether has a profound influence on the amount of 6,6-fused 
bicyclic product formed. This effect can be explained in terms of inductive polarization 
of the alkyne as illustrated in Figure 3.3. The initial binding of the alkyne and Pd(II) 
catalyst will make the alkyne more electrophilic and allow the nucleophile (in this case 
acetic acid) to attack through either path A or path B. This binding will result in the 
formation of one of two possible vinyl-Pd intermediates (A or B) that then continue on to 
perform migratory insertion. We expect that the presence of an electronegative atom 
polarizes the alkyne in such a way that the distal carbon atom is more electrophilic than 
the proximal carbon. The magnitude of this effect would depend on the distance between 
the electronegative atom and the alkyne. If this atom is close, a greater amount of B will 
be formed, leading to the preferential formation of the 5,6-fused bicyclic product. 
However, if the electronegative atom is positioned farther away, the alkyne polarization 
becomes less significant and the preference for forming either A or B is reduced. 
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Figure 3.3. Regioselectivity influenced by inductive effects in the acetoxypalladation of alkynes. 
This inductive effect appears to be a relatively unexplored phenomenon in the 
area of Pd-catalyzed acetoxylation reactions. There have been numerous reports on the 
use of unsymmetrically substituted alkynes; however, the substrate scope has largely 
been limited to alkynoates, alkynamides, and haloakynes.
114–116,155–162
 These compounds 
are biased by electronic resonance to favor the formation of one regioisomer. We are 
aware of only three examples by Lu
117,163,164
 where the regioselectivity could be 
attributed to the inductive effect of a nearby electron-withdrawing group. 
In order to test this hypothesis, we attempted the cyclization of propargylic ether 
3.62l and propargylic acetate 3.62m, expecting to observe an increase in the relative 
production of the 6,6-bicyclic products. The cyclization of 3.62l proceeded to give a 
complex, inseparable mixture of 3.63l, 3.89l, and the unexpected uncyclized alkene 3.90, 
with a ratio of 1:2.1 of 3.63l and 3.89l (Scheme 3.22A). The cyclization of 3.62m 
proceeded much more cleanly, providing 3.63m and 3.89m in a 1:4.9 ratio and good 
yield (Scheme 3.22B). These are the first examples in which the 6,6-fused bicycle is 
formed as the major product. Although these results are consistent with the presence of 
the proposed inductive effect, it is plausible that the propargylic acetate in 3.62m 
participates in directing the course of the acetoxypalladation event.
165–172
 Coordination of 
the Pd center to both the acetate and the alkyne (3.91) would lead preferentially to vinyl-
Pd intermediate 3.92 after acetoxypalladation. Finally, Pd enolate 3.93 would undergo 
protonolysis to provide the 6,6-fused bicycle 3.89m. 
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Scheme 3.22. Pd-catalyzed cyclization of oxygen-tethered substrates with propargylic ether substituents. 
 
We also sought to determine the influence of the ligand on the regioselective 
outcome of the reaction by performing the cyclization of 3.62b with ligand 3.82 (Scheme 
3.23). Products 3.62b and 3.89b were obtained in a 1:1 ratio, compared to the 2.3:1 
observed when bipy was used as the ligand. 
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Scheme 3.23. Pd-catalyzed cyclization of substrate 3.62k with chiral ligand 3.82. 
 
To further investigate this effect, the crude 
1
H NMR spectra from our initial 
ligand screening were examined (see Section 3.4.1). The chiral ligands consistently 
induced a slight increase in the formation of 3.89b (Table 3.4). 
Table 3.4. Effect of ligand choice on regioselectivity. 
 
Entry Ligand 3.63b : 3.89b 
1 bipy 7.6 : 1 
2 3.79 6.6 : 1 
3 3.82 6.6 : 1 
4 3.84 6.9 : 1 
5 3.85 6.5 : 1 
 
These results cannot be explained by the model proposed above and we believe 
that, in this case, the steric bulk of the chiral ligands is likely playing a dominant role. As 
described above in Figure 3.3, vinyl-Pd intermediate B is required to form the 5,6-fused 
bicyclic product. In this configuration, the Pd and its associated ligands are closer to the 
fully substituted carbon of the cyclohexadienone and, therefore, in a more sterically 
crowded environment. As the size of the ligand increases, the steric crowding increases 
as well, disfavoring path B and favoring formation of vinyl-Pd intermediate A, directly 
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competing with the inductive effect discussed above. As all of the chiral ligands are 
larger than the achiral bipy, the observed decrease in selectivity for the 5,6-fused bicyclic 
systems is consistent with this model. 
This steric rationalization can also be used to explain the lower reaction efficiency 
observed with larger ligands. For example, ligand 3.83 failed to promote the cyclization 
of 3.62b (see Section 3.4.1). This ligand has more localized steric demand that interferes 
with alkyne-Pd binding, thus disfavoring initial coordination. Similarly, the cyclization of 
nitrogen-tethered alkynes 3.62i and 3.62j exhibited a drastic rate reduction with the used 
of chiral ligands. The presence of the large sulfonamide moiety in these substrates would 
compromise the efficiency with which the alkyne binds to a Pd center that is coordinated 
with a large ligand (e.g., 3.83), thus requiring ligands with smaller steric demand (e.g., 
bipy, 3.84 or 3.85) in order to proceed with high levels of efficiency. 
3.6 Conclusions 
We have found that the stereoselective Pd-catalyzed cyclization of alkyne-
tethered cyclohexadienones is remarkably sensitive to the steric environment of both the 
ligand and the substrate. We have identified a bipyridine-based ligand [(−)-iso-PINDY, 
3.82] capable of inducing selectivity in select substrates, providing a new opportunity for 
the desymmetrization of cyclohexadienones. Taken as a whole, this work implies that 
chiral ligands with smaller steric demands are needed in order to realize a 
desymmetrization reaction that proceeds with high conversion and selectivity. 
Additionally, we have shown that the regioselectivity of this reaction is greatly 
influenced by the presence of electronegative atoms proximal to the alkyne. This effect 
allows for the formation of both 5,6- and 6,6-fused bicyclic products, both of which are 
common motifs in natural product synthesis. 
3.7 Future work 
Further studies will be required in order to identify a ligand capable of providing 
consistently high levels of enantioselectivity. Although there are certainly a large number 
of bidentate pyridine- and oxazoline-based ligands available, they often require lengthy 
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syntheses, making a large-scale screening a very time-consuming process. We are aware 
of promising preliminary results
51
 (Scheme 3.24) obtained by Sasai in an extension of 
this reaction utilizing the SPRIX ligands (e.g., 3.96) developed by their group.
173
 In this 
case, alkyne-tethered substrates 3.94 underwent a tandem cyclization/oxidation process to 
afford products 3.95 in an enantiomeric ratio of up to 91:9.  
Scheme 3.24. Sasai's enantioselective cyclative diacetoxylation. 
 
Additionally, Tian and Lin recently published a Cu-catalyzed cyclization that 
provides very similar bicyclic enone products with up to 99:1 enantioselectivity.
50
 
Cyclization of the alkyne substrates 3.97 proceeds through cis-borylation to give 
intermediate alkenyl cuprate 3.98 (Scheme 3.25). This intermediate then undergoes 
conjugate addition into the cyclohexadienone to generate bicyclic products 3.99. 
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Scheme 3.25. Tian and Lin's Cu-catalyzed boralative cyclization. 
 
Notably, NaBO3 oxidation of 3.101 provides ketone 3.102 (Scheme 3.26A), 
which is identical to the hypothetical hydrolysis product of our byclic enone 3.63b 
(Scheme 3.26B). 
Scheme 3.26. Elaboration of bicyclic enone products. 
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We are also interested in submitting additional compounds for testing as NF-κB 
inhibitors (see Section 3.1.4). Specifically, our initial screening only included substrates 
from the oxygen-tethered series – testing of the nitrogen- and carbon-tethered substrates 
could provide new insights into the structure-activity relationships and mechanism of 
action of the class of molecules. Prior to undertaking this work, efforts would be required 
to access a larger variety of nitrogen-tethered products (e.g., different protecting groups 
on the nitrogen atom) and to successfully separate (or selectively form) the 5,6- and 6,6-
fused bicyclic products from the carbon-tethered substrates. 
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Chapter 4  
Applications in Natural Product Synthesis: 
the Briaranes 
4.1 Background 
The briaranes are a large family of natural products characterized by a unique 
bicyclo[8.4.0]tetradecane ring system (4.1, Figure 4.1). Many members of the family 
contain a γ-lactone fused at C7 and C8, and also at least four contiguous stereocenters 
(C1, C2, C10, and C14). Much of the variety observed in these products arises from 
various levels of oxidation throughout the briarane core. Over 500 different briaranes 
have been isolated from various marine organisms around the world.
174–183
 Individual 
family members exhibit a wide range of biological activity,
184,185
 including anti-
inflammatory, antifouling, antiviral, cytotoxic, and immunomodulatory activity. We are 
particularly interested in two specific briaranes: brianthein W (4.2) and briareolate ester L 
(4.3). 
 
Figure 4.1. The briarane family of natural products. 
Brianthein W (4.2) was isolated in 1984 from the soft coral Briareum 
polyanthes.
186
 Although this compound has been shown to have significant activity 
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against the P-388 leukemia cell line (ED50 of 0.76 μg/mL),
187
 our interest lies primarily in 
the relatively simple structure of the molecule. We intend to use this as an initial target 
and proof of concept for our synthetic studies towards the briarane family. 
Briareolate ester L (4.3) was isolated in 2011 from the gorgonian Briareum 
asbestinum.
188
 This briarane contains a characteristic (E,Z)-diene in the 10-membered 
ring. Additionally, it contains a C19 methyl ester instead of the γ-lactone, a feature 
common to the briareolate esters. Briareolate ester L exhibits activity against the BXPC-3 
pancreatic cell line (EC50 of 9.3 μM), making it a potential lead compound for drug 
development. It was found that the (E,Z)-dienone is capable of acting as an extended 
Michael acceptor, and that the configuration of the double bonds is critical for the 
observed biological activity.
180
 
To our knowledge, no total synthesis of any member of the briarane family has 
been reported; however, various approaches to the briarane ring system have been 
described. These reports are discussed below. 
4.1.1 Procter’s synthesis of the solenolide skeleton 
In 1995, Procter and coworkers reported the construction of the 6,10-fused 
bicyclic structure 4.4 (Scheme 4.1) in their pursuit of solenolide F (4.9).
189,190
 They 
intended to form the 10-membered ring via the intramolecular Nozaki–Hiyama–Kishi 
(NHK) coupling
191,192
 of intermediate 4.5, which would be obtained from the three-
component reaction of enone 4.6, alkyl Grignard reagent 4.7, and Michael acceptor 4.8. 
Chapter 4 – Applications in Natural Product Synthesis: the Briaranes | 78 
 
Scheme 4.1. Procter's retrosynthetic analysis of the solenolide core. 
 
Conjugate addition of Grignard reagent 4.7 into cyclohexenone 4.6 proceeded 
efficiently (Scheme 4.2); however, addition of the resulting enolate into Michael acceptor 
4.8 did not occur under the reaction conditions. The authors found it necessary to trap the 
enolate as the silyl enol ether 4.10, which did successfully add into 4.8 after treatment 
with MeLi. Finally, elimination of the sulfoxide provided substituted cyclohexanone 4.11 
as a 1:1 mixture of diastereomers. Reduction and protecting group manipulation afforded 
diastereomers 4.12 and 4.13, which were separable by column chromatography. 
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Scheme 4.2. Procter's synthesis of the solenolide core. 
 
The authors noted that the natural diastereomer 4.13 contained the alkyl 
sidechains in a trans-axial configuration and postulated that this would cause 
considerable difficulty in the required ring-closing step. Therefore, the unnatural 
diastereomer 4.12 was used for the remainder of the study. Protection of the secondary 
alcohol in 4.12 as a methyl ether followed by Takai olefination
193
 of the ketone provided 
vinyl iodide 4.14. Removal of the TBS protecting group and oxidation of the primary 
alcohol afforded aldehyde 4.5, the required substrate for the NHK coupling reaction. 
Subjecting 4.5 to the cyclization conditions provided the solenolide skeleton 4.4 as a 1:1 
mixture of diastereomers. 
Chapter 4 – Applications in Natural Product Synthesis: the Briaranes | 80 
 
4.1.2 Nantz’s approach to the solenolide F 
In 1997, Nantz and coworkers reported the synthesis of two chiral, quaternary 
carbon-containing fragments essential to their proposed synthesis of solenolide F (4.9, 
Scheme 4.3).
194
 In their proposal, 4.9 would be formed from the elaboration of 
intermediate 4.15. They envisioned that the 10-membered ring in 4.15 could be obtained 
from the intramolecular McMurry coupling
195
 of dialdehyde 4.16, which in turn could be 
provided by the stepwise alkylation of 4.17 and 4.18
†
 using a common nucleophile. 
Fragments 4.17 and 4.18 would be obtained by the regioselective methylation of epoxides 
4.19 and 4.20, respectively, which could both arise from common alkene precursor 4.21. 
Scheme 4.3. Nantz's retrosynthetic analysis of solenolide F. 
 
The authors targeted fragments 4.17 and 4.18 for their initial studies. The 
synthesis of common intermediate 4.21 began with ketone 4.22 (Scheme 4.4). 
Acetylation of both alcohols followed by Horner–Wadsworth–Emmons olefination196,197 
                                                 
†
 The stereochemical configuration of 4.18 is shown as presented in the original article. The configuration 
of 4.18 does not match that of retrosynthetic intermediate 4.16 or solenolide F (4.9). 
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providing unsaturated ester 4.23. Treatment with TsOH released the free diol, which 
spontaneously cyclized to afford lactone 4.24. The remaining alcohol was benzylated to 
give 4.25, which provided the desired intermediate 4.21 after reduction. This was then 
treated with n-BuLi and dimethylthexylsilyl chloride (DTSCl) to afford 4.26 and 4.27 as 
a 1:1 mixture, which were separated and used in the syntheses of 4.17 and 4.18, 
respectively. 
Scheme 4.4. Synthesis of Nantz's common intermediate 4.21. 
 
Sharpless epoxidation
198
 of compound 4.26 provided epoxide 4.28, bearing the 
appropriate configuration for desired fragment 4.17 (Scheme 4.5A). Oxidation of the 
primary alcohol, Wittig olefination
199
 and removal of the DTS protecting group afforded 
intermediate 4.29. After an extensive investigation using model substrates, compound 
4.29 was treated with trimethylaluminum to effect regioselective ring opening at the more 
hindered carbon atom. This resulted in a 10:3:2 mixture of desired alcohol 4.30, 
regioisomer 4.31, and alkyl migration product 4.32. This crude mixture was treated with 
methanesulfonyl chloride and KOH to provide solenolide fragment 4.17 in 25% yield 
from 4.29. 
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Scheme 4.5. Nantz's synthesis of solenolide fragments 4.17 and 4.18. 
 
The synthesis of fragment 4.18 began with allylic alcohol 4.27 (Scheme 4.5B). 
Sharpless epoxidation provided epoxide 4.33. In this case, the epoxide opening was 
performed with lithium dimethylcuprate and followed by acetonide formation to afford 
compound 4.34. Debenzylation and oxidation of the primary alcohol provided the desired 
solenolide fragment 4.18. 
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4.1.3 Iguchi’s approach to pachyclavulide B 
In 2006, Iguchi and coworkers reported the construction of the briarane core as 
part of their studies towards the total synthesis of pachyclavulide B (4.35, Scheme 4.6).
200
 
For this study, the authors targeted the synthesis of key intermediate 4.36. This diol could 
be obtained from epoxide 4.37, which is the desymmetrization product of cyclohexadiene 
4.38. 
Scheme 4.6. Iguchi's retrosynthetic analysis of pachyclavulide B. 
 
Cyclohexadiene 4.38 was obtained from the Birch reduction
201–205
 and 
methylation of benzoic acid 4.39 (Scheme 4.7). Epoxidation with Oxone in the presence 
of fructose-derived catalyst 4.40 provided compound 4.37. Reduction of the methyl ether 
and protection of the resulting alcohol afforded 4.41. Treatment with Et2AlTMP induced 
elimination and opening of the epoxide and the resulting alcohol was converted to acetal 
4.42. Radical cyclization followed by oxidation provided lactone 4.43, and subsequent 
oxygenation afforded product 4.44. The lactone was reduced to the diol, which 
underwent oxidative cleavage to give aldehyde 4.45. Finally, nucleophilic addition of 
vinylmagnesium chloride provided the briarane core 4.36 in 15 overall steps. 
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Scheme 4.7. Iguchi's synthesis of the briarane core. 
 
4.1.4 Bates’ approach to the briarane core 
In 2010, Bates and coworkers reported their own synthesis of the briarane core, 
highlighted by a diastereoselective Diels–Alder reaction (Scheme 4.8).206 Starting from 
crotyl chloride (4.46), displacement of the chloride with 4-toluenesulfinate followed by 
treatment with n-BuLi and paraformaldehyde provided alcohol 4.47. 
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Scheme 4.8. Bates' synthesis of the briarane core. 
 
Mesylation and elimination afforded dieone 4.48, which participated in the Diels–
Alder reaction with methyl acrylate (4.49), providing cyclohexene 4.50. Reduction of the 
methyl ester, isomerization of the alkene, and protection of the primary alcohol afforded 
product 4.51. Desulfonation was accomplished via treatment with MoOPD 
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(MoO5•pyridine•DMPU)
207
 to give enone 4.52. The ketone was reduced with NaBH4 to 
provide 4.53. To install the required quaternary stereocenter, various conditions for [3,3]-
sigmatropic rearrangments were investigated. Eventually, Eschenmoser–Claisen 
conditions
208
 provided cyclohexene 4.54 with high diastereoselectivity. Iodolactonization 
and hydrolysis afforded product 4.55, and subsequent elimination provided the 
cyclohexene 4.56. A two-step oxidation afforded β-ketolactone 4.57, which was then 
reduced in a two-step procedure to provide triol 4.58. Conversion of the primary alcohol 
to iodide 4.59 followed by radical coupling with allylstannane 4.60 afforded the briarane 
core 4.61 in 18 overall steps. 
4.1.5 Crimmins’ approach to brianthein A 
In 2014, Crimmins and coworkers reported their use of a dianionic Ireland–
Claisen rearrangement to obtain products containing the four contiguous stereocenters 
found in brianthein A (4.62, Scheme 4.9).
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Scheme 4.9. Crimmins' retrosynthetic analysis of brianthein A. 
 
The authors envisioned that the both rings in 4.62 could be formed by ring-closing 
metathesis, proceeding through intermediates 4.63 and 4.64. Intermediate 4.64 would 
arise from methyl ester 4.65, which is the product of the key Ireland–Claisen 
rearrangement of ester 4.66. 
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The authors began their synthesis with oxazolidinone 4.67 (Scheme 4.10). 
Alkylation with methallyl iodide followed by reductive cleavage of the auxiliary 
provided product 4.68. The primary alcohol was oxidized afford aldehyde 4.69, which 
was used in an aldol reaction with thiazolidinone 4.70 to provide intermediate 4.71 with 
good diastereoselectivity. 
Scheme 4.10. Crimmins' approach to brianthein A. 
 
Esterification with alcohol 4.72 provided the Ireland–Claisen substrate 4.66. 
Treatment of 4.66 with LHMDS induced the desired rearrangement, which provided 
brianthein A intermediate 4.65 upon methylation with diazomethane. The proposed 
rationalization for the observed diastereoselectivity is that chair-like transition state 4.73, 
which would lead to 4.65, is favored over the boat-like transition state 4.74, which would 
lead to the undesired epi-4.65. 
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4.2 Objective 
Although the results discussed above do provide potential access to the briaranes, 
we feel that a more efficient strategy would be very beneficial for pursuing this goal. The 
methods above either access the briarane skeleton with very limited remaining 
functionality, or provide the briarane core in a large number of synthetic steps. The 
shortest route, developed by Crimmins (Section 4.1.5), accesses a key intermediate in 
only 7 steps; however, completion of the 6-membered ring and installation of an 
additional stereocenter are still required to obtain an intermediate similar to those 
provided by previous methodologies. We recognized that the briarane core could be 
achieved through the elaboration of our phase-transfer catalysis methodology products 
(see Chapter 2). We chose to investigate this possibility in the context of the total 
synthesis of brianthein W (4.2). 
We envisioned that the 10-membered ring in brianthein W (4.2, Scheme 4.11) 
would be formed by ring-closing metathesis and that the butenolide could be installed via 
an intramolecular Horner–Wadsworth–Emmons olefination. Given these disconnections, 
we identified cyclohexene 4.75 as a key intermediate, which could be obtained from the 
reductive decarboxylation of lactone 4.76. This intermediate could be obtained through 
the elaboration of bicyclic enone 2.13a, which is the product of the cyclization of 
substrate 2.8a using our phase-transfer catalysis methodology. For our preliminary 
investigations of this synthetic route, we targeted the synthesis of intermediate 4.75, 
which contains all four of the contiguous stereocenters found in brianthein W. 
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Scheme 4.11. Retrosynthetic analysis of brianthein W. 
 
4.3 Elaboration of PTC cyclization products 
4.3.1 Conversion of the malonate ester to a ketone 
One key difference between PTC cyclization product 2.13a and the briarane core 
4.75 is the presence of a malonic ester in the former and a β-ketoester in the latter. The 
most straightforward way to address this issue would be the direct use of a β-ketoester in 
our cyclization reaction; however, the necessary cyclohexadienone substrate is not 
accessible, as discussed in Section 2.6. Therefore, we sought to convert the t-butyl ester 
in 2.13a to the required ketone. Gratifyingly, this transformation was achieved by 
acylation of the malonate to provide triacyl compound 4.77, followed by acidic 
hydrolysis to induce decarboxylation of the t-butyl ester and provide β-ketoester 4.78 in a 
one-pot procedure (Scheme 4.12). 
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Scheme 4.12. Conversion of malonic ester 2.13a to β-ketoester 4.78. 
 
4.3.2 Methylation 
Our initial investigation towards installation of the α methyl group in 4.75 began 
with the attempted direct methylation of PTC cyclization substrate 2.13a (Scheme 4.13). 
Unfortunately, the use of a variety of bases (LDA, LHMDS, KHMDS) with methyl 
iodide did not provide the desired α-methylated product 4.79. The addition of HMPA or 
DMPU also did not prove successful. Additionally, attempts at amine catalyzed 
alkylation only resulted in the formation of rearomatized products. 
Scheme 4.13. Attempted methylation of bicyclic lactone 2.13a. 
 
At this point, it was unclear whether the failure of the reaction was a result of 
problems with enolization of the ketone, or methylation of the resulting enolate. To 
explore this, 2.13a was treated with two equivalents of LHMDS to ostensibly provide 
dianion 4.80 (Scheme 4.14). This was then quenched with D2O in an attempt to provide 
the bis-deuterated product 4.81. Surprisingly, product 4.82 was obtained instead, which 
contained two deuterium atoms positioned α to the cyclohexadienone ketone. This result 
has three implications: (1) the desired enolate is successfully being formed, (2) the ketone 
enolate is more reactive than the malonic ester enolate towards electrophiles, and (3) 
equilibration occurs between the two enolates after reaction with the first electrophile. 
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Based on this result, we postulate that methyl iodide is simply an ineffective electrophile 
under these conditions. 
Scheme 4.14. Enolate quenching with D2O. 
 
We also decided to investigate whether the presence of the second enolate (on the 
malonic ester) was the source of our alkylation problems. To this end, we attempted the 
methylation of substrate 4.83,
210
 in which enolization of the malonic ester is prevented by 
the presence of an additional methyl substituent. Unfortunately, only starting material 
was recovered and the methylated product 4.84 was not observed (Scheme 4.15). 
Scheme 4.15. Attempted methylation of substrate 4.83. 
 
We next investigated the enolate formation via desilylation of silyl enol ethers. To 
this end, TBS enol ether 4.85 was accessed directly from bicyclic lactone 2.13a (Scheme 
4.16A), whereas the analogous TMS ether 4.86 was provided by performing the 
cyclization of 2.8a in the presence of TMSCl (Scheme 4.16B). Unfortunately, in both 
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cases, treatment with an anhydrous fluoride source (tetrabutylammonium 
difluorotriphenylsilicate, TBAT) resulted in no reaction at room temperature and 
rearomatization upon heating (Scheme 4.16C). 
Scheme 4.16. Attempted methylation of silyl enol ethers. 
 
We recognized that they cyclopropane PTC cyclization products (Section 2.5.1) 
presented an alternative strategy for the synthesis of 4.75. Hypothetically, addition of an 
appropriate methyl nucleophile into the cyclopropane in 2.23 would provide the desired 
methylated product. Because of the potential for competitive nucleophilic addition into 
the ketone carbonyl, we chose to investigate the use of an alkyl cyanocuprate, a soft 
nucleophile, as opposed to hard nucleophiles such as alkyllithium or Grignard reagents. 
Unfortunately, treatment of either 2.23r or 2.23j with MeCu(CN)Li did not provide the 
desired products 4.79 or 4.87 (Scheme 4.17). 
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Scheme 4.17. Attempted cyclopropane ring opening with methyl cyanocuprate. 
 
4.3.3 Aldol reactions 
We also investigated aldol reactions of 2.13a, intending to install the sidechain in 
4.75 representing a segment of the 10-membered ring in the briarane framework. 
However, treatment with a strong base and a variety of aldehydes resulted only in the 
recovery of starting material, with no desired product 4.88 observed (Scheme 4.18). 
Boron aldol conditions afforded similar results. 
Scheme 4.18. Attempted aldol reactions of bicyclic lactone 2.13a. 
 
Turning again to cyclopropane product 2.23r, we proposed that ring opening with 
SmI2 (Section 2.7) would provide a Sm enolate that might be suitable for undergoing an 
aldol reaction. Treatment of 2.23r with SmI2 and hexanal did provide the desired aldol 
product 4.88; however, the reaction was low yielding and a large amount of side products 
were present (Scheme 4.19). Although this result was encouraging, the reaction was 
found to be generally unreliable and we were unable to optimize the conditions and 
improve the observed yields. 
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Scheme 4.19. SmI2 induced aldol reaction of 2.23r. 
 
4.4 Elaboration of decarboxylated products 
In an attempt to circumvent the issues observed above, we decided to remove the 
malonic ester from substrate 2.13a, leaving the cyclohexadienone ketone as the primary 
site for deprotonation. To accomplish this, 2.13a was subjected to decarboxylation 
conditions to remove the malonic ester and provide bicyclic lactone 4.90 through the 
intermediate β-ketoacid 4.89.  
Scheme 4.20. Synthesis of decarboxylated substrate 4.90. 
 
4.4.1 Methylation 
Initial attempts at the methylation of substrate 4.90 with strong bases and methyl 
iodide were unsuccessful; however, in this case the use of LDA with HMPA did prove 
beneficial and the methylated product 4.91 was obtained as a single diastereomer 
(Scheme 4.21). Encouraged by this result, optimization of the reaction conditions was 
attempted. Altering the solvent, temperature, order of addition, and reaction time did not 
improve conversion. The use of alternate bases, such as LHMDS and KHMDS, resulted 
in no reaction. Unfortunately, we were unable to identify conditions that provided 
improved results. 
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Scheme 4.21. Methylation of decarboxylated substrate 2.13a. 
 
4.4.2 Aldol reactions 
Although the methylation of 4.90 did not proceed efficiently, we were able to 
obtain enough material to attempt the required aldol reaction of 4.91 under various 
conditions (Scheme 4.22). Upon treatment with strong base and aldehyde, similar results 
were obtained as seen for the malonic ester substrate 2.13a above. In this case, the use of 
HMPA was avoided, as the additive would have prevented formation of the chelated 
transition state required to achieve the necessary diastereoselectivity. 
Scheme 4.22. Attempted aldol reaction of methylated substrate 4.91. 
 
4.5 Elaboration of Pd-catalyzed cyclization products 
Given the low yields of the methylation reaction in combination with the lack of 
reactivity of 4.91 under aldol conditions, we decided to consider other routes to the 
briarane intermediate 4.75. Specifically, we identified a strategy for this intermediate 
from the products of our Pd-catalyzed cyclization methodology. Although the direct 
cyclization of alkynoate substrates had previously proven unsuccessful (Section 3.4.2), 
we realized that oxidation of cyclization product 2.63b would provide bicyclic lactone 
4.90 and subsequent hydrolysis of the vinyl acetate (4.94) would afford the desired 
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β-ketoester 4.78. If successful, this strategy would allow us to attempt the methylation 
directly on substrate 2.63b, which would likely display different reactivity than the ester 
containing substrates 2.13a and 4.90. In practice, however, the oxidation conditions 
provided a complex mixture of unidentifiable products (Scheme 4.23). 
Scheme 4.23. Attempted oxidation of Pd-catalyzed cyclization product 2.63b. 
 
4.6 Conclusions 
We have successfully utilized the products of our PTC cyclization methodology 
in both methylation and aldol reactions towards the synthesis of the briarane core; 
however, the low efficiency and high variability of these reactions has precluded their use 
in further synthetic studies. These results can likely be attributed to the instability of the 
required enolates of substrates 2.13a and 4.90, an observation that is corroborated by 
earlier work on similar systems by Helmchen and coworkers,
211
 as well as investigations 
of a similar acylation reaction in our group’s synthesis of sorbicillactone A.83 
4.7 Future work 
Work has continued in our lab in pursuit of the briarane family of natural 
products.
†
 One specific strategy currently under investigation involves transformation of 
the enone functionality in 2.13a, potentially altering the reactivity of the substrate to be 
more amenable to the desired methylation and aldol reaction. Additionally, we are 
investigating a route starting from 2,4-dimethylphenol (4.95), which has the required 
methyl group already incorporated (Scheme 4.24). Although this route will not take 
advantage of the enantioselective desymmetrization methodologies discussed here, it will 
                                                 
†
 This work is currently being performed by Nicholas Moon. 
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potentially demonstrate the utility of the enantioselective dearomatization catalysts 
currently under development in our group.
32
 
Scheme 4.24. Synthetic strategy using 2,4-dimethylphenol. 
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Appendix I  
Experimental Procedures and Data 
 Materials and Methods 
Unless otherwise stated, reactions were performed in flame- or oven-dried 
glassware under an argon or nitrogen atmosphere using anhydrous solvents. Acetic acid 
was distilled from acetic anhydride with CrO3 or KMnO4. Acetonitrile, CH2Cl2, and 
toluene were dried by passage through an activated alumina column under argon. 
Dimethyl sulfoxide (DMSO) was placed over activated alumina overnight, and then 
distilled from CaH2 and stored over 4Å molecular sieves. Methanol was dried over 3Å 
molecular sieves. 1,4-Dioxane and tetrahydrofuran (THF) were distilled from 
sodium/benzophenone. Powdered 4Å molecular sieves were activated by heating under 
vacuum and stored at 90 ºC until use. Pd(OAc)2 was purchased from Strem Chemicals. 
Unless otherwise stated, reactions were monitored using thin-layer chromatography 
(TLC) using plates precoated with silica gel XHL w/ UV254 (250 μm) and visualized by 
UV light or KMnO4, phosphomolybdic acid, or anisaldehyde stains, followed by heating. 
Silica gel (particle size 32–63 μm) was used for flash column chromatography. 1H and 
13C NMR spectra are reported relative to the residual solvent peak (δ 7.26 and δ 77.2 for 
1
H and 
13
C in CDCl3, δ 7.16 and δ 128.0 for 
1
H and 
13
C in C6D6, respectively), or 
tetramethylsilane (δ 0.00 for 1H) when the residual solvent peak is obscured. Data for 1H 
NMR spectra are reported as follows: chemical shift (ppm) (multiplicity, coupling 
constant (Hz), integration). Multiplicity is described using the following abbreviations: s 
= singlet, d = doublet, t = triplet, q = quartet, hept = heptet, m = multiplet, bs = broad 
singlet. IR samples were prepared on NaCl plates either neat or by evaporation from 
CHCl3 or CH2Cl2. 
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 Experimental Details – Chapter 2 
General method A: dearomatization of phenols using PIDA 
A solution of the corresponding phenol (1 equiv) in 3:1 MeCN/H2O (0.1 M in 
substrate) was cooled to 0 ºC and treated with PIDA (1.1 equiv). The reaction mixture 
was stirred until consumption of the starting material (usually within 1 h), then diluted 
with CH2Cl2, washed with saturated aq. NaHCO3 and brine, dried over Na2SO4, filtered 
and concentrated. 
General method B: coupling of phenols  using trifluoroacetic anhydride 
A procedure by Stork
1
 was adapted. Trifluoroacetic anhydride (2 mL per mmol of 
substrate) was added to a flask containing the mono-alkyl malonate (2.5 equiv). The 
mixture was stirred for 30 min before it was placed it under high vacuum to remove 
formed TFA and excess trifluoroacetic anhydride. The flask was back-filled with nitrogen 
and a solution of the appropriate quinol (1 equiv) in DME (0.05 M in substrate) was 
added. The solution was stirred until consumption of the starting material (usually 
between 1 and 3 h), at which point it was quenched by addition of saturated aq. NaHCO3. 
The mixture was extracted with CH2Cl2 and the organic layer was dried over Na2SO4, 
filtered, and concentrated. 
General method C: coupling of phenols using DCC 
DCC (3 equiv) was added to a solution of the appropriate quinol (1 equiv), the 
corresponding acid (3 equiv), and DMAP (10 mol%) in CH2Cl2 (0.4 M in substrate). The 
mixture was stirred until consumption of the starting material (usually between 1 and 
3 h), then diluted with Et2O, filtered, and concentrated. 
                                                 
1
 Stork, G.; La Clair, J. J.; Spargo, P.; Nargund, R. P.; Totah, N. J. Am. Chem. Soc. 1996, 118, 5304–5305. 
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General method D: cyclization using Cs2CO3 in MeCN 
A solution of the appropriate substrate (1 equiv) in MeCN (0.05 M in substrate) 
was treated with solid Cs2CO3 (2.5 equiv). The reaction mixture was stirred until 
consumption of the starting material (usually within 30 min for sterically unhindered 
substrates), then concentrated and purified directly by flash-column chromatography. 
General method E: asymmetric cyclization using phase-transfer catalysis 
A mixture of the cyclohexadienone substrate (1 equiv), 4Å molecular sieves 
(100% w/w), and catalyst 2.24 (10 mol%) was suspended in α,α,α-trifluorotoluene 
(0.05 M in substrate) and cooled to 0 ºC. Cs2CO3 (1 equiv) was added and the mixture 
was stirred until consumption of the starting material. In cases where no conversion was 
observed after ~4 h, the reaction mixture was allowed to gradually reach rt and stirred 
until consumption of the starting material. The solvent was then removed under reduced 
pressure and the products purified directly by flash-column chromatography. 
Allyl malonate-tethered cyclohexadienone 2.6 
 
Using general method B, mono-allyl malonate (2.18)
2
 was coupled to quinol 2.17a
3
 to 
give 2.6 in 66% yield after flash-column chromatography (3:1 hexanes/EtOAc). 
IR (thin film) 2983, 2941, 1736, 1668, 1631, 1329, 1270, 1150, 1053, 992, 858 cm
-1
 
                                                 
2
 Prepared according to: Navarro, I.; Basset, J.-F.; Hebbe, S.; Major, S. M.; Werner, T.; Howsham, C.; 
Bräckow, J.; Barret, A. G. M. J. Am. Chem. Soc. 2008, 130, 10293–10298. 
3
 Carreño, M. C.; González-López, M.; Urbano, A. Angew. Chem. Int. Ed. 2006, 45, 2737–2741. 
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1
H NMR (300 MHz, CDCl3) δ 6.90 (d, J = 10.2 Hz, 2 H), 6.25 (d, J = 10.2 Hz, 2 H), 
6.00–5.81 (m, 1 H), 5.35 (ddd, J = 17.2, 2.6, 1.2 Hz, 1 H), 5.28 (ddd, J = 10.4, 2.3, 
1.2 Hz, 1 H), 4.65 (d, J = 5.8 Hz, 2 H), 3.40 (s, 3H) 
13
C NMR (75 MHz, CDCl3, DEPT) δ 185.0 (C), 166.0 (C), 165.0 (C), 148.4 (CH × 2), 
131.4 (CH), 128.6 (CH × 2), 119.3 (CH2), 75.5 (C), 66.4 (CH2), 41.8 (CH2); 26.3 (CH3) 
HRMS (ESI+) 273.0733 calcd for C13H14O5Na, found 273.0742 
Benzyl malonate-tethered cyclohexadienone 2.7 
 
Using general method B, mono-benzyl malonate (2.19)
4
 was coupled to quinol 2.17a to 
give 2.7 in 63% yield after flash-column chromatography (3:1 hexanes/EtOAc). 
IR (thin film) 3036, 2983, 2937, 1734, 1666, 1630, 1328, 1266, 1149, 1152, 858 cm
-1
 
1
H NMR (300 MHz, CDCl3) δ 7.36 (s, 5 H), 6.78 (d, J = 10.2 Hz, 2 H), 6.20 (d, J = 
10.2 Hz, 2 H), 5.18 (s, 2 H), 3.41 (s, 2 H), 1.49 (s, 3 H) 
13
C NMR (75 MHz, CDCl3, DEPT) δ 184.9(C), 166.1(C), 164.9(C), 148.4 (CH × 2), 
135.1(C), 128.8 (CH × 4), 128.7 (CH), 128.5 (CH × 2), 75.4(C), 67.5 (CH2), 41.9 (CH2), 
26.2 (CH3) 
HRMS (ESI+) 323.0890 calcd for C17H16O5Na, found 323.0898 
                                                 
4
 Thetiot-Laurent, S. A.-L.; Nadal, B.; Le Gall, T. Synthesis 2010, 1697–1701. 
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Malonate-tethered cyclohexadienone 2.8a 
 
Using general method B, mono-t-butyl malonate (2.20)
5
 was coupled to quinol 2.17a to 
give 2.8a in 43% yield after flash-column chromatography (3:1 hexanes/EtOAc). 
IR (thin film) 2983, 2937, 1755, 1728, 1671, 1629, 1144, 1055, 854 cm
-1
 
1
H NMR (300 MHz, C6D6) δ 6.35 (d, J = 10.2 Hz, 2 H), 6.07 (d, J = 10.2 Hz, 2 H), 2.97 
(s, 2 H), 1.30 (s, 9 H), 1.04 (s, 3 H) 
13
C NMR (75 MHz, C6D6, DEPT) δ 189.6 (C), 165.4 (C), 165.1 (C), 147.8 (CH × 2), 
128.6 (CH × 2), 81.7 (C), 75.0 (C), 43.0 (CH2), 27.9 (CH3 × 3), 25.9 (CH3) 
HRMS (ESI+) 289.1046 calcd for C14H18O5Na, found 289.1059 
Malonate-tethered cyclohexadienone 2.8b 
 
Using general method B, mono-t-butyl malonate was coupled to quinol 2.17b
6
 to give 
2.8b in 36% yield after flash-column chromatography (4:1 hexanes/EtOAc). 
IR (thin film) 1729, 1670, 1625, 1325, 1135, 994, 842 cm
-1
 
1
H NMR (300 MHz, CDCl3) δ 7.47–7.30 (m, 5 H), 6.97 (d, J = 10.1 Hz, 2 H), 6.34 (d, J 
= 10.1 Hz, 2 H), 3.40 (s, 2 H), 1.48 (s, 9 H) 
                                                 
5
 Although this substrate is commercially available, it is also easily obtained by DCC coupling of malonic 
acid with 1 equiv of t-BuOH; see: Shelkov, R.; Nahmany, M.; Melman, A. J. Org. Chem. 2002, 
67, 8975. 
6
 Prepared according to: Felpin, F.-X. Tetrahedron Lett. 2007, 48, 409–412. 
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13
C NMR (75 MHz, CDCl3, DEPT) δ 185.5 (C), 165.3 (C), 165.0 (C), 147.1 (CH × 2), 
136.1 (C), 129.2 (CH × 2), 129.0 (CH), 128.4 (CH × 2), 125.4 (CH × 2), 82.7 (C), 78.2 
(C), 43.4 (CH2), 28.1 (CH3 × 3) 
HRMS (ESI+) 351.1203 calcd for C19H20O5Na, found 351.1199 
Malonate-tethered cyclohexadienone 2.8c 
 
Using general method B, mono-t-butyl malonate (2.20) was coupled to quinol 2.17c to 
give 2.8c in 56% yield after flash-column chromatography (5:1 hexanes/EtOAc). 
IR (thin film) 2976, 2937, 2880, 1751, 1730, 1670, 1629, 1461, 1333, 1272, 1146, 
1005 cm
-1
 
1
H NMR (300 MHz, CDCl3) δ 6.77 (d, J = 10.3 Hz, 2 H), 6.31 (d, J = 10.3 Hz, 2 H), 3.27 
(s, 2 H), 2.11 (hept, J = 6.9 Hz, 1 H), 1.45 (s, 9 H), 0.93 (d, J = 6.9 Hz, 6 H) 
13
C NMR (75 MHz, CDCl3, DEPT) δ 185.3 (C), 165.5 (C), 165.3 (C), 146.8 (CH × 2), 
130.1 (CH × 2), 82.5 (C), 80.4 (C), 43.2 (CH2), 36.5 (CH), 28.0 (CH3 × 3), 16.9 (CH3) 
HRMS (ESI+) 317.1359 calcd for C16H22O5Na, found 317.1417 
Malonate-tethered cyclohexadienone 2.8d 
 
Using general method B, mono-t-butyl malonate (2.20) was coupled to jacaranone
7
 (1d) 
to give 4d in 38% yield after flash-column chromatography (3:1 hexanes/EtOAc). 
IR (thin film) 2980, 1734, 1672, 1633, 1333, 1249, 1154, 1032, 855 cm
-1
 
                                                 
7
 Parker, K. A.; Andrade, J. R. J. Org. Chem. 1979, 44, 3964–3966. 
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1
H NMR (300 MHz, CDCl3) δ 7.07 (d, J = 10.2 Hz, 2 H), 6.29 (d, J = 10.2 Hz, 2 H), 3.67 
(s, 3 H), 3.26 (s, 2 H), 2.82 (s, 2 H), 1.44 (s, 9 H) 
13
C NMR (75 MHz, CDCl3, DEPT) δ 184.7 (C), 168.0 (C), 165.2 (C), 165.1 (C), 146.2 
(CH × 2), 129.4 (CH), 82.7 (C), 74.5 (C), 52.3 (CH3), 43.8 (CH2), 43.0 (CH2), 28.0 (CH3 
× 3) 
HRMS (ESI+) 347.1101 calcd for C16H20O7Na, found 347.1126 
Malonate-tethered cyclohexadienone 2.8e 
 
Using general method C, mono-t-butyl malonate (2.20) was coupled to quinol 2.17e to 
give 2.8e in quantitative yield after flash-column chromatography (5:1 hexanes/EtOAc). 
IR (thin film) 2976, 2935, 2870, 1732, 1671, 1630, 1368, 1331, 1143, 1046, 853 cm
-1
 
1
H NMR (300 MHz, CDCl3) δ 6.99 (d, J = 10.2 Hz, 2 H), 6.22 (d, J = 10.2 Hz, 2 H), 3.24 
(s, 2 H), 1.81 (s, 2 H), 1.44 (s, 9 H), 0.99 (s, 9 H) 
13
C NMR (75 MHz, CDCl3, DEPT) δ 185.4 (C), 165.4 (C), 165.2 (C), 149.0 (CH × 2), 
128.0 (CH × 2), 82.6 (C), 78.5 (C), 53.1 (CH2), 43.3 (CH2), 31.8 (C), 31.5 (CH3 × 3), 
28.0 (CH3 × 3) 
HRMS (ESI+) 345.1672 calcd for C18H26O5Na, found 345.1679 
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Malonate-tethered cyclohexadienone 2.8f 
 
Using general method C, mono-t-butyl malonate (2.20) was coupled to quinol 2.17f
8
 to 
give 2.8f as a white solid in 74% yield after flash-column chromatography (10:1 
hexanes/EtOAc). 
IR (thin film) 2955, 2929, 2857, 1757, 1730, 1674, 1632, 1258, 1148, 1100, 839, 
778 cm
-1
 
1
H NMR (300 MHz, CDCl3) δ 6.93 (d, J = 10.2 Hz, 2 H), 6.24 (d, J = 10.2 Hz, 2 H), 3.72 
(t, J = 6.1 Hz, 2 H), 3.27 (s, 2 H), 2.03 (t, J = 6.1 Hz, 2 H), 1.46 (s, 9 H), 0.85 (s, 9 H), 
0.00 (s, 6 H) 
13
C NMR (75 MHz, CDCl3, DEPT) δ 185.3 (C), 165.4 (C), 165.3 (C), 148.1 (CH × 2), 
128.6 (CH × 2), 82.6 (C), 76.8 (C), 57.8 (CH2), 43.2 (CH2), 42.9 (CH2), 28.1 (CH3 × 3), 
25.9 (CH3 × 3), 18.2 (C), −5.4 (CH3 × 2) 
HRMS (ESI+) 433.2017 calcd for C21H34O6SiNa, found 433.2028 
Malonate-tethered cyclohexadienone 2.8g 
 
Using general method C, mono-t-butyl malonate (2.20) was coupled to quinol 2.17g to 
give 2.8g in 50% yield after flash-column chromatography (3:1 hexanes/Et2O). 
IR (thin film) 2977, 2941, 1759, 1731, 1671, 1629, 1332, 1257, 1143, 1000, 914, cm
-1
 
                                                 
8
 Prepared according to: You, A.; Hoveyda, A. H.; Snapper, M. L. Ang. Chem. Int. Ed. 2009, 48, 547–550. 
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1
H NMR (300 MHz, CDCl3) δ 6.88 (d, J = 10.3 Hz, 2 H), 6.35 (d, J = 10.3 Hz, 2 H), 5.75 
(ddt, J = 17.3, 10.0, 7.4 Hz, 1 H), 5.07 (d, J = 10.3 Hz, 1 H), 5.02 (d, J = 17.2 Hz, 1 H) 
3.31 (s, 2 H), 2.15 (d, J = 7.4 Hz, 2 H), 1.47 (s, 9 H), 0.98 (s, 6 H) 
13
C NMR (75 MHz, CDCl3, DEPT) δ 185.0 (C), 165.5 (C), 165.2 (C), 146.9 (CH × 2), 
134.0 (CH), 130.4 (CH × 2); 118.6 (CH2), 82.7 (C), 82.0 (C), 43.3 (C), 43.2 (CH2), 41.5 
(CH2), 28.1 (CH3 × 3), 21.9 (CH3 × 2) 
HRMS (ESI+) 357.1672 calcd for C19H26O5Na, found 357.1690 
Malonate-tethered cyclohexadienone 2.8h 
 
Using general method C, mono-t-butyl malonate (2.20) was coupled to quinol 2.17h to 
give 2.8h in quantitative yield after flash-column chromatography (9:1 hexanes/EtOAc). 
IR (thin film) 2979, 2930, 1731, 1679, 1644, 1370, 1333, 1144, 1048, 971, 847 cm
-1
 
1
H NMR (300 MHz, CDCl3) δ 6.65 (s, 2 H), 3.22 (s, 2 H), 1.87 (s, 6 H), 1.52 (s, 3 H), 
1.45 (s, 9 H) 
13
C NMR (75 MHz, CDCl3, DEPT) δ 186.4 (C), 165.7 (C), 165.5 (C), 143.4 (CH × 2), 
134.9 (C × 2), 82.3 (C), 75.9 (C), 43.5 (CH2), 28.1 (CH3 × 3), 26.4 (CH3), 16.0 (CH3 × 2) 
HRMS (ESI+) 317.1359 calcd for C16H22O5Na, found 317.1373 
Malonate-tethered cyclohexadienone 2.8i 
 
Using general method C, mono-t-butyl malonate (2.20) was coupled to quinol 2.17i to 
give 2.8i in 86% yield after flash-column chromatography (19:1 hexanes/EtOAc). 
IR (thin film) 2953, 1725, 1630, 1313, 1244, 1157, 1047, 843 cm
-1
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1
H NMR (300 MHz, CDCl3) δ 6.99 (s, 2 H), 3.26 (s, 2 H), 1.50 (s, 3 H), 1.47 (s, 9 H), 
0.16 (s, 18 H) 
13
C NMR (75 MHz, CDCl3, DEPT) δ 190.7 (C), 165.5(C), 165.3(C), 155.1 (CH × 2), 
140.9 (C × 2), 82.2 (C), 75.3 (C), 43.5 (CH2), 28.1 (CH3 ×3), 26.6 (CH3), −1.3 (CH3 ×6) 
HRMS (ESI+) 433.1837 calcd for C20H34O5Si2Na, found 433.1853 
Malonate-tethered cyclohexadienone 2.8j 
 
Using general method C, mono-t-butyl malonate (2.20) was coupled to quinol 2.17j
9
 to 
give 2.8j in quantitative yield after flash-column chromatography (5:1 hexanes/EtOAc). 
IR (thin film) 3051, 2977, 2927, 1729, 1681, 1600, 1310, 1142, 1052, 698 cm
-1
 
1
H NMR (300 MHz, CDCl3) δ 7.35 (s, 2 H), 3.30 (s, 2 H), 1.63 (s, 3 H), 1.48 (s, 9 H) 
13
C NMR (75 MHz, CDCl3, DEPT) δ 165.3 (C × 2), 165.1 (C), 148.9 (CH × 2), 82.9 (C), 
77.7(C), 42.9 (CH2), 28.1 (CH3 × 3), 25.7 (CH3) 
HRMS (ESI+) 444.9257 calcd for C14H16Br2O5Na, found 444.9250 
Malonate-tethered cyclohexadienone 2.8k 
 
Using general method C, mono-t-butyl malonate (2.20) was coupled to quinol 2.17k to 
give 2.8k in 95% yield after flash-column chromatography (9:1 hexanes/EtOAc). 
IR (thin film) 2976, 2934, 1730, 1682, 1599, 1463, 1329, 1255, 1147, 1002, 842 cm
-1
 
                                                 
9
 Prepared according to: McKillop, A.; McLaren, L.; Taylor, R. J. K. J. Chem. Soc., Perkin Trans. 1 1994, 
2047–2048. 
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1
H NMR (300 MHz, CDCl3) δ 7.29 (s, 2 H), 3.35 (s, 2 H), 2.22 (hept, J = 6.9 Hz 1 H), 
1.49 (s, 9 H), 1.01 (d, J = 6.9 Hz, 6 H) 
13
C NMR (75 MHz, CDCl3, DEPT) δ 172.2 (C), 165.1 (C), 165.0 (C), 147.6 (CH × 2), 
122.6 (C), 82.8 (C), 82.6 (C), 42.8 (CH2), 36.9 (CH), 27.9 (CH3 × 3), 16.9 (CH3 × 2) 
HRMS (ESI+) 474.9550 calcd for C16H20
81
Br2O5, found 474.9569 
Malonate-tethered cyclohexadienone 2.8l 
 
Using general method C, mono-t-butyl malonate (2.20) was coupled to quinol 2.17l to 
give 2.8l in 81% yield after flash-column chromatography (19:1 hexanes/EtOAc). 
IR (thin film) 2974, 1730, 1682, 1595, 1466, 1313, 1254, 1145, 991, 697 cm
-1
 
1
H NMR (300 MHz, CDCl3) δ 7.36 (s, 2 H), 5.75 (ddt, J = 17.3, 10.1, 7.4 Hz, 1 H), 5.12 
(dd, J = 10.1, 1.8 Hz, 1 H), 5.06 (dd, J = 17.3, 1.7 Hz, 1 H), 3.35 (s, 2 H) 2.17 (d, J = 
7.4 Hz, 2 H), 1.50 (s, 9 H), 1.03 (s, 6 H) 
13
C NMR (75 MHz, CDCl3, DEPT) δ 172.1 (C), 165.1 (C), 165.0 (C), 147.8 (CH × 2), 
133.2 (CH), 122.7 (C), 119.2 (CH2), 84.7 (C), 82.9 (C), 44.3 (C), 42.9 (CH2), 41.8 (CH2), 
28.1 (CH3 × 3), 22.3 (CH3 × 2) 
HRMS (ESI+) 514.9864 calcd for C19H24Br2O5Na, found 514.9882 
Malonate-tethered cyclohexadienone 2.8m 
 
Using general method C, mono-t-butyl malonate (2.20) was coupled to quinol 2.17m to 
give 2.8m as a colorless oil in 96% yield after flash-column chromatography (10:1 
hexanes/EtOAc). 
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IR (thin film) 2953, 2929, 2856, 1757, 1732, 1682, 1599, 1369, 1257, 1142, 1099, 838, 
779 cm
-1
 
1
H NMR (300 MHz, CDCl3) δ 7.43 (s, 2 H), 3.79 (t, 5.5 Hz, 2 H), 3.30 (s, 2 H), 2.08 (t, 
5.5 Hz, 2 H), 1.48 (s, 9 H), 0.88 (s, 9 H), 0.05 (s, 6 H) 
13
C NMR (75 MHz, CDCl3, DEPT) δ 172.5 (C), 165.0 (C × 2, overlapped), 148.7 (CH × 
2), 121.9 (C × 2), 82.9 (C), 79.5 (C), 57.5 (CH2), 43.0 (CH2), 42.7 (CH2), 28.1 (CH3 × 3), 
26.0 (CH3 × 3), −5.3 (CH3 × 2) 
HRMS (ESI+) 589.0227 calcd for C21H32Br2O6SiNa, found 589.0229 
Malonate-tethered cyclohexadienone 2.8n 
 
Using a modification of general method C, in which MeCN was used as solvent, mono-t-
butyl malonate (2.20) was coupled to quinol 2.17n to give 2.8n in 98% yield (3:1 
hexanes/EtOAc). 
IR (neat) 2987, 2922, 1753, 1730, 1665, 1614, 1321, 1143, 1056 cm
-1
 
1
H NMR (300 MHz, CDCl3)  6.61 (d, J = 10.0 Hz, 1H), 6.22 (d, J = 10.0 Hz, 1 H), 3.91 
(s, 3 H), 3.29 (s, 2 H), 1.92 (s, 3 H), 1.56 (s, 3 H), 1.48 (s, 9 H) 
13
C NMR (75 MHz, CDCl3)  187.7, 170.1, 165.40, 165.35, 144.4, 128.0, 118.2, 82.4, 
76.6, 61.5, 43.1, 28.1, 25.4, 9.7 
HRMS (ESI+) 333.1309 calcd for C16H22NaO6, found 333.1307 
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Malonate-tethered cyclohexadienone 2.8p 
 
Using a modification of general method C, in which MeCN was used as solvent, mono-t-
butyl malonate (2.20) was coupled to quinol 2.17p to give 2.8p, in 73% yield (9:1 
hexanes/EtOAc). 
IR (neat) 2979, 2932, 1753, 1729, 1670, 1635, 1142, 1958 cm
-1
 
1
H NMR (300 MHz, CDCl3) δ 6.83 (d, J = 10.1, 1 H), 6.21 (dd, J =1.9, 10.0, 1 H), 6.10–
6.08 (m, 1 H), 3.29 (s, 2 H), 1.97 (d, J = 1.4 Hz, 3 H), 1.51 (s, 3 H), 1.47 (s, 9 H) 
13
C NMR (75 MHz, CDCl3, DEPT) δ 185.4 (C), 165.4 (C), 165.1 (C), 158.7 (C), 149.2 
(CH), 128.2 (CH), 127.0 (CH), 82.6 (C), 77.3 (C), 43.0 (CH2), 28.1 (CH3  3), 26.3 
(CH3), 17.9 (CH3) 
HRMS (ESI+) 303.1203 calcd for C15H20O5Na, found 303.1206 
Malonate-tethered cyclohexadienone 2.8o 
 
Using general method C, mono-t-butyl malonate (2.20) was coupled to quinol 2.17o
3
 to 
give 2.8o, in 95% yield (9:1 hexanes/EtOAc). 
IR (thin film) 2980, 1753, 1730, 1673, 1645, 1369, 1333, 1144, 1051, 969 cm
-1
 
1
H NMR (300 MHz, CDCl3) δ 6.82 (dd, J = 10.1, 3.2 Hz, 1 H), 6.61 (dq, J = 3.2, 1.4 Hz, 
1 H), 6.15 (d, J = 10.1 Hz, 1 H) 3.19 (s, 3 H), 1.82 (d, J = 1.4 Hz, 3 H), 1.48 (s, 3 H), 1.40 
(s, 9 H) 
13
C NMR (75 MHz, CDCl3, DEPT) δ 185.5 (C), 165.4 (C), 165.3 (C), 148.3 (CH), 143.6 
(CH), 135.1 (C), 128.1 (CH), 82.2 (C), 75.6 (C), 43.1 (CH2), 27.9 (CH3 × 3), 26.2 (CH3), 
15.6 (CH3) 
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HRMS (ESI+) 303.1203 calcd for C15H20O5Na, found 303.1196 
Malonate-tethered cyclohexadienone 2.8q 
 
Using general method C, mono-t-butyl malonate (2.20) was coupled to quinol 2.17q to 
give 2.8q in 82% yield after flash-column chromatography (9:1 hexanes/EtOAc). 
IR (thin film) 2978, 1754, 1732, 1657, 1628, 1369, 1333, 1248, 1140, 1055, 845 cm
-1
 
1
H NMR (300 MHz, CDCl3) δ 6.94 (d, J = 3.1 Hz, 1 H), 6.85 (dd, J = 10.0, 3.1 Hz, 1 H), 
6.15 (d, J = 10.0 Hz, 1 H), 3.23 (s, 2 H), 1.50 (s, 3 H), 1.43 (s, 9 H), 0.14 (s, 9 H) 
13
C NMR (75 MHz, CDCl3, DEPT) δ 187.8 (C), 165.4 (C), 165.3 (C), 155.6 (CH), 147.6 
(CH), 140.4 (C), 129.0 (CH), 82.3 (C), 75.2 (C), 43.3 (CH2), 28.0 (CH3 × 3), 26.4 (CH3), 
−1.5 (CH3 × 3) 
HRMS (ESI+) 361.1442 calcd for C17H26O5SiNa, found 361.1443 
Cyclization of 2.8q 
Using general method D, 2.8q cyclized to give 2.13a (70% yield) and 2.13i (8% yield) 
after flash-column chromatography (3:1 hexanes/EtOAc). Both products were identified 
by comparison of their spectroscopic data with that previously obtained. 
Malonate-tethered cyclohexadienone 2.8r 
 
Using a modification of general method B, in which the concentration was 0.2 M in 
quinol, mono-t-butyl malonate (2.20) was coupled to quinol 2.17r to give 2.8r as a 
yellow oil in 69% yield after flash-column chromatography (3:1 hexanes/EtOAc). 
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IR (neat) 3050, 2981, 2934, 1759, 1728, 1672, 1640, 1606, 1334, 1146, 1056, 965, 
824 cm
-1
 
1
H NMR (500 MHz, CDCl3) δ 7.36 (d, J = 2.9 Hz, 1 H), 6.94 (dd, J = 10.0, 2.9 Hz, 1 H), 
6.37 (d, J = 10.0 Hz, 1 H), 3.30 (s, 2 H), 1.62 (s, 3 H), 1.49 (s, 9 H) 
13
C NMR (MHz, CDCl3, DEPT) δ 177.9 (C), 165.3 (C), 165.2 (C), 148.79 (CH), 148.72 
(CH), 126.7 (CH), 124.6 (C), 82.7 (C), 76.7 (C), 43.0 (CH2), 28.0 (CH3 × 3), 25.9 (CH3) 
HRMS (ESI+) 367.0152 calcd for C14H17BrO5Na, found 367.0143 
Malonate-tethered cyclohexadienone 2.8s 
 
Using general method C, mono-t-butyl malonate (2.20) was coupled to quinol 2.17s to 
give 2.8s in 96% yield after flash-column chromatography (5:1 hexanes/EtOAc). 
IR (thin film) 2979, 2933, 2859, 1729, 1666, 1332, 1222, 1145 1030 cm
-1
 
1
H NMR (300 MHz, CDCl3) δ 7.27 (s, 1 H), 6.20 (q, J = 1.3 Hz, 1 H), 3.30 (s, 2 H), 1.99 
(d, J = 1.3 Hz, 3 H), 1.55 (s, 3 H) 1.47 (s, 9 H) 
13
C NMR (75 MHz, CDCl3, DEPT) δ 177.9 (C), 165.0 (C), 164.8 (C), 159.3 (C), 149.2 
(CH), 124.8 (CH), 124.0 (C), 82.4 (C), 78.4 (C), 42.6 (CH2), 27.8 (CH3 × 3), 25.7 (CH3), 
17.5 (CH3) 
HRMS (ESI+) 381.0308 calcd for C15H19O5BrNa, found 381.0337 
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Malonate-tethered cyclohexadienone 2.8t 
 
Using a modification of general method C, in which MeCN was used as solvent, mono-t-
butyl malonate (2.20) was coupled to quinol 2.17t to give 2.8t in 55% yield and 19% of 
recovered 2.17t after flash-column chromatography (9:1 hexanes/EtOAc). 
IR (neat) 2979, 2933, 2853, 1754, 1730, 1657, 1651, 1613, 1309, 1214, 1143, 1054 cm
-1
 
1
H NMR (300 MHz, CDCl3) δ 7.04 (s, 1 H), 3.90 (s, 3 H), 3.28 (s, 2 H), 1.95 (s, 3 H), 
1.56 (s, 3 H), 1.46 (s, 9 H) 
13
C NMR (75 MHz, CDCl3, DEPT) δ 180.5 (C), 170.2 (C), 165.3 (C), 165.1 (C), 144.1 
(CH), 124.7 (C), 117.0 (C), 82.5 (C), 77.6 (C), 61.7 (CH3), 42.9 (CH2), 28.0 (CH3  3), 
25.1 (CH3), 10.6 (CH3) 
HRMS (ESI+) 441.0414 calcd for C16H21BrO6Na, found 411.0432 
Morpholine-tethered cyclohexadienone 2.9 
 
Using general method C, mono-morpholine malonic acid (2.21)
10
 was coupled to quinol 
2.17a to give 2.9 in 96% yield after flash-column chromatography (2:1 hexanes/acetone). 
IR (thin film) 3497, 3288, 2925, 2856, 1744, 1657, 1444, 1313, 1230, 1052, 857 cm
-1
 
                                                 
10
 (a) Angelastro, M. R.; Baugh, L. E.; Bey, P.; Burkhart, J. P.; Chen, T.-M.; Durham, S. L.; Hare, C. M.; 
Huber, E. W.; Janusz, M. J.; Koehl, J. R.; Marquart, A. L.; Mehdi, S.; Peet, N. P. J. Med. Chem. 
1994, 37, 4538–4553. (b) Rigo, B.; Fasseur, D.; Cauliez, P.; Couturier, D. Tetrahedron Lett. 1989, 
30, 3073–3076. 
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1
H NMR (300 MHz, CDCl3) δ 6.89 (d, J = 10.2 Hz, 2 H), 6.20 (d, J = 10.2 Hz, 2 H), 
3.69–3.55 (m, 6 H), 3.40 (s, 2 H), 3.43–3.34 (m, 2 H) 1.54 (s, 3 H) 
13
C NMR (75 MHz, CDCl3, DEPT) δ 184.9 (C), 166.0 (C), 164.3 (C), 148.6 (CH × 2), 
128.4 (CH × 2), 75.3 (C), 66.6 (CH2), 66.4 (CH2), 46.6 (CH2), 42.2 (CH2), 41.1 (CH2), 
26.3 (CH3) 
HRMS (ESI+) 302.0999 calcd for C14H17NO5Na, found 302.0990 
Sulfone-tethered cyclohexadienone 2.10 
 
Sulfide S13 (89 mg, 0.30 mmol) was dissolved in CH2Cl2 (5 mL) and treated with 77% 
mCPBA (207 mg, 0.9 mmol). The mixture was stirred for 2 h before being quenched with 
saturated aq. NaHCO3 (10 mL). The phases were separated and the aqueous layer 
extracted with CH2Cl2. The combined organic layers were dried over Na2SO4, filtered, 
and concentrated to give 2.10 (87.3 mg, 88% yield) after flash-column chromatography 
(2:11:1 hexanes/EtOAc). 
IR (thin film) 3051, 2992, 2937, 1746, 1669, 1632, 1391, 1320, 1280, 1152, 1050, 
859 cm
-1
 
1
H NMR (300 MHz, CDCl3) δ 7.76 (d, J = 8.3 Hz, 2 H), 7.35 (d, J = 8.4 Hz, 2 H), 6.78 
(d, J = 10.2 Hz, 2 H), 6.18 (d, J = 10.2 Hz, 2 H), 4.07 (s, 2 H), 2.43 (s, 3 H), 1.50 (s, 3 H) 
13
C NMR (75 MHz, CDCl3, DEPT) δ 184.7 (C), 160.9 (C), 147.5 (CH × 2), 145.8 (C), 
135.7 (C), 130.0 (CH × 2), 128.7 (CH × 2), 128.5 (CH × 2), 76.3 (C), 61.4 (CH2), 25.9 
(CH3), 21.8 (CH3) 
HRMS (ESI+) 343.0611 calcd for C16H16O5SNa, found 343.0616 
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Bicyclic lactone 2.11 
 
Using a modification of general method E, in which CH2Cl2 was used as solvent, 
CsOH·H2O was used as a base, and the reaction temperature was −78 °C, 2.6 cyclized to 
give 2.11 in 75% yield after flash-column chromatography (3:1 hexanes/EtOAc). Chiral-
phase HPLC analysis (Chiralcel OD, 3% ethanol in hexanes, 1.5 mL/min, λ= 225 nm) 
showed 65:35 er (RTmajor = 22.3 min., RTminor = 23.5 min.). When crude 2.6 (obtained 
using general method B) was allowed to stand at –15 ºC overnight, racemic 2.11 was 
obtained in 88% yield after chromatographic purification. The relative stereochemistry of 
2.11 was determined by NOE analysis. 
IR (thin film) 2983, 2929, 1785, 1737, 1685, 1381, 1294, 1164, 1093, 998, 781 cm
-1
; 
1
H NMR (300 MHz, CDCl3) δ 6.68 (dd, J = 10.3, 2.0 Hz, 1 H), 6.09 (d, J = 10.3 Hz, 
1 H), 5.90 (dddd, J = 16.2, 10.5, 5.8, 5.8 Hz, 1 H), 5.38 (dq, J = 17.2, 1.4 Hz, 1 H), 5.28 
(dd, J = 10.4, 1.1 Hz, 1 H), 4.77–4.62 (m, 2 H), 3.49 (d, J = 12.5 Hz, 1 H), 3.38–3.31 (m, 
1 H), 2.75 (dd, J = 17.8, 5.3 Hz, 1 H), 2.64 (dd, J = 17.8, 1.6 Hz, 1 H), 1.72 (s, 3H) 
13
C NMR (75 MHz, CDCl3, DEPT) δ 194.2 (C), 168.7 (C), 166.1 (C), 146.7 (CH), 131.0 
(CH), 129.5 (CH), 119.6 (CH2), 80.6 (C), 67.1 (CH2), 51.5 (CH), 44.7 (CH), 35.9 (CH2), 
23.9 (CH3) 
HRMS (ESI+) 273.0733 calcd for C13H14O5Na, found 273.0729 
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Bicyclic lactone 2.12 
 
Using a modification of general method E, in which CH2Cl2 was used as solvent and the 
reaction was started at −78 °C and gradually allowed to warm to rt, 2.7 cyclized to give 
2.12 in 99% yield after flash-column chromatography (3:1 hexanes/EtOAc). Chiral-phase 
HPLC analysis (Chiralcel OD-H, 8% ethanol in hexanes, 1 mL/min, λ= 225 nm) showed 
~racemic material (RTfirst = 20.4 min., RTsecond = 23.7 min.). Also, using general method 
D, racemic 2.12 was obtained in 91% yield. 
IR (thin film) 3059, 3032, 2910, 1778, 1731, 1679, 1378, 1291, 1158, 1090, 987 cm
-1
 
1
H NMR (300 MHz, CDCl3) δ 7.39–7.36 (m, 5 H), 6.68 (dd, J = 10.4, 2.0 Hz, 1 H), 6.08 
(d, J = 10.4 Hz, 1 H) 5.28 (d, J = 12.3 Hz, 1 H), 5.22 (d, J = 12.3 Hz, 1 H), 3.52 (d, J = 
12.5 Hz, 1 H), 3.39–3.32 (m, 1 H), 2.74 (dd, J = 17.8, 5.3 Hz, 1 H), 2.63 (dd, J = 17.9, 
2.3 Hz, 1 H), 1.73 (s, 3 H) 
13
C NMR (75 MHz, CDCl3, DEPT) δ C 194.1 (C), 168.6 (C), 166.3 (C), 146.7 (CH), 
134.8 (C), 129.5 (CH), 128.9 (CH × 2), 128.8 (CH), 128.4 (CH × 2), 80.6 (C), 68.3 
(CH2), 51.5 (CH), 44.7 (CH), 35.9 (CH2), 23.9 (CH3) 
HRMS (ESI+) 323.0890 calcd for C17H16O5Na, found 323.0889 
Bicyclic lactone 2.13a 
 
Using general method E, 2.8a cyclized in 2 h to give 2.13a in 79% yield after flash-
column chromatography (5:1 hexanes/EtOAc). Using general method D, racemic 2.13a 
was obtained in 80% yield. 
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IR (thin film) 2983, 2929, 1786, 1728, 1686, 1371, 1295, 1150, 1148, 1089, 983 cm
-1
 
1
H NMR (300 MHz, CDCl3) δ 6.67 (dd, J = 10.3, 1.6 Hz, 1 H), 6.08 (d, J = 10.3 Hz, 
1 H), 3.35 (d, J = 12.3 Hz, 1 H), 3.32–3.29 (m, 1 H), 2.74 (dd, J = 17.8, 4.8 Hz, 1 H), 
2.63 (d, J = 17.8 Hz, 1 H), 1.71 (s, 3 H), 1.49 (s, 9H) 
13
C NMR (75 MHz, CDCl3, DEPT) δ 194.5 (C), 169.2 (C), 165.3 (C), 147.0 (CH), 129.4 
(CH), 83.8 (C), 80.3 (C), 52.4 (CH), 44.5 (CH); 36.0 (CH2), 28.1 (CH3 × 3), 24.0 (CH3) 
HRMS (ESI+) 289.1046 calcd for C14H18O5Na, found 289.1056 
HPLC (CHIRALCEL OJ, 8% isopropanol in hexanes, 1 mL/min, λ = 225 nm) TR = 20.4, 
23.7 min 
Bicyclic lactone 2.13b 
 
Using general method E, 2.8b cyclized in 3 h to give 2.13b in 72% yield after flash-
column chromatography (5:1 hexanes/EtOAc). Using general method D, racemic 2.13b 
was obtained in 95% yield. 
IR (thin film) 2976, 2930, 1786, 1727, 1688, 1370, 1293, 1144, 989, 767, 700 cm
-1
 
1
H NMR (300 MHz, CDCl3) δ 7.47–7.44 (m, 5 H), 6.81 (dd, J = 10.3 Hz, 1 H), 6.37 (d, J 
= 10.3 Hz, 1 H), 3.47–3.45 (m, 2 H), 2.78–2.71 (m, 1 H), 2.61 (d, J = 17.7 Hz, 1 H), 1.50 
(s, 9 H) 
13
C NMR (75 MHz, CDCl3, DEPT) δ 194.8 (C), 169.4 (C), 165.3 (C), 144.8 (CH), 137.3 
(C), 130.9 (CH), 129.5 (CH), 129.4 (CH × 2), 125.2 (CH × 2), 84.0 (C), 83.2 (C), 52.9 
(CH), 46.9 (CH), 35.6 (CH2), 28.1 (CH3 × 3) 
HRMS (ESI+) 351.1203 calcd for C19H20O5Na, found 351.1217 
HPLC (CHIRALCEL OD-H, 10% isopropanol in hexanes, 1 mL/min, λ = 225 nm) 
TR = 9.6, 10.3 min 
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Bicyclic lactone 2.13c 
 
Using general method E, 2.8c cyclized in 3 h to give 2.13c in 77% yield after flash-
column chromatography (3:1 hexanes/EtOAc). Using general method D, racemic 2.13c 
was obtained in 96% yield. 
IR (thin film) 2976, 2937, 2884, 1784, 1730, 1688, 1470, 1369, 1294, 1149, 980 cm
-1
 
1
H NMR (300 MHz, CDCl3) δ 6.70 (dd, J = 10.5, 1.9 Hz, 1 H), 6.21 (d, J = 10.5 Hz, 
1 H), 3.43 (dddd, J = 12.0, 5.5, 1.9, 1.9 Hz, 1 H), 3.33 (d, J = 12.1 Hz, 1 H), 2.72 (dd, J = 
18.3, 5.7, Hz, 1 H), 2.58 (d, J = 17.2 Hz, 1 H), 2.25 (hept. J = 6.9 Hz, 1 H), 1.49 (s, 9 H), 
1.11 (d, J = 6.9 Hz, 6 H) 
13
C NMR (75 MHz, CDCl3, DEPT) δ 194.9 (C), 169.3 (C), 165.6 (C), 145.6 (CH), 131.1 
(CH), 84.7 (C), 83.8 (C), 53.6 (CH), 40.1 (CH), 37.4 (CH2), 36.1 (CH), 28.1 (CH3 × 3), 
17.7 (CH3), 16.8 (CH3) 
HRMS (ESI+) 317.1359 calcd for C16H22O5Na, found 317.1375 
HPLC (CHIRALCEL OD-H, 10% isopropanol in hexanes, 1 mL/min, λ = 225 nm) 
TR = 7.7, 8.2 min 
Bicyclic lactone 2.13d 
 
Using general method E, 2.8d cyclized in 3 h to give 2.13d in 44% yield after flash-
column chromatography (3:1 hexanes–EtOAc). Using general method D, racemic 2.13d 
was obtained in 53% yield. 
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IR (thin film) 2979, 2926, 2884, 1783, 1724, 1679, 1431, 1364, 1298, 1253, 1131, 
979 cm
-1
 
1
H NMR (300 MHz, CDCl3) δ 6.82 (dd, J = 10.4, 2.0 Hz, 1 H), 6.17 (d, J = 10.4 Hz, 
1 H), 3.74 (s, 3 H), 3.58–3.68 (m, 1 H), 3.35(d, J = 12.2 Hz, 1 H), 3.05 (d, J = 15.5 Hz, 
1 H), 2.99 (d, J = 15.5 Hz, 1 H), 2.84 (dd, J = 18.0, 5.8 Hz, 1 H), 2.62 (d, J = 17.0 Hz, 
1 H), 1.50 (s, 9 H) 
13
C NMR (75 MHz, CDCl3, DEPT) δ 194.5 (C), 168.6 (C), 168.3 (C), 165.0 (C), 144.5 
(CH), 130.7 (CH), 84.1 (C), 79.2 (C), 52.6 (CH3), 52.4 (CH), 42.7 (CH), 42.3 (CH2) 
36.1(CH2), 28.1 (CH3 × 3) 
HRMS (ESI+) 347.1101 calcd for C16H20O7Na, found 347.1111 
HPLC (CHIRALCEL OD-H, 10% isopropanol in hexanes, 1 mL/min, λ = 225 nm) 
TR = 21.9, 27.4 min 
Bicyclic lactone 2.13e 
 
Using general method E, 2.8e cyclized in 2.5 h to give 2.13e in 52% yield after flash-
column chromatography (9:15:1 hexanes/EtOAc). Using general method D, racemic 
2.13e was obtained in 58% yield. 
IR (thin film) 2957, 1783, 1731, 1687, 1369, 1295, 1260, 1141, 983, 941 cm
-1
 
1
H NMR (300 MHz, CDCl3) δ 6.89 (d, J = 10.5 Hz, 1 H), 6.06 (d, J = 10.5 Hz, 1 H), 3.29 
(s, 2 H), 2.74 (ddd, J = 17.9, 3.7, 1.4 Hz, 1 H), 2.61 (d, J = 18.2 Hz, 1 H), 2.04 (d, J = 
15.2 Hz, 1 H), 1.93 (d, J = 15.2 Hz, 1 H), 1.49 (s, 9 H), 1.09 (s, 9 H) 
13
C NMR (75 MHz, CDCl3, DEPT) δ 194.6 (C), 169.7 (C), 165.6 (C), 146.9 (CH), 128.7 
(CH), 83.8 (C), 83.0 (C), 51.36 (CH), 51.30 (CH2), 45.7 (CH), 35.7(CH2), 31.5 (C), 31.4 
(CH3 × 3), 28.0 (CH3 × 3) 
HRMS (ESI+) 345.1672 calcd for C18H26O5Na, found 345.1677 
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HPLC (CHIRALCEL OJ, e% ethanol in hexanes, 1 mL/min, λ = 225 nm) TR = 8.8, 
9.8 min 
Bicyclic lactone 2.13f 
 
Using general method E, 2.8f cyclized in 22 h to give 2.13f in 89% yield after flash-
column chromatography (5:1 hexanes/EtOAc). Using general method D, racemic 2.13f 
was obtained in 50% yield. 
IR (thin film) 2952, 2931, 2857, 1789, 1732, 1689, 1147, 1087, 838, 779 cm
-1
 
1
H NMR (300 MHz, CDCl3) δ 6.71 (dd, J = 10.4, 1.8 Hz, 1 H), 6.10 (d, J = 10.4 Hz), 
3.91–3.79 (m, 2 H), 3.55 (dddd, J = 12.6, 5.6, 2.0, 2.0 Hz, 1 H), 3.34 (d, J = 12.4 Hz), 
2.87 (dd, J = 17.9, 5.6 Hz, 1 H), 2.60 (d, J = 17.9 Hz, 1 H), 2.23 (ddd, J = 14.8, 7.1, 
4.6 Hz, 1 H), 2.13 (ddd, J = 14.8, 6.1, 4.4 Hz, 1 H), 1.49 (s, 9 H), 0.88 (s, 9H), 0.07 (s, 
6 H) 
13
C NMR (75 MHz, CDCl3, DEPT) δ 195.1 (C), 169.5 (C), 165.4 (C), 146.7 (CH), 129.6 
(CH), 83.6 (C), 82.0 (C), 57.9 (CH2), 52.4 (CH), 43.0 (CH), 40.4 (CH2), 36.1 (CH2), 28.1 
(CH3 × 3), 25.9 (CH3 × 3), 18.2 (C), −5.4 (CH3 × 2) 
HRMS (ESI+) 433.2028 calcd for C21H34O6SiNa, found 433.1996 
HPLC (CHIRALCEL OD-H, 2% isopropanol in hexanes, 1 mL/min, λ = 225 nm) 
TR = 11.8, 12.9 min 
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Bicyclic lactone 2.13g 
 
Using general method E, 2.8g cyclized in 19 h to give 2.13g in 88% yield after flash-
column chromatography (5:1 hexanes/EtOAc). Using general method D, racemic 2.13g 
was obtained in 61% yield. 
IR (thin film) 2977, 2934, 1784, 1730, 1689, 1369, 1291, 1146, 982, 784 cm
-1
 
1
H NMR (300 MHz, CDCl3) δ 6.83 (dd, J = 10.7, 2.0 Hz, 1 H), 6.24 (d, J = 10.6 Hz, 
1 H), 5.81 (dddd, J = 17.4, 10.2, 7.3, 7.3 Hz, 1 H), 5.13 (d, J = 10.2, Hz, 1 H) 5.08 (d, J = 
17.6 Hz, 1 H), 3.66 (dddd, J = 11.8, 6.1, 1.8, 1.8 Hz, 1 H), 3.31 (d, J = 11.9 Hz, 1 H), 
2.75 (dd, J = 18.6, 6.1 Hz, 1 H), 2.57 (d, J = 18.1 Hz, 1 H), 2.28 (dd, J = 13.9, 7.7 Hz, 
1 H), 2.21 (dd, J = 13.7, 7.8 Hz), 1.50 (s, 9 H), 1.10 (s, 3 H), 1.09 (s, 3 H) 
13
C NMR (75 MHz, CDCl3, DEPT) δ 194.7 (C), 169.2 (C), 165.7 (C), 145.0 (CH), 133.3 
(CH), 131.4 (CH), 119.2 (CH2), 86.5 (C), 83.9 (C), 54.0 (CH),  41.7 (C), 41.5 (CH2), 38.4 
(CH), 37.9 (CH2), 28.1 (CH3 × 3), 22.0 (CH3), 21.8 (CH3) 
HRMS (ESI+) 357.1672 calcd for C19H26O5Na, found 357.1662 
HPLC (CHIRALCEL OJ, 3% isopropanol in hexanes, 1 mL/min, λ = 225 nm) TR = 16.1, 
19.5 min 
Bicyclic lactone 2.13h 
 
Using general method E, 2.8h cyclized in 36 h to give 2.13h in 67% yield (isolated as a 
12:1 mixture of diastereomers, measured by 
1
H NMR) after flash-column 
chromatography (9:15:1 hexanes/EtOAc). Using general method D, racemic 2.13h was 
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obtained in 74% yield. The relative stereochemistry of 2.13h was determined by NOE 
analysis. 
IR (thin film) 2991, 2987, 1785, 1736, 1690, 1451, 1371, 1283, 1148, 1078 cm
-1
 
1
H NMR (300 MHz, CDCl3, data for major diastereomer) δ 6.34 (dq, J = 1.6, 1.4 Hz, 
1 H), 3.32 (ddd, J = 12.1, 5.0, 2.0 Hz, 1 H), 3.15 (d, J = 12.1 Hz, 1 H), 2.79 (qd, J = 6.9, 
5.0 Hz, 1 H), 1.79 (d, J = 1.5 Hz, 3 H), 1.69 (s, 3 H), 1.46 (s, 9 H), 1.11 (d, J = 6.9 Hz, 
3 H) 
13
C NMR (75 MHz, CDCl3, DEPT, data for major diastereomer) δ 197.9 (C), 170.3 (C), 
166.7 (C), 141.2 (CH), 136.2 (C), 83.3 (C), 81.8 (C), 51.5 (CH), 51.4 (CH), 40.4 (CH), 
27.8 (CH3 × 3), 24.1 (CH3), 15.9 (CH3), 12.9 (CH3) 
HRMS (ESI+) 317.1359 calcd for C16H22O5Na, found 317.1370 
HPLC (CHIRALCEL AS, 8% isopropanol in hexanes, 1 mL/min, λ = 225 nm) TR = 5.0 
(major diastereomer), 5.9 (minor diastereomer), 6.4 (both diastereomers) min 
Bicyclic lactone 2.13i 
 
Using general method E, 2.8i cyclized in 4 d to give 2.13i in 61% yield after flash-
column chromatography (19:19:1 hexanes/EtOAc). Using general method D, racemic 
2.13i was obtained in 49% yield. 
IR (thin film) 2984, 2927, 1779, 1730, 1655, 1340, 1297, 1248, 1145, 1096, 978, cm
-1
 
1
H NMR (300 MHz, CDCl3) δ 6.71 (d, J = 1.2 Hz, 1 H), 3.26–3.25 (m, 2 H), 2.71 (ddd, J 
= 17.4, 3.9, 1.5 Hz, 1 H), 2.56 (dd, J = 17.5, 1.8 Hz, 1 H), 1.68 (s, 3 H), 1.49 (s, 9 H), 
0.15 (s, 9 H) 
13
C NMR (75 MHz, CDCl3, DEPT) δ 197.9 (C), 169.6 (C), 165.4 (C), 153.4 (CH), 142.8 
(C), 83.8 (C), 80.6 (C), 52.5 (CH), 44.4 (CH), 36.7 (CH2), 28.1 (CH3 × 3), 24.1 (CH3), 
−1.5 (CH3 × 3) 
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HRMS (ESI+) 361.1442 calcd for C17H26O5SiNa, found 361.1437 
HPLC (CHIRALCEL OD-H, 8% isopropanol in hexanes, 1 mL/min, λ = 225 nm) 
TR = 4.7, 5.1 min 
Bicyclic lactone 2.13n 
 
Using a modification of general method D, in which 1.1 equiv of Cs2CO3 was used, 2.8n 
cyclized to give 2.13n as a single regioisomer in 95% yield after flash-column 
chromatography (3:1 hexanes/EtOAc). 
IR (neat) 2978, 2928, 1784, 1732, 648, 1610, 1369, 1311, 1150 cm
-1
 
1
H NMR (300 MHz, CDCl3) δ 3.95 (s, 3 H), 3.35 (d, J = 12.4 Hz, 1 H), 3.21 (ddd, J = 
12.4, 4.9, 2.9 Hz, 1 H), 2.73–2.59 (m, 2 H), 1.79 (s, 3 H), 1.77 (s, 3 H), 1.48 (s, 9 H) 
13
C NMR (75 MHz, CDCl3, DEPT) δ 195.1 (C), 169.4 (C), 166.4 (C), 165.4 (C), 121.2 
(C), 83.8 (C), 82.6 (C), 61.4 (CH3), 52.0 (CH), 44.1 (CH), 35.7 (CH2), 28.0 (CH3  3), 
22.9 (CH3), 9.2 (CH3) 
HRMS (ESI+) 333.1309 calcd for C16H22O6Na, found 333.1308 
Bicyclic lactone 2.13o 
 
Using general method D, 2.8o gave 2.13o and its regioisomer as a 9:1 inseparable 
mixture in 74% combined yield after flash-column chromatography (9:15:1 
hexanes/EtOAc). 
IR (thin film) 2981, 2932, 1785, 1730, 1684, 1369, 1297, 1151, 1078, 983, 916, 840 cm
-1
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1
H NMR (300 MHz, CDCl3, data for major regioisomer) δ 6.42 (s, 1 H), 3.31 (d, 
J = 12.3 Hz, 1 H), 3.27–3.20 (m, 1 H), 2.71 (dd, J = 17.7, 4.6 Hz, 1 H), 2.63 (dd, 
J = 17.6, 2.2 Hz, 1 H), 1.80 (d, J = 1.2 Hz, 3 H), 1.67 (s, 3 H), 1.48 (s, 9 H). Signals at δ 
6.58 (dd, J = 10.3, 2.0 Hz) and δ 6.04 (d, J = 10.3 Hz) were ascribed to the minor 
regioisomer. 
13
C NMR (75 MHz, CDCl3, DEPT, data for major regioisomer) δ 195.0 (C), 169.6 (C), 
169.5 (C), 142.3 (CH), 136.4 (C), 83.6 (C), 81.1 (C), 52.6 (CH), 44.7 (CH), 36.2 (CH2), 
28.0 (CH3 × 3), 24.2 (CH3), 15.8 (CH3) 
HRMS (ESI+) 303.1203 calcd for C15H20O5Na, found 303.1213 
Bicyclic lactone 2.13p 
 
Using general method D, 2.8p gave 2.13p and its regioisomer as a 12:1 inseparable 
mixture in 73% combined yield (3:1 hexanes/EtOAc). 
IR (neat) 2986, 2921, 1783, 1732, 1660, 1369, 1304, 1145, 1084 cm
-1
 
1
H NMR (300 MHz, CDCl3) δ 5.94 (dq, J = 1.2, 1.2 Hz, 1 H), 3.36 (d, J = 12.7 Hz, 1 H), 
3.27 (ddd, J = 12.7, 5.2, 2.1 Hz, 1 H), 2.71 (dd, J = 18.0, 5.3 Hz, 1 H), 2.59 (ddd, J = 
18.0, 2.1, 0.9 Hz, 1 H), 2.02 (d, J = 1.4 Hz, 3 H), 1.72 (s, 3 H), 1.48 (s, 9 H) 
13
C NMR (75 MHz, CDCl3, DEPT) δ 194.2 (C), 169.4 (C), 165.5 (C), 157.9 (C), 127.9 
(CH), 83.7 (C), 82.4 (C), 51.9 (CH), 45.4 (CH), 35.7 (CH2), 28.0 (CH3  3), 23.0 (CH3), 
18.5 (CH3) 
HRMS (ESI+) 303.1203 calcd for C15H20O5Na, found 303.1204 
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Bicyclic lactone 2.14 
 
Using general method E, 2.9 cyclized to give 2.14 in 87% yield after flash-column 
chromatography (2:1 hexanes/EtOAc). Using general method D, racemic 2.14 was 
obtained in 92% yield. 
IR (thin film) 2971, 2859, 1773, 1681, 1645, 1441, 1297, 1242, 1113, 1094, 975 cm
-1
 
1
H NMR (300 MHz, CDCl3) δ 6.68 (dd, J = 10.3, 2.0 Hz, 1 H), 6.06 (d, J = 10.3, 1.0 Hz, 
1 H), 4.00 (dt, J = 13.4, 3.0 Hz, 1 H), 3.82–3.57 (m, 6 H), 3.58 (d, J = 11.9 Hz, 1 H), 
3.39–3.26 (m, 2 H), 2.72 (dd, J = 17.8, 5.5 Hz, 1 H), 2.54 (ddd, J = 17.9, 2.0, 1.1 Hz, 
1 H), 1.72 (s, 3 H) 
13
C NMR (75 MHz, CDCl3, DEPT) δ 195.2 (C), 169.9 (C), 162.4 (C), 147.1 (CH), 129.7 
(CH), 80.9 (C), 66.9 (CH2), 66.6 (CH2), 48.5 (CH), 46.6 (CH2), 43.7 (CH), 43.2 (CH2), 
36.2 (CH2), 23.9 (CH3) 
HRMS (ESI+) 302.0999 calcd for C14H17NO5Na, found 302.1016 
HPLC (CHIRALCEL OD, 10% ethanol in hexanes, 1 mL/min, λ = 225 nm) TR = 23.2, 
42.5 min 
Bicyclic lactone 2.15 
 
Using general method E, 2.10 cyclized to give 2.15 in 90% yield after flash column 
chromatography (1:1 hexanes/EtOAc). Using general method D, racemic 2.15 was 
obtained in 70% yield. 
IR (thin film) 2923, 1783, 1687, 1595, 1318, 1245, 1149, 1085, 965, 813 cm
-1
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1
H NMR (300 MHz, CDCl3) δ 7.85 (d, J = 8.4 Hz, 2 H), 7.39 (d, J = 8.1 Hz, 2 H), 6.61 
(dd, J = 10.4, 1.8 Hz, 1 H), 6.06 (dd, J = 10.4, 0.9 Hz, 1 H), 3.94 (d, J = 11.6 Hz, 1 H), 
3.55 (ddt, J = 11.6, 5.8, 2.0 Hz, 1 H), 3.18 (ddd, J = 17.9, 1.8, 1.1 Hz, 1 H), 2.82 (dd, J = 
17.9, 5.8 Hz, 1 H), 2.46 (s, 3 H), 1.75 (s, 3 H) 
13
C NMR (75 MHz, CDCl3, DEPT) δ 193.9 (C), 165.6 (C), 146.5 (CH), 146.4 (C), 134.0 
(C), 130.0 (CH × 2), 129.9 (CH × 2), 129.8 (CH), 80.1 (C), 67.1 (CH), 42.7 (CH), 36.7 
(CH2), 23.9 (CH3), 22.0 (CH3) 
HRMS (ESI+) 343.0611 calcd for C16H16O5SNa, found 343.0604 
HPLC (CHIRALCEL OD, 10% isopropanol in hexanes, 1 mL/min, λ = 225 nm) 
TR = 27.9, 32.0 min 
Quinol 2.17c 
 
Using general method A, 4-isopropyl phenol was converted into quinol 2.17c in 73% 
yield after flash-column chromatography (3:1 hexanes/EtOAc). This compound has been 
prepared and characterized before;
11
 however, our 
1
H NMR spectrum differs from the 
literature data. 
IR (thin film) 3343, 2960, 1648, 1641, 1496, 1454, 1367, 1311, 1186, 1028, 968, 865, 
774 cm
-1
 
1
H NMR (300 MHz, CDCl3) δ 6.80 (d, J = 10.2 Hz, 2 H), 6.14 (d, J = 10.2 Hz, 2 H), 3.14 
(bs, 1 H), 1.96 (hept, J = 6.9 Hz, 1 H), 0.91 (d, J = 6.9 Hz, 6 H) 
13
C NMR (75 MHz, CDCl3, DEPT) δ 186.3 (C), 151.1 (CH × 2), 128.8 (CH × 2), 72.3 
(C), 36.7 (CH), 17.0 (CH3 × 2) 
HRMS (ESI+) 175.0740 calcd for C9H12O2Na, found 175.0741 
                                                 
11
 McKinley, J.; Aponick, A.; Raber, J. C.; Fritz, C.; Montgomery, D.; Wigal, C. T.  J. Org. Chem. 1997, 
62, 4874–4876. 
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Quinol 2.17e 
 
Using general method A, phenol S1 was converted into 2.17e in 31% yield after flash-
column chromatography (3:1 hexanes/EtOAc) 
IR (thin film) 3429, 2960, 2873, 1661, 1621, 1470, 1397, 1279, 1074 cm
-1
 
1
H NMR (300 MHz, CDCl3) δ 6.91 (d, J = 10.1 Hz, 2 H), 6.12 (d, J = 10.1 Hz, 2 H), 2.42 
(bs, 1 H), 1.85 (s, 2 H), 0.93 (s, 9 H) 
13
C NMR (75 MHz, CDCl3, DEPT) δ 186.1 (C), 152.7 (CH × 2), 127.2 (CH × 2), 69.6 
(C), 53.8 (CH2), 31.3 (CH3 × 3), 30.9 (C) 
HRMS (ESI+) 203.1043 calcd for C11H16O2Na, found 203.1059 
Quinol 2.17g 
 
Using general procedure A, 4-(2-methylpent-4-en-2-yl)phenol
12
 was converted into 
quinol 2.17g in 37% yield after flash-column chromatography (3:1 hexanes/EtOAc). 
IR (thin film) 3398, 2970, 1667, 1620, 1385, 1463, 1173, 1063, 955, 916, 859 cm
-1
 
1
H NMR (300 MHz, CDCl3) δ 6.99 (d, J = 10.4 Hz, 2 H), 6.18 (d, J = 10.4 Hz, 2 H), 5.80 
(ddt, J = 17.7, 10.3, 7.4 Hz, 1 H), 5.10–4.97 (m, 2 H), 2.66 (s, 1 H), 2.14 (d, J = 7.4 Hz, 
1 H), 0.98 (s, 6 H) 
13
C NMR (75 MHz, CDCl3, DEPT) δ 185.7 (C), 150.5 (CH × 2), 134.8 (CH), 129.0 (CH 
× 2), 118.2 (CH2), 74.1 (C), 41.8 (C, overlapped), 41.8 (CH2), 21.9 (CH3 × 2) 
HRMS (ESI+) 215.1043 calcd for C12H16O2Na, found 215.1059 
                                                 
12
 Cella, J. A. J. Org. Chem. 1982, 47, 2125–2130. 
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Quinol 2.17h 
 
Using general method A, 2,4,6-trimethylphenol was converted to 2.17h in 78% yield 
after flash-column chromatography (4:13:1 hexanes–EtOAc). Identity was verified by 
comparison of 
1
H NMR spectrum with literature data.
3,13
 
Quinol 2.17i 
 
Using a modification of general method A in which 10:1 acetone/H2O was used as 
solvent, phenol S2 was converted to quinol 2.17i in 67% yield after flash-column 
chromatography (19:1 hexanes/EtOAc). 
IR (thin film) 3464, 1619, 1351, 1246, 1032, 841, 740 cm
-1
 
1
H NMR (300 MHz, CDCl3) δ 6.97 (s, 2 H), 1.84 (bs, 1 H), 1.42 (s, 3 H), 0.17 (s, 18 H) 
13
C NMR (75 MHz, CDCl3, DEPT) δ 190.9 (C), 158.7 (CH × 2), 140.2 (C × 2), 66.6 (C), 
27.3 (CH3), −1.3 (CH3 × 6) 
HRMS (ESI+) 291.1207 calcd for C13H24O2Si2Na, found 291.1209 
                                                 
13
 Ochiai, M.; Miyamoto, K.; Shiro, M.; Ozawa, T. Yamaguchi, K. J. Am. Chem. Soc. 2003, 125, 13006–
13007. 
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Quinol 2.17k 
 
Using general method A, phenol S3 was converted into quinol 2.17k in 78% yield after 
flash-column chromatography (5:1 hexanes/EtOAc). 
IR (thin film) 3434, 1671, 1596, 1461, 1358, 997, 692 cm
-1
 
1
H NMR (300 MHz, CDCl3) δ 7.29 (s, 2 H), 2.29 (bs, 1 H), 2.06 (hept, J = 6.9 Hz, 1 H), 
1.01 (d, J = 6.9 Hz, 6 H) 
13
C NMR (75 MHz, CDCl3, DEPT) δ 172.5 (C), 151.0 (CH × 2), 122.2 (C × 2), 77.3 (C), 
37.3 (CH), 17.1 (CH3 × 2) 
HRMS (ESI+) 330.8940 calcd for C9H10Br2O2Na, found 330.8940 
Quinol 2.17l 
 
Using general method A, phenol S4 was converted into quinol 2.17l in 74% yield after 
flash-column chromatography (5:1 hexanes/EtOAc). 
IR (thin film) 3470, 2970, 1677, 1592, 1467, 1312, 988, 918 cm
-1 
 
1
H NMR (300 MHz, CDCl3) δ 7.48 (s, 2 H), 5.79 (ddt, J = 17.5, 10.1, 7.4 Hz, 1 H), 5.11 
(d, J = 10.1 Hz, 1 H), 5.07 (d, J = 17.5 Hz, 1 H), 3.08 (s, 2 H) 2.17 (d, J = 7.4 Hz, 2 H), 
1.04 (s, 6 H) 
13
C NMR (75 MHz, CDCl3, DEPT) δ 172.5 (C), 151.5 (CH × 2), 134.0 (CH), 121.8 (C × 
2), 118.7 (CH2), 79.0 (C), 43.0 (C), 42.0 (CH2), 22.2 (CH3 × 2) 
HRMS (ESI+) 370.9253 calcd for C12H14Br2O2Na, found 370.9264 
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Quinol 2.17m 
 
Using a modification of general method A, in which 10:1 acetone/H2O was used as 
solvent, S6 gave 2.17m as a yellow solid in 42% yield after flash-column 
chromatography (5:1 hexanes/EtOAc). 
IR (thin film) 3466, 3036, 2926, 2856, 1668, 1592, 1471, 1349, 1093, 992, 840, 770, 
701 cm
-1
 
1
H NMR (300 MHz, CDCl3) δ 7.42 (s, 2 H), 4.51 (s, 1 H), 3.96 (t, J = 5.4 Hz, 2 H), 1.99 
(t, J = 5.4 Hz, 2 H), 0.91 (s, 9 H), 0.11 (s, 6 H) 
13
C NMR (75 MHz, CDCl3, DEPT) δ 172.4 (C), 151.7 (CH × 2), 121.0 (C × 2), 74.3 (C), 
60.4 (CH2), 41.0 (CH2), 25.9 (CH3 × 3), 18.1 (C), 5.5 (CH3 × 2) 
HRMS (ESI+) 446.9608 calcd for C17H22Br2O3SiNa, found 446.9600 
Quinol 2.17n 
 
A mixture of phenol S10 (53 mmol, 8.0 g) and hexamethyldisilazane (17 mL) was heated 
at 125 °C for 10 minutes in a microwave reactor.
14
 General method A was then used to 
convert the resulting TMS phenol to quinol 2.17n in 80% yield after flash-column 
chromatography (1:01:1 hexanes/EtOAc). 
IR (neat) 3391, 2981, 2932, 2851, 1662, 1608, 1456, 1214, 1094 cm
-1
 
1
H NMR (300 MHz, CDCl3)  6.66 (d, J = 9.9 Hz, 1 H), 6.09 (d, J = 9.9 Hz, 1 H), 4.02 
(s, 3 H), 2.61 (s, 1 H), 1.87 (s, 3 H), 1.51 (s, 3 H) 
                                                 
14
 Mojtahedi, M. M.; Saidi, M. R.; Bolourtchian, M.; Heravi, M. M. Phosphorus, Sulfur Silicon Relat. 
Elem. 2002, 177, 289–292. 
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13
C NMR  (75 MHz, CDCl3, DEPT)  188.5 (C), 171.5 (C), 147.8 (CH), 126.5 (CH), 
117.5 (C), 69.8 (C), 61.7 (CH3), 26.5 (CH3), 9.2 (CH3) 
HRMS (ESI+) 191.0679 calcd for C9H12NaO3, found 191.0674 
Quinol 2.17p 
 
A mixture of 3,4-dimethylphenol (8.84 mmol, 1.08 g) and hexamethyldisilazane (2 mL) 
was heated at 125 °C for 10 min in a microwave reactor.
14
 General method A was then 
used to convert the resulting TMS phenol to quinol 2.17p in 48% yield (two steps) after 
flash-column chromatography (1:01:1 hexanes/EtOAc). Identity was verified by 
comparison of the 
1
H NMR spectrum with literature data.
3 
Quinol 2.17q 
 
Using a modification of general method A in which 10:1 acetone/H2O was used as 
solvent, phenol S11 was converted into quinol 2.17q in 51% yield after flash-column 
chromatography (5:1 hexanes/EtOAc). 
IR (thin film) 3381, 2958, 1649, 1611, 1361, 1242, 1138, 1050, 841 cm
-1
 
1
H NMR (300 MHz, CDCl3) δ 6.99 (d, J = 3.1 Hz, 1 H), 6.83 (dd, J = 10.0, 3.1 Hz, 1 H), 
2.12 (bs, 1 H), 1.44 (s, 3 H), 0.17 (s, 9 H) 
13
C NMR (75 MHz, CDCl3, DEPT) δ 188.5 (C), 160.0 (CH), 151.7 (CH), 139.0 (C), 
127.8 (CH), 66.8 (C), 27.0 (CH3), −1.4 (CH3 × 3) 
HRMS (ESI+) 219.0812 calcd for C10H16O2SiNa, found 219.0825 
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Quinol 2.17r 
 
Using a modification of general method A, in which 10:1 acetone/H2O was used as 
solvent, 2-bromo-4-methylphenol gave 2.17r as a yellow/orange solid in 76% yield after 
flash-column chromatography (3:1 hexanes/EtOAc). 
IR (thin film) 3474, 3045, 2980, 2937, 1660, 1594, 1052 cm
-1
 
1
H NMR (300 MHz, CDCl3) δ 7.34 (d, J = 2.8 Hz, 1 H), 6.92 (dd, J = 10.0, 2.8 Hz, 1 H), 
6.27 (d, 10.0 Hz, 1 H), 2.04 (bs, 1 H), 1.53 (s, 3 H) 
13
C NMR (75 MHz, CDCl3, DEPT) δ 178.6 (C), 152.9 (CH), 152.7 (CH), 125.6 (CH), 
123.4 (C), 70.1 (C), 26.5 (CH3) 
HRMS (ESI+) 224.9522 calcd for C7H7BrO2Na, found 224.9531 
Quinol 2.17s 
 
Using general method A, 2-bromo-4,5-dimethylphenol
15
 was converted into quinol 2.17s 
in 74% yield after flash-column chromatography (3:1 hexanes/EtOAc). 
IR (thin film) 3457, 3038, 2986, 2934, 1648, 1626, 1596, 1363, 1231, 1132, 1041, cm
-1
 
1
H NMR (300 MHz, CDCl3) δ 7.29 (s, 1 H), 5.95 (q, J = 1.4 Hz, 1 H), 3.64 (s, 1 H), 2.05 
(d, J = 1.4 Hz, 3 H), 1.41 (s, 3 H) 
13
C NMR (75 MHz, CDCl3, DEPT) δ 179.3 (C), 164.1 (C), 154.1 (CH), 123.8 (CH), 
122.6 (C), 71.7 (C), 25.9 (CH3), 18.2 (CH3) 
HRMS (ESI+) 238.9678 calcd for C8H9OBr2Na, found 238.9736 
                                                 
15
 Kajigaeshi, S.; Kakinami, T.; Okamoto, T.; Nakamura, H.; Fujikawa, M.; Ube, T. Bull Chem. Soc. Jpn. 
1987, 60, 4187–4189. 
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Quinol 2.17t 
 
Using general method A, phenol S12 was converted into quinol 2.17t in 51% after flash-
column chromatography (1:01:1 hexanes/EtOAc). 
IR (neat) 3397, 2928, 2853, 1640, 1601, 1370, 1299, 1208, 1150, 1062, 868, 762 cm
-1
 
1
H NMR (300 MHz, CDCl3) δ 7.08 (s, 1 H), 4.05 (s, 3 H), 1.85 (s, 3 H), 1.51 (s, 3 H) 
13
C NMR (75 MHz, CDCl3, DEPT) δ 181.6 (C), 171.7 (C), 148.7 (CH), 122.7 (C), 116.8 
(C), 71.6 (C), 61.6 (CH3), 25.8 (CH3  3), 9.9 (CH3) 
HRMS (ESI+) 268.9784 calcd for C9H11BrO3Na, found 268.9781 
Cyclopropane 2.23j 
 
Using general method E, 2.8j cyclized in 5.5 h to give 2.23j in 56% yield after flash-
column chromatography (4:1 hexanes–EtOAc). Using a modification of general method 
D, in which CH2Cl2 was used as solvent and 10 mol% tetrabutylammonium iodide was 
added, racemic 2.23j was obtained in 85%. 
IR (thin film) 3055, 2980, 2929, 1786, 1723, 1692, 1602, 1454, 1326, 1154, 1036, 
917 cm
-1
 
1
H NMR (300 MHz, CDCl3) δ 7.28 (s, 1 H), 3.25 (d, J = 7.5 Hz, 1 H), 3.18 (d, J = 
7.5 Hz, 1 H) 1.81 (s, 3 H), 1.51 (s, 9 H) 
13
C NMR (75 MHz, CDCl3, DEPT) δ 181.6 (C), 165.0 (C), 163.0 (C), 149.3 (CH), 128.5 
(C), 84.9 (C), 76.3 (C), 44.8 (C), 42.3 (CH), 35.4 (CH), 28.0 (CH3 × 3), 25.9 (CH3) 
HRMS (ESI+) 342.0097 calcd for C14H15BrO5, found 341.9251 
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HPLC (CHIRALCEL OD-H, 10% isopropanol in hexanes, 1 mL/min, λ = 225 nm) 
TR = 13.1, 16.6 min 
Cyclopropane 2.23k 
 
Using general method E, 2.8k cyclized in 3.5 h to give 2.23k in 81% yield after flash-
column chromatography (5:1 hexanes/EtOAc). Using general method D, racemic 2.23k 
was obtained in 49% yield. 
IR (thin film) 3060, 2977, 1788, 1693, 1608, 1465, 1324, 1153, 1080, 955 cm
-1
 
1
H NMR (300 MHz, CDCl3) δ 7.33 (s, 1 H), 3.20 (d, J = 7.9 Hz, 1 H), 3.17 (d, J = 
7.7 Hz, 1 H), 2.27 (qq, J = 6.8, 6.8 Hz, 1 H), 1.50 (s, 9 H), 1.10 (d, J = 6.9 Hz, 3 H), 1.09 
(d, J = 6.8 Hz, 3 H) 
13
C NMR (75 MHz, CDCl3, DEPT) δ 182.0 (C), 165.4 (C), 163.0 (C), 147.8 (CH), 129.3 
(C), 84.7 (C), 81.7 (C), 44.6 (C), 38.5 (CH), 34.6 (CH), 34.3 (CH), 28.0 (CH3 × 3), 16.1 
(CH3), 15.6 (CH3) 
HRMS (ESI+) 370.0410 calcd for C16H19BrO5, found 370.0141 
HPLC (CHIRALCEL OD-H, 10% isopropanol in hexanes, 1 mL/min, λ = 225 nm) 
TR = 8.3, 11.9 min 
Cyclopropane 2.23l 
 
Using general method E, 2.8l cyclized in 6.5 d to give 2.23l in 63% yield after flash-
column chromatography (9:1 hexanes/EtOAc). Using general method D, racemic 2.23l 
was obtained in 42% yield. 
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IR (thin film) 2976, 1786, 1728, 1694, 1314, 1261, 1150, 1092, 990, 837 cm
-1
 
1
H NMR (300 MHz, CDCl3) δ 7.54 (s, 1 H), 5.83 (ddt, J = 17.4, 10.1, 7.4 Hz, 1 H), 5.17 
(dd, J = 10.1, 1.0 Hz, 1 H), 5.12 (dd, J = 17.4, 1.5 Hz, 1 H), 3.31 (d, J = 7.7 Hz, 1 H), 
3.16 (d, J = 7.7 Hz, 1 H), 2.22 (d, J = 7.4 Hz, 2 H), 1.51 (s, 9 H), 1.11j (s, 3 H), 1.09 (s, 
3 H) 
13
C NMR (75 MHz, CDCl3, DEPT) δ 181.9 (C), 165.4 (C), 163.0 (C), 146.3 (CH), 132.8 
(CH), 129.6 (C), 119.5 (CH2), 84.8 (C), 83.7 (C), 44.7 (C), 40.7 (CH2), 39.2 (C), 39.1 
(CH), 34.3 (CH), 28.0 (CH3 × 3), 21.0 (CH3), 20.6 (CH3) 
HRMS (ESI+) 433.0621 calcd for C19H23O5BrNa, found 433.0556 
HPLC (CHIRALCEL OD, 10% isopropanol in hexanes, 1 mL/min, λ = 225 nm) 
TR = 6.5, 10.1 min 
Cyclopropane 2.23m 
 
Using general method E, 2.8m cyclized in 22 h to give 2.23m in 35% yield after flash-
column chromatography (9:1 hexanes/EtOAc). Using general method D, racemic 2.23m 
was obtained in 24% yield. 
IR (thin film) 2952, 2930, 2857, 1792, 1726, 1694, 1152, 837 cm
-1
 
1
H NMR (500 MHz, CDCl3) δ 7.55 (s, 1 H), 3.98–3.89 (m, 2 H), 3.59 (d, 7.5 Hz), 3.18 
(d, 7.5 Hz), 2.33–2.18 (m, 2 H), 1.51 (s, 9 H), 0.90 (s, 9 H), 0.084 (s, 3 H), 0.078 (s, 3 H) 
13
C NMR (75 MHz, CDCl3, DEPT) δ 181.8 (C), 165.2 (C), 163.0 (C), 149.2 (CH), 127.9 
(C), 84.7 (C), 78.3 (C), 57.9 (CH2), 44.4 (C), 41.4 (CH), 40.2 (CH2), 35.4 (CH), 28.0 
(CH3 × 3), 26.0 (CH3 × 3), 18.3 (C), −5.4 (CH3 × 2) 
HRMS (ESI+) 509.0965 calcd for C21H31BrO6SiNa, found 509.0965 
HPLC (CHIRALCEL OD, 10% isopropanol in hexanes, 1 mL/min, λ = 225 nm) 
TR = 7.4, 8.4 min 
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Cyclopropane 2.23r 
 
Using a modification of general method D, in which 1.0 equiv of Cs2CO3 was used and 
the concentration was 0.1 M in substrate, 2.8r cyclized to give 2.23r in 45% yield after 
flash-column chromatography (2:1 hexanes/EtOAc). 
IR (thin film) 2979, 2932, 2856, 1784, 1726, 1685, 1370, 1315, 1137 cm
-1 
1
H NMR (300 MHz, CDCl3) δ 6.87 (d, J = 9.8 Hz, 1 H), 6.18 (d, J = 9.8 Hz, 1 H), 3.18 
(d, J = 7.5 Hz, 1 H), 3.02 (d, J = 7.5 Hz, 1 H), 1.80 (s, 3 H), 1.50 (s, 9 H) 
13
C NMR (75 MHz, CDCl3, DEPT) δ 188.0 (C), 165.7 (C), 163.6 (C), 149.2 (CH), 131.6 
(CH), 84.5 (C), 74.2 (C), 44.3 (C), 42.2 (CH), 35.6 (CH), 28.0 (CH3 × 3), 25.6 (CH3) 
HRMS (ESI+) 287.0890 calcd for C14H16O5Na, found 287.0880 
Cyclopropane 2.23s 
 
Using general method D, 2.8s cyclized to give 2.23s in >99% crude yield. Attempts to 
further purify the crude material by chromatography resulted in decomposition. 
IR (thin film) 2980, 2934, 1782, 1724, 1671, 1370, 1314, 1251, 1161, 1032, 919, cm
-1
 
1
H NMR (300 MHz, CDCl3,) δ 6.03 (app. t, J = 1.3 Hz, 3 H), 3.13 (d, J = 7.5 Hz, 1 H), 
3.01 (dd, J = 7.5, 1.2 Hz, 1 H), 2.06 (d, J = 1.5 Hz, 3 H), 1.77 (s, 3 H), 1.51 (s, 9 H) 
13
C NMR (75 MHz, CDCl3, DEPT) δ 187.9 (C), 165.8 (C), 163.7 (C), 159.2 (C), 129.1 
(CH), 84.4 (C), 76.5 (C), 44.0 (C), 42.9 (CH), 36.1 (CH), 28.0 (CH3 × 3), 23.3 (CH3), 
20.2 (CH3) 
HRMS (ESI+) 301.1046 calcd for C15H18O5Na, found 301.1052 
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Cyclopropane 2.23t 
 
Using a modification of general method D, in which 1.1 equiv of Cs2CO3 was used, 2.8t 
cyclized to give 2.23t as a single regioisomer in 65% yield after flash column 
chromatography (3:1 hexanes/EtOAc). 
IR (neat) 2980, 2936, 1784, 1723, 1661, 1607, 1370, 1316, 1164, 1034 cm
-1
 
1
H NMR (300 MHz, CDCl3) δ 3.90 (s, 3 H), 3.08 (d, J = 7.7 Hz, 1 H), 3.02 (d, J = 
7.7 Hz, 1 H), 1.86 (s, 3 H), 1.71 (s, 3 H), 1.49 (s, 9 H) 
13
C NMR (75 MHz, CDCl3, DEPT) δ 189.3 (C), 170.4 (C), 166.0 (C), 163.4 (C), 120.5 
(C), 84.2 (C), 78.3 (C), 61.6 (CH3), 43.8 (C), 41.6 (CH), 35.4 (CH), 28.0 (CH3  3), 22.1 
(CH3), 9.8 (CH3) 
HRMS (ESI+) 331.1152 calcd for C16H20O6Na, found 331.1158 
Sulfide 2.30 
 
A mixture of crude cyclopropane 2.23s (68 mg, 0.24 mmol) and 4-toluenethiol (30.3 mg, 
0.24 mmol) was dissolved in 5 mL toluene. A condenser was attached to the flask and the 
reaction was heated to 115 ºC for 1 h. The mixture was allowed to cool to rt. The solvent 
was removed in vacuo and the residue purified by flash-column chromatography to give 
2.32 (36.7 mg, 37.2% yield from 2.8s), as a 2:1 inseparable mixture of diastereomers. 
IR (thin film) 2979, 2928, 1787, 1731, 1675, 1370, 1293, 1257, 1153, 1090, 952 cm
-1
 
1
H NMR (300 MHz, CDCl3, *denotes minor diastereomer) δ *7.39 (d, J = 8.2 Hz), 7.34 
(d, J = 8.2 Hz, 2 H), 7.16 (d, J = 7.9 Hz, 2 H), *7.15 (d, J = 8.4 Hz), *6.02 (q, J = 1.4 
Appendix I: Experimental Procedures and Data | 153 
 
 
Hz), 5.94 (dq, J = 1.3, 1.3 Hz, 1 H), *4.16 (d, J = 5.0 Hz), 3.74 (dd, J = 1.9, 1.2 Hz, 1 H), 
*3.66 (dd, J = 11.9, 5.0 Hz), 3.48 (dd, J = 12.5, 2.0 Hz, 1 H), *3.37 (d, J = 11.9 Hz), 3.32 
(d, J = 12.5, Hz, 1 H), 2.34 (s, 3 H) *2.34 (s), 2.06 (d, J = 1.4 Hz, 3 H), *2.01 (d, J = 1.3 
Hz), 1.90 (s, 3 H), *1.66 (s), *1.53 (s), 1.46 (s, 9 H) 
13
C NMR (75 MHz, CDCl3, DEPT, mixture of diastereomers) δ 191.2 (C), 190.5 (C), 
169.7 (C), 168.5 (C), 166.3 (C), 164.9 (C), 157.1 (C), 156.0 (C), 139.5 (C), 138.5 (C), 
133.9 (CH), 132.8 (CH), 130.3 (CH), 130.2 (CH), 129.6 (C), 128.6 (C), 127.0 (CH), 
126.0 (CH), 84.0 (C), 83.4 (C), 83.3 (C), 81.9 (C), 56.3 (CH), 52.7 (CH), 51.9 (CH), 51.7 
(CH), 51.3 (CH), 50.0 (CH), 28.04 (CH3), 28.02 (CH3), 25.5 (CH3), 22.5 (CH3), 21.4 
(CH3), 21.3 (CH3), 18.6 (CH3), 18.3 (CH3) 
HRMS (ESI+) 425.1393 calcd for C22H26O5SNa, found 425.1403 
Bicyclic lactone 2.31 
 
A solution of SmI2 in THF (4.5 mL, ~0.16 mmol) was added slowly to cyclopropane 
2.23k (22 mg, 0.059 mmol) at 0 °C. The reaction mixture was stirred for ~5 min before 
quenching with 0.5 mL of 10% aq. HCl. The cooling bath was removed and the mixture 
was extracted with CH2Cl2. The organic layer was dried over Na2SO4, filtered, and 
concentrated. The crude material was purified by flash-column chromatography (5:1 
hexanes/EtOAc) to give 2.33 (8.7 mg, 39% yield). 
IR (thin film) 2978, 2927, 1785, 1716, 1699, 1371, 1152, 994, 948 cm
-1
 
1
H NMR (300 MHz, CDCl3) δ 7.17 (d, J = 1.7 Hz, 1 H), 3.47 (dtd, J = 11.9, 3.8, 1.7 Hz, 
1 H), 3.35 (d, J = 12.0 Hz, 1 H), 2.84 (d, J = 3.8 Hz, 2 H), 2.27 (hept, J = 6.9 Hz, 1 H), 
1.50 (s, 9 H), 1.14 (d, J = 6.9 Hz, 6 H) 
13
C NMR (75 MHz, CDCl3, DEPT) δ 187.3 (C), 168.8 (C), 165.2 (C), 146.4 (CH), 126.5 
(C), 86.5 (C), 84.2 (C), 53.3 (CH), 40.0 (CH), 37.4 (CH2), 36.1 (CH), 28.1 (CH3 × 3), 
17.7 (CH3), 16.9 (CH3) 
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HRMS (ESI+) 395.0465 calcd for C16H21BrO5Na, found 395.0445 
Phenol S1 
 
A solution of 4-hydroxybenzaldehyde (1.0 g, 8.2 mmol) in THF (40 mL) was cooled to 0 
ºC and treated with t-BuLi (1.28 M in pentane, 14.0 mL, 18.0 mmol). The mixture was 
stirred for 1 h before being quenched with 10% aq. HCl (1 mL). The mixture was diluted 
with brine and acidified with 10% aq. HCl until a clear solution was obtained. Extraction 
with Et2O followed by drying over MgSO4 and concentration gave a residue that was 
purified by flash-column chromatography (3:1 hexanes–EtOAc). Further purification was 
achieved by suspending the obtained solid in chloroform, followed by filtration to give 
471 mg of the intermediate benzylic alchohol. This material was dissolved in EtOH 
(35 mL), treated with 100 mg Pd/C (10% w/w) and 1 drop of conc. HCl. The mixture was 
stirred under an atmosphere of H2 (balloon) for 14 h, then filtered through a short plug of 
Celite. Solvent was removed in vacuo and the residue purified by flash-column 
chromatography (19:1 hexanes/EtOAc) to give S1 (387 mg, 24% yield over two steps). 
Identity was verified by comparison of the 
1
H NMR spectrum with literature data.
16
 
                                                 
16
 Bates, R. B.; Siahaan, T. J. J. Org. Chem. 1986, 51, 1432–1434. 
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Phenol S2 
 
A mixture of 2-bromo-4-methyl-6-(trimethylsilyl)phenol
17
 (660 mg, 2.54 mmol), TMSCl 
(0.64 mL, 5.1 mmol) and Et3N (0.71 mL, 5.1 mmol) was dissolved in toluene (20 mL) 
and refluxed for 12 h. The mixture was then allowed to cool to rt and concentrated. Full 
conversion of the phenol to the TMS ether was confirmed by 
1
H NMR analysis. The 
residue was then dissolved in 20 mL THF and cooled to −100 ºC. n-BuLi (2.5 M in 
hexanes, 1.01 mL, 2.54 mmol) was added and the mixture was allowed to gradually 
warm to −50 ºC, at which point it was quenched with saturated aq. NH4Cl (1 mL). The 
cooling bath was removed and the mixture was diluted with Et2O, washed with brine, 
dried over MgSO4, filtered, and concentrated. Flash-column chromatography (100% 
petroleum ether) afforded phenol S2 (564.2 mg, 87% yield over two steps). 
IR (thin film) 3599, 2951, 1572, 1403, 1241, 1169, 832 cm
-1
 
1
H NMR (300 MHz, CDCl3) δ 7.17 (s, 2 H), 4.85 (s, 1 H), 2.29 (s, 3 H), 0.34 (s, 18 H) 
13
C NMR (75 MHz, CDCl3, DEPT) δ 163.4 (C), 137.3 (CH × 2), 129.2 (C), 124.1 (C × 
2), 20.8 (CH3), −0.3 (CH3 × 6) 
HRMS (ESI–) 251.1282 calcd for C13H23OSi2, found 251.0992 
Phenol S3 
 
A solution of 4-isopropyl phenol (266 mg, 1.95 mmol) in 15 mL of dry CH2Cl2 was 
treated with 1,3-dibromo-5,5-dimethylhydantoin (614.3 mg, 2.14 mmol) in small 
                                                 
17
 Akai, S.; Ikawa, T.; Takayanagi, S.-i.; Morikawa, Y.; Mohri, S.; Tsubakiyama, M.; Egi, M.; Wada, Y. 
Kita, Y. Angew. Chem. Int. Ed. 2008, 47, 7673–7676. 
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portions. The mixture was then protected from light and stirred. After 16 h, the mixture 
was diluted with CH2Cl2 and washed with 10% HCl solution, dried over Na2SO4, filtered 
and concentrated. Crude product was purified by flash-column chromatography (39:1 
hexanes/EtOAc) to give 285.8 mg of S3 in 49% yield. Identity was verified by 
comparison of 
1
H NMR spectrum with literature data.
18
 
Phenol S4 
 
A solution of 4-(2-methylpent-4-en-2-yl)phenol
12
 (159.9 mg, 0.90 mmol) in 12 mL of 
CH2Cl2 was treated with 1,3-dibromo-5,5-dimethylhydantoin (259.3 mg, 0.9 mmol). The 
reaction flask was protected from light and stirred for 16 h. The mixture was then diluted 
with CH2Cl2, washed with 10% aq. HCl and brine, dried over Na2SO4, filtered, and 
concentrated. Flash-column chromatography (20:1 hexanes/Et2O) provided S4 (243 mg, 
80% yield) 
IR (thin film) 3498, 2964, 1555, 1475, 1393, 1285, 1163, 998, 917, 733 cm
-1
 
1
H NMR (300 MHz, CDCl3) δ 7.38 (s, 2 H), 5.74 (s, 1 H), 5.61–5.42 (m, 1 H), 4.99 (s, 
1 H), 4.97–4.90 (m, 1 H), 2.28 (d, J = 7.3 Hz, 2 H), 1.24 (s, 6 H) 
13
C NMR (75 MHz, CDCl3, DEPT) δ 147.2 (C), 144.2 (C), 134.6 (CH), 129.8 (CH × 2), 
117.8 (CH2), 48.7 (CH2), 37.4 (C), 28.5 (CH3 × 2) 
HRMS (ESI–) 333.9386 calcd for C12H14Br2O, found 333.1305 
                                                 
18
 (a) A. Fitton, O.; Rigby, A.; Hurlock, R. J. J. Chem. Soc. C 1968, 1000–1001. (b) Eriksson, J.; Rahm, S.; 
Green, N.; Bergman, Å.; Jakobsson, E. Chemosphere 2004, 54, 117–126. 
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Alcohol S5 
 
To a solution of 2-(4-hydroxyphenyl)ethanol
19
 (150 mg, 1.09 mmol) in EtOAc (11 mL) 
was added 1,3-dibromo-5,5-dimethylhydantoin (312 mg, 1.09 mmol). The solution was 
protected from light and stirred for 15 h. The reaction was then diluted with EtOAc and 
quenched with 10% aq. HCl. The organic layer was washed with water and brine, dried 
over Na2SO4, filtered, and concentrated. The crude material was purified by flash-column 
chromatography (2:1 hexanes/EtOAc) to give S5 as a yellow solid (190 mg, 59% yield). 
IR (thin film) 3389, 2975, 2952, 2891, 1557, 1475, 1408, 1238, 1012, 997, 736 cm
-1
 
1
H NMR (300 MHz, CDCl3) δ 7.33 (s, 2 H), 5.80 (bs, 1 H), 3.83 (t, J = 6.4 Hz, 2 H), 
2.76 (t, J = 6.4 Hz, 2 H), 1.47 (s, 1 H) 
13
C NMR (75 MHz, CDCl3, DEPT) δ 148.1 (C), 133.5 (C), 132.6 (CH × 2), 109.9 (C × 
2), 63.4 (CH2), 37.7 (CH2) 
HRMS (ESI–) 292.8818 calcd for C8H7Br2O2, found 292.8810 
Phenol S6 
 
Imidazole (48 mg, 0.71 mmol) was added to a solution of alcohol S5 (175 mg, 
0.591 mmol) in THF (6 mL). The solution was cooled to 0 °C and TBSCl (107 mg, 
0.710 mmol) was added. The mixture was stirred for 7 h, then quenched with saturated 
aq. NaHCO3 (10 mL). The mixture was diluted with Et2O and the organic layer was 
                                                 
19
 Although this substrate is commercially available, we chose to prepare it by LAH reduction of the less 
expensive methyl 4-hydroxyphenylacetate. 
Appendix I: Experimental Procedures and Data | 158 
 
 
washed with water and brine, dried over MgSO4, and concentrated. The crude material, a 
mixture of alkyl and aryl silyl ethers, was purified by flash-column chromatography (5:1 
toluene/petroleum ether) to give S6 as a yellow oil (65 mg, 27% yield). 
IR (thin film) 3512, 2955, 2928, 2858, 1563, 1472, 1256, 1163, 1100, 836, 778, 738 cm
-1
 
1
H NMR (300 MHz, CDCl3) δ 7.31 (s, 2 H), 5.77 (s, 1 H), 3.74 (t, J = 6.4 Hz, 2 H), 2.69 
(t, J = 6.4 Hz, 2 H), 0.87 (s, 9 H), –0.03 (s, 6 H) 
13
C NMR (75 MHz, CDCl3, DEPT) δ 147.7 (C), 134.4 (C), 132.8 (CH × 2), 109.5 (C × 
2), 63.9 (CH2), 38.0 (CH2), 26.0 (CH3 × 3), 18.4 (C), −5.3 (CH3 × 2) 
HRMS (ESI–) 406.9683 calcd for C14H21Br2O2Si, found 406.9683 
Hydroxybenzaldehyde S7 
 
Phosphorus oxychloride (83 mL, 0.89 mol) was added dropwise to DMF (250 mL) at 0 
°C. This was transferred via cannula to a solution of 2-methylresorcinol (50.0 g, 
0.40 mol) in DMF (250 mL) at 0 °C. The reaction was stirred for 1.5 h, gradually 
warming to rt The mixture was then cooled to 0 °C and quenched with 2 M NaOH until 
pH 6. The product was extracted with EtOAc and concentrated. The resulting residue was 
recrystallized from hot 10% IPA/H2O to give S7 (30.30 g) as beige crystalline needles. A 
second crop of crystals yielded an additional 6.99 g for a total of 37.29 g (61% yield). 
mp 153.0–154.4 °C (uncorrected) 
IR (neat): 3276, 2780, 1622,1596, 1493, 1435, 1306, 1251, 1217, 1095 cm
-1
 
1
H NMR (300 MHz, CDCl3)  11.67 (s, 1 H), 9.69 (s, 1 H), 7.29 (d, J = 8.5 Hz, 1 H), 
6.47 (d, J = 8.5 Hz, 1 H), 5.62 (s, 1 H), 2.14 (s, 3 H) 
13
C NMR (75 MHz, CDCl3)  194.8, 162.4, 161.2, 133.1, 115.3, 111.2, 108.2, 7.2 
HRMS (ESI+) 151.0390 calcd for C8H7O3, found 151.0399 
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Benzyloxybenzaldehyde S8 
 
A literature procedure was adapted.
20
 2,4-Dihydroxy-3-methylbenzaldehyde (S7) (30.0 g, 
0.197 mol), NaHCO3 (18.88 g, 0.23 mol), and KI (6.54 g, 0.039 mol) were dissolved in 
MeCN (500 mL). The flask was fitted with a reflux condenser and slowly warmed to 60 
°C. At this time, benzyl bromide (28.3 mL, 0.236 mol) was added and the mixture was 
warmed to 80 °C. After refluxing overnight, KHCO3 (9.86 g, 0.099 mol) was added and 
the mixture was stirred for an additional 5 h, then cooled to rt and concentrated. The 
residue was quenched with 10% aq. HCl (100 mL) and extracted with EtOAc. The 
combined organic layers were washed with brine, dried with Na2SO4, filtered, and 
concentrated. The resulting oil was purified by flash-column chromatography using 
100% hexanes until removal of benzyl bromide, then 6:1 hexanes/EtOAc to afford a S8 
as a yellow solid (46.89 g, 98% yield). 
IR (thin film) 3030, 2923, 2839, 1641, 1626, 1498, 1289, 1250, 1111 cm
-1
 
1
H NMR (300 MHz, CDCl3)  11.47 (s, 1 H), 9.71 (s, 1 H), 7.42–7.34 (m, 6 H), 6.61 (d, 
J = 8.7, 1H), 5.19 (s, 2 H), 2.17 (s, 3 H) 
13
C NMR (75 MHz, CDCl3)  194.9, 163.5, 161.3, 136.4, 133.3, 128.8, 128.3, 127.2, 
115.6, 104.4, 104.2, 70.4, 7.7 
HRMS (CI, CH4) 243.1016 calcd for C15H15O3, found 243.1031 
                                                 
20
 Mendelson, W. L.; Holmes, M.; Dougherty, J. Synth. Commun. 1996, 26, 593–601. 
Appendix I: Experimental Procedures and Data | 160 
 
 
Methoxybenzaldehyde S9 
 
To a solution of benzaldehyde S8 (18.5 g, 0.076 mol) in DMF (300 mL) was added 
K2CO3 (31.7 g, 0.229 mol) and MeI (5.14 mL, 0.826 mol). The flask was fitted with a 
reflux condenser and the solution was heated to 80 °C for 3 hours. The reaction was then 
cooled to rt, diluted with water and extracted with Et2O. The combined organic layers 
were washed with water, 10% aq. NaOH and brine; dried over MgSO4; filtered; and 
concentrated to obtain S9 as a yellow solid (19.1 g, 97% yield). 
IR (thin film) 2934, 2861, 1678, 1591, 1277, 1256, 1100 cm
-1
 
1
H NMR (300 MHz, CDCl3)  10.24 (s, 1 H), 7.73 (d, J = 8.7 Hz, 1 H), 7.46–7.32 (m, 
5 H), 6.81 (d, J = 8.7 Hz, 1 H), 5.16 (s, 2 H), 3.87 (s, 3 H), 2.23 (s, 3 H) 
13
C NMR (75 MHz, CDCl3)  189.3, 163.2, 162.8, 136.4, 128.8, 128.3, 128.0, 127.3, 
123.1, 120.7, 107.9, 70.4, 63.4, 8.9 
HRMS (ESI+) 279.0992 calcd for C16H16NaO3, found 279.0986 
Phenol S10 
 
Benzaldehyde S9 (15.0 g, 58.5 mmol) 10% Pd/C
21
 (3 mol%, 3.2 g) were suspended in 
MeOH (250 mL) and placed under a H2 atmosphere (balloon). The mixture was stirred 
for 3 h. After such time, 1 drop of conc. HCl was added and the reaction was stirred 
overnight. The mixture was then filtered through a pad of Celite and concentrated. The 
                                                 
21
 Pd/C catalyst obtained from Johnson Matthey (56% H2O, Type 10R39). 
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crude residue was purified by flash-column chromatography (3:1 hexanes/EtOAc) to give 
S10 as a pale yellow crystalline solid (8.6 g, 96% yield). 
IR (neat) 3388, 2940, 2861, 1603, 1496, 1469, 1411, 1285, 1079, 999 cm
-1
 
1
H NMR (500 MHz, CDCl3)  6.87 (d, J = 8.1 Hz, 1 H), 6.50 (d, J = 8.2, 1 H), 4.58 (s, 
H), 3.71 (s, 3 H), 2.21 (s, 3 H), 2.18 (s, 3 H) 
13
C NMR (75 MHz, CDCl3)  157.5, 153.0, 128.2, 122.9, 117.4, 110.8, 60.1, 15.8, 9.0 
HRMS (CI, CH4) 153.0910 calcd for C9H13O2, found 153.0930 
Phenol S11 
 
A solution of 2-bromo-4-methyl phenol (500 mg, 2.67 mmol) in 1 mL of 
hexamethyldisilazane was heated at 125 ºC for 20 min in a microwave reactor.
14
 After 
excess hexamethyldisilazane was removed in vacuo, the resulting TMS ether was 
dissolved in 15 mL of dry THF and cooled to −100 ºC. n-BuLi (2.5 M in hexanes, 
1.06 mL, 2.65 mmol) was added slowly, then the mixture was allowed to warm to −50 
ºC. The reaction was then quenched with saturated aq. NH4Cl (10 mL). The cooling bath 
was removed and the mixture was diluted with Et2O, washed with brine, dried over 
MgSO4, filtered, and concentrated. Flash-column chromatography (95:5 hexanes/EtOAc) 
afforded phenol S11 (343.1 mg, 62% yield over two steps). 
IR (thin film) 3533, 2953, 1599, 1490, 1389, 1244, 1181, 1073, 890, 839 cm
-1
 
1
H NMR (300 MHz, CDCl3) δ 7.16 (d, J = 1.7 Hz, 1 H), 7.04 (dd, J = 8.1, 2.3 Hz, 1 H), 
6.59 (d, J = 8.1, 1 H), 4.62 (s, 1 H), 2.29 (s, 3 H), 0.31 (s, 9 H) 
13
C NMR (75 MHz, CDCl3, DEPT) δ 158.3 (C), 135.8 (CH), 131.2 (CH), 129.5 (C), 
125.2 (C), 114.5 (CH), 20.7 (CH3), −0.8 (CH3 × 3) 
HRMS (ESI–) 179.0887 calcd for C10H15OSi, found 179.1305 
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Phenol S12 
 
Phenol S10 (500 mg, 3.29 mmol) was dissolved in chloroform (30 mL). To this, 1,3-
dibromo-5,5-dimethylhydantoin (70 mg, 2.5 mmol) was added portionwise. The reaction 
mixture was protected from light and stirred overnight before being quenched with 10% 
aq. Na2S2O3 and extracted with CH2Cl2. The combined organic layers were washed with 
brine, dried over MgSO4, filtered, and concentrated. The resulting brown solid was 
purified by flash-column chromatography (9:1 hexanes/EtOAc) to afford S12 as a yellow 
solid (39 mg, 51% yield), which quickly turned brown upon standing (product is 
suspected to be light sensitive). 
IR (neat) 3511, 2939, 1596, 1470, 1405, 1308, 1235, 1209, 1085, 1003, 778 cm
-1
 
1
H NMR (300 MHz, CDCl3) δ 7.12 (s, 1 H), 5.42 (s, 1 H), 3.69 (s, 3 H), 2.23 (s, 3 H), 
2.20 (s, 3 H) 
13
C NMR (75 MHz, CDCl3, DEPT) δ 157.3 (C), 149.3 (C), 129.8 (CH), 124.3 (C), 119.2 
(C), 104.7 (C), 60.1 (CH3), 15.6 (CH3), 10.1 (CH3) 
HRMS (ESI+) 229.9937 calcd for C9H11BrO2, found 229.0151 
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Sulfide-tethered cyclohexadienone S13 
 
Using general method C, 2-(p-tolylthio)acetic acid (2.22)
22
 was coupled to 2.17a to give 
sulfide S13 in 65% yield after flash-column chromatography (3:1 hexanes/EtOAc). 
IR (thin film) 3022, 2779, 2924, 1739, 1668, 1631, 1269, 1134, 1052, 857 cm
-1
 
1
H NMR (300 MHz, CDCl3) δ 7.31 (d, J = 8.1 Hz, 2 H), 7.11 (d, J = 8.0 Hz, 2 H), 6.72 
(d, J = 10.2 Hz, 2 H), 6.17 (d, J = 10.2 Hz, 2 H), 3.52 (s, 2 H), 2.31 (s, 3 H), 1.45 (s, 3 H) 
13
C NMR (75 MHz, CDCl3, DEPT) δ 184.9 (C), 168.3 (C), 148.5 (CH × 2), 137.8 (C), 
131.4 (CH × 2), 130.6 (C), 129.9 (CH × 2), 128.3 (CH × 2), 75.0 (C), 37.5 (CH2), 26.0 
(CH3), 21.1 (CH3) 
HRMS (ESI+) 311.0712 calcd for C16H16O3SNa, found 311.0708 
                                                 
22
 (a) Prepared according to Kenney, W. J.; Walsh, J. A.; Davenport, D. A. J. Am. Chem. Soc. 1961, 83, 
4019–4022. (b) Nagao, Y.; Miyamoto, S.; Miyamoto, M.; Takeshige, H.; Hayashi, K.; Sano, S.; 
Shiro, M.; Yamaguchi, K.; Sei, Y. J. Am. Chem. Soc. 2006, 128, 9722–9729. 
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 Experimental Details – Chapter 3 
General method F: Pd-catalyzed cyclization 
A mixture of the appropriate cyclohexadienone (1 equiv), Pd(OAc)2 (0.05 equiv.), and 
ligand (0.1 equiv) was suspended in acetic acid and heated to 80 °C. The reaction mixture 
was stirred until the starting material was consumed (2–144 h). The solvent was removed 
under vacuum and the resulting residue was purified by flash column chromatography. 
Product configuration was determined by analogy to 3.63a, 3.62i, or 3.89m, unless 
otherwise stated. 
Alkyne-tethered cyclohexadienone 3.62d 
 
4-Ethylphenol (107 mg, 0.876 mmol) was dissolved in 2-butyn-1-ol (1 mL) and cooled to 
0 ºC. PIFA (377 mg, 0.877 mmol) was added and the mixture and stirred for 1 h. The 
reaction mixture was diluted with EtOAc; washed with saturated aq. NaHCO3, water, and 
brine; dried over Na2SO4; filtered; and concentrated under reduced pressure. The 
resulting residue was purified by flash column chromatography (3:1 hexanes/EtOAc) to 
give cyclohexadienone 3.62d (60 mg, 36% yield) as a yellow oil. 
IR (thin film) 2970, 2922, 2858, 1669, 1632, 1515, 1082, 1051, 859 cm
-1
 
1
H NMR (500 MHz, CDCl3): δ 6.77 (d, J = 10.3 Hz, 2 H), 6.37 (d, J = 10.2 Hz, 2 H), 
3.99 (q, J = 2.4 Hz, 2 H), 1.84 (t, J = 2.4 Hz, 3 H), 1.84 (q, J = 7.7 Hz, 2 H), 0.83 (t, J = 
7.6 Hz, 3 H) 
13
C NMR (75 MHz, CDCl3, DEPT) δ 185.6 (C), 150.4 (CH × 2), 131.7 (CH × 2), 129.0 
(C), 115.2 (C), 75.9 (C), 54.4 (CH2), 32.4 (CH2), 8.0 (CH3), 3.9 (CH3) 
HRMS (ESI+): Calculated for C12H14O2Na
+
: 213.0886; Observed: 213.0885 
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Alkyne-tethered cyclohexadienone 3.62e 
 
4-Isopropylphenol (136 mg, 0.999 mmol) was dissolved in 2-butyn-1-ol (1 mL) and 
cooled to 0 ºC. PIFA (430 mg, 1.00 mmol) was added and the mixture and stirred for 2 h. 
The reaction mixture was diluted with EtOAc; washed with saturated aq. NaHCO3, water, 
and brine; dried over Na2SO4; filtered; and concentrated under reduced pressure. The 
resulting residue was purified by flash column chromatography (3:1 hexanes/EtOAc) to 
give cyclohexadienone 3.62e (36 mg, 18% yield) as a yellow oil. 
IR (thin film) 2964, 2922, 1669, 1630, 1384, 1048, 855 cm
-1
 
1
H NMR (500 MHz, CDCl3): δ 6.78 (d, J = 10.3 Hz, 2 H), 6.39 (d, J = 10.3 Hz, 2 H), 
3.96 (q, J = 2.4 Hz, 2 H), 2.05 (sept, J = 6.9 Hz, 1 H), 1.84 (t, J = 2.4 Hz, 3 H), 0.95 (d, J 
= 6.9 Hz, 6 H) 
13
C NMR (75 MHz, CDCl3, DEPT) δ 185.7 (C), 149.6 (CH × 2), 132.3 (CH × 2), 83.1 
(C), 78.8 (C), 76.1 (C), 54.3 (CH2), 36.7 (CH), 17.2 (CH3 × 2), 3.87 (CH3) 
HRMS (ESI+): Calculated for C13H16O2Na
+
: 227.1043; Observed: 227.1043 
Alkyne-tethered cyclohexadienone 3.62f 
 
Methyl 4'-hydroxyphenylacetate (166 mg, 0.999 mmol) was dissolved in 2-butyn-1-ol 
(1 mL) and cooled to 0 ºC. PIFA (430 mg, 1.00 mmol) was added and the mixture and 
stirred for 1 h. The reaction mixture was diluted with EtOAc; washed with saturated aq. 
NaHCO3, water, and brine; dried over Na2SO4; filtered; and concentrated under reduced 
pressure. The resulting residue was purified by flash column chromatography (3:1 
hexanes/EtOAc) to give cyclohexadienone 3.62f (58 mg, 25% yield) as a yellow oil. 
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IR (thin film) 2953, 2922, 2856, 1734, 1670, 1634, 1436, 1159, 1051, 860 cm
-1
 
1
H NMR (500 MHz, CDCl3): δ 6.97 (d, J = 10.3 Hz, 2 H), 6.37 (d, J = 10.3 Hz, 2 H), 
3.98 (q, J = 2.4 Hz, 2 H), 3.66 (s, 3 H), 2.78 (s, 2 H), 1.83 (t, J = 2.4 Hz, 3 H) 
13
C NMR (75 MHz, CDCl3, DEPT) δ 185.0 (C), 168.7 (C), 148.4 (CH × 2), 131.6 (CH × 
2), 83.8 (C), 75.5 (C), 73.2 (C), 54.3 (CH2), 52.2 (CH3), 44.6 (CH2), 3.8 (CH3) 
HRMS (ESI+): Calculated for C13H14O4Na
+
: 257.0784; Observed: 257.0781 
Alkyne-tethered cyclohexadienone 3.62h 
 
Terminal alkyne 3.62a (155.6 mg, 0.9594 mmol), Pd(Ph3P)2Cl2 (6.7 mg, 0.0095 mmol), 
and CuI (0.9 mg, 0.005 mmol) were suspended in Et3N (5 mL). 2-Bromopyridine 
(0.10 mL, 1.0 mmol) was added and the mixture was stirred overnight. The reaction 
mixture was then diluted with Et2O, washed with brine, dried over MgSO4, filtered, and 
concentrated under reduced pressure. The crude material was purified by flash-column 
chromatography (1:1 hexanes/EtOAc) to give 3.62h (103.7 mg, 46% yield), although it 
still contained significant impurities. 
1
H NMR (300 MHz, CDCl3) δ 8.58 (dt, J = 4.9, 0.8 Hz, 1 H), 7.66 (td, J = 7.7, 1.8 Hz, 
1 H), 7.42 (d, J = 7.8 Hz, 1 H), 7.28-7.23 (m, 1 H), 6.90 (d, J = 10.2 Hz, 3 H), 6.35 (d, 
J = 10.2 Hz, 3 H), 4.25 (s, 2 H), 1.51 (s, 3 H). 
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Alkyne-tethered cyclohexadienone 3.62i 
 
Dienone 3.70i (27 mg, 0.099 mmol) and Cs2CO3 (49 mg, 0.15 mmol) were added to a 
solution of 5-iodopent-2-yne
23
 (60 mg, 0.33 mmol) in acetonitrile (1 mL). The mixture 
was stirred for 5 h, at which point it was diluted with CH2Cl2, washed with water and 
brine, dried over MgSO4, filtered and concentrated under reduced pressure to give alkyne 
3.62i as a white solid (28 mg, 86% yield). 
IR
 
(thin film) 2919, 1667, 1628, 1333, 1157, 1090, 889, 861, 810 cm
-1
 
1
H NMR (500 MHz, CDCl3): δ 7.79 (d, J = 8.3 Hz, 2 H), 7.28 (d, J = 8.2 Hz, 2 H), 7.03 
(d, J = 10.2 Hz, 2 H), 6.14 (d, J = 10.2 Hz, 2 H), 4.23 (q, J = 2.3 Hz, 2 H), 2.43 (s, 3 H), 
1.78 (t, J = 2.3 Hz, 3 H), 1.60 (s, 3 H) 
13
C NMR (75 MHz, CDCl3, DEPT): δ 184.7 (C), 151.8 (CH × 2), 143.9 (C), 138.6 (C), 
129.5 (CH × 2), 128.0 (CH × 2), 127.7 (CH × 2), 81.9 (C), 75.6 (C), 60.0 (C), 37.0 (CH2), 
26.3 (CH3), 21.7 (CH3), 3.6 (CH3) 
HRMS (ESI+): Calculated for C18H19NO3SNa
+
: 352.0978; Observed: 352.0975 
Alkyne-tethered cyclohexadienone 3.62j 
 
A mixture of 3.70j (249 mg, 0.734 mmol) and Cs2CO3 (357 mg, 1.10 mmol) was treated 
with a solution of 5-iodopent-2-yne
23
 in MeCN (7 mL). The reaction mixture was stirred 
for 1.5 h, and then concentrated under reduced pressure. The resulting solids were 
partitioned between CH2Cl2 and water. The aqueous layer was extracted with EtOAc and 
                                                 
23
 Hewson A. T.; MacPherson, D. T. J. Chem. Soc. Perkin Trans. 1 1985, 2625–2635. 
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the combined organic layers were dried over Na2SO4, filtered, and concentrated under 
reduced pressure. The resulting residue was purified by flash column chromatography 
(2:1 hexanes/EtOAc) to give alkyne 3.62j (287 mg, 100% yield) as a white foam. 
IR (thin film) 3062, 2919, 1668, 1629, 1339, 1159, 1089, 923, 811, 699 cm
-1
 
1
H NMR (300 MHz, CDCl3): δ 7.69 (d, J = 8.3 Hz, 2 H), 7.38–7.30 (m, 7 H), 7.19 (d, J = 
8.4 Hz, 2 H), 6.10 (d, J = 10.1 Hz, 2 H), 4.08 (q, J = 2.3 Hz, 2 H), 2.39 (s, 3 H), 1.75 (t, J 
= 2.3 Hz, 3 H) 
13
C NMR (75 MHz, CDCl3, DEPT) δ 184.7 (C), 147.8 (CH × 2), 144.0 (C), 138.1 (C), 
137.2 (C), 129.4 (CH × 2), 129.1, (CH), 129.1 (CH × 2), 128.5 (CH × 2), 127.5 (CH × 2), 
126.7 (CH × 2), 81.7 (C) 75.5 (C), 65.1 (C), 37.3 (CH2), 21.6 (CH3), 3.7 (CH3) 
HRMS (ESI+): Calculated for C23H21NO3SNa
+
: 414.1134; Observed: 414.1132 
Alkyne-tethered cyclohexadienone 3.62k 
 
A mixture of phenol 3.73k (199 mg, 1.24 mmol) and NaHCO3 (521 mg, 6.20 mmol) was 
suspended in methanol (12 mL) and cooled to 0 ºC. PIFA (587 mg, 1.37 mmol) was 
added and the mixture and stirred for 20 min. The methanol was then removed under 
reduced pressure, and the resulting residue was purified by flash column chromatography 
(9:1 hexanes/EtOAc) to give cyclohexadienone 3.62k (46 mg, 19% yield). 
IR (thin film) 3040, 2933, 2827, 1673, 1632, 1075, 861, 703 cm
-1
 
1
H NMR (300 MHz, CDCl3): δ 6.73 (d, J = 10.2 Hz, 2 H), 6.34 (d, J = 10.2 Hz, 2 H), 
3.17 (s, 3 H), 2.12 (tq, J = 7.7, 2.5 Hz, 2 H), 1.89 (t, J = 7.9 Hz, 2 H), 1.71 (t, J = 2.5 Hz, 
3 H) 
13
C NMR (75 MHz, CDCl3, DEPT) δ 185.3 (C), 150.5 (CH × 2), 131.7 (CH × 2), 78.1 
(C), 76.7 (C), 75.1 (C), 53.1 (CH3), 39.0 (CH2), 13.5 (CH2), 3.5 (CH3) 
HRMS (ESI+): Calculated for C12H15O2
+
: 191.1067; Observed: 191.1053 
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Alkyne-tethered cyclohexadienone 3.62l 
 
A mixture of phenol 3.73l (135 mg, 0.661 mmol) and NaHCO3 (277 mg, 3.30 mmol) was 
suspended in methanol (6 mL) and cooled to 0 ºC. PIFA (312 mg, 0.726 mmol) was 
added in small portions. The reaction mixture was stirred for 30 min, and then diluted 
with CH2Cl2, filtered through a silica gel plug, and concentrated under reduced pressure. 
The crude material was a mixture of the desired product and an impurity.
24
 The residue 
was dissolved in acetic acid, heated to 50 ºC, and stirred overnight. The acetic acid was 
removed under reduced pressure and the resulting residue was purified by flash column 
chromatography (5:1 hexanes/EtOAc) to give cyclohexadienone 3.62l (38 mg, 25% 
yield) as a yellow oil. An additional ~35 mg of product was obtained in fractions 
containing an unknown impurity. 
IR (thin film) 2968, 2929, 1671, 1631, 1078, 859 cm
-1
 
1
H NMR (300 MHz, CDCl3) δ 6.74 (d, J = 10.3 Hz, 2 H), 6.36 (d, J = 10.3 Hz, 2 H), 
4.06–4.05 (m, 2 H), 3.50 (q, J = 7.0 Hz, 2 H), 3.19 (s, 3 H), 2.27–2.21 (m, 2 H), 1.95 (t, J 
= 7.7 Hz, 2 H), 1.19 (t, J = 7.0 Hz, 3 H) 
13
C NMR (75 MHz, CDCl3, DEPT) δ 185.0 (C), 150.1 (CH × 2), 131.7 (CH × 2), 85.2 
(C), 77.2 (C), 74.8 (C), 65.3 (CH2), 58.2 (CH2), 53.0 (CH3), 38.5 (CH2), 15.0 (CH3), 13.5 
(CH2) 
HRMS (ESI+): Calculated for C14H18O3Na
+
: 257.1148; Observed: 257.1156 
                                                 
24
 This impurity can likely be attributed to product rearrangement to reestablish aromaticity followed by an 
additional oxidation to form the dimethyl acetal. 
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Alkyne-tethered cyclohexadienone 3.62m 
 
Phenol 3.73m (60 mg, 0.27 mmol) and NaHCO3 (116 mg, 1.38 mmol) were 
suspended in methanol (2.5 mL). PIFA (131 mg,  0.305 mmol) was added in small 
portions. The reaction mixture was stirred for 20 min, and then diluted with CH2Cl2, 
filtered through a silica gel plug, and concentrated under reduced pressure. The residue 
was dissolved in acetic acid, heated to 50 ºC, and stirred overnight. The acetic acid was 
removed under reduced pressure and the resulting residue was purified by flash column 
chromatography (3:1 hexanes/EtOAc) to give cyclohexadienone 3.62m (35 mg, 52% 
yield) as a yellow oil. 
IR (thin film) 2937, 2827, 1745, 1745, 1672, 1633, 1227, 1097, 1076, 1026, 862 cm
-1
 
1
H NMR (300 MHz, CDCl3) δ 6.69 (d, J = 10.3 Hz, 2 H), 6.30 (d, J = 10.3 Hz, 2 H), 4.54 
(t, J = 2.1 Hz, 2 H), 3.12 (s, 3 H), 2.19 (tt, J = 7.8, 1.9 Hz, 2 H), 2.00 (s, 3 H), 1.88 (t, J = 
7.8 Hz, 2 H) 
13
C NMR (75 MHz, CDCl3, DEPT) δ 185.0 (C), 170.2 (C), 150.1 (CH × 2), 131.8 (CH × 
2), 86.1 (C), 75.0 (C), 74.7 (C), 53.0 (CH3), 52.5 (CH2), 38.2 (CH2), 20.7 (CH3), 13.4 
(CH2) 
HRMS (ESI+): Calculated for C14H16O4Na
+
: 271.0941; Observed: 271.0946 
Alkyne-tethered cyclohexadienone 3.62n25 
 
Enone 3.78 (28 mg, 0.16 mmol), DDQ (42 mg, 0.19 mmol), and anhydrous p-
TsOH (27 mg, 0.16 mmol) were dissolved in 1,4-dioxane (3 mL). The reaction mixture 
                                                 
25
 Procedure adapted from: Chai K.-B.; Sampson, P. J. Org. Chem. 1993, 58, 6807–6813. 
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was refluxed for 7 h. It was then diluted with diethyl ether, washed with 10% aq. NaOH 
and brine, dried over MgSO4, filtered, and concentrated under reduced pressure. The 
resulting residue was purified by flash column chromatography (3:1 hexanes/EtOAc) to 
give cyclohexadienone 3.62n (15 mg, 54% yield) as a colorless oil. 
1
H NMR (300 MHz, CDCl3) δ 6.75 (d, J = 10.2 Hz, 2 H), 6.27 (d, J = 10.2 Hz, 2 H), 
1.95–1.82 (m, 4 H), 1.72 (t, J = 2.4 Hz, 3 H), 1.25 (s, 3 H) 
13
C NMR (75 MHz, CDCl3, DEPT) δ 186.2 (C), 154.9 (CH × 2), 129.4 (CH × 2), 78.3 
(C), 76.7 (C), 41.9 (C), 40.0 (CH2), 26.2 (CH3), 15.0 (CH2), 3.5 (CH3) 
HRMS (ESI+): Calculated for C12H14ONa
+
: 197.0937; Observed: 197.0932 
Bicyclic enones 3.63b and 3.89b 
 
Cyclohexadienone 3.62b
26
 was cyclized using general method F to give 3.63b and 3.89b 
after flash column chromatography (5:1 hexanes/EtOAc). Product 3.62b has been 
reported previously.
26
 
3.89b: 
1
H NMR (300 MHz, CDCl3) δ 6.68 (d, J = 10.2 Hz, 1 H), 6.02 (d, J = 10.2 Hz, 1 H), 4.08 
(dq, J = 1.9, 1.9 Hz, 2 H), 2.71–2.65 (m, 1 H), 2.64–2.59 (m, 1 H) 2.58–2.53 (m, 1 H), 
2.16 (s, 3 H), 1.59 (t, J = 1.9 Hz, 3 H), 1.52 (s, 3 H) 
HPLC (CHIRALCEL AS, 10% isopropanol in hexanes, 1 mL/min, λ = 225 nm) 
TR = 15.7, 23.2 min 
                                                 
26
 Tello-Aburto, R.; Harned, A. M. Org. Lett. 2009, 11, 3998–4000. 
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Bicyclic enone 3.63c 
 
Cyclohexadienone 3.62c was cyclized using general method F to give 3.63c after flash 
column chromatography. This product has been reported previously.
27
 
HPLC (CHIRALCEL OD, 10% isopropanol in hexanes, 1 mL/min, λ = 225 nm) 
TR = 13.1, 17.6 min 
Bicyclic enone 3.63d 
 
Cyclohexadienone 3.62d was cyclized using general method F to give 3.63d after flash 
column chromatography (2:1 hexanes/EtOAc). 
IR (thin film) 2969, 2924, 2882, 2853, 1754, 1688, 1378, 1256, 1208, 1093, 934 cm
-1
 
1
H NMR (500 MHz, CDCl3) δ 6.59 (d, J = 10.3 Hz, 2 H), 6.08 (d, J = 10.3 Hz, 2 H), 
4.31–4.30 (m, 1 H), 4.23 (ddq, J = 13.2, 2.0, 2.0 Hz, 1 H), 3.13 (app t, J = 6.0 Hz, 1 H), 
2.74 (dd, J = 16.4, 6.5 Hz, 1 H), 2.59 (dd, J = 16.4, 5.8 Hz, 1 H), 2.10 (s, 3 H), 1.93 (ddd, 
J = 1.7, 1.7, 1.7 Hz, 3 H), 1.82–1.74 (m, 2 H), 1.00 (t, J = 7.5 Hz, 3 H) 
13
C NMR (75 MHz, CDCl3, DEPT) δ 197.5 (C), 168.4 (C), 148.7 (CH), 138.9 (C), 130.6 
(CH), 128.3 (C), 82.6 (C), 67.6 (CH2), 43.0 (CH), 38.4 (CH2), 29.9 (CH2), 20.8 (CH3), 
17.2 (CH3), 8.3 (CH3) 
HRMS (ESI+): Calculated for C14H18O4Na
+
: 273.1097; Observed: 273.1094 
HPLC (CHIRALCEL OD, 10% isopropanol in hexanes, 1 mL/min, λ = 225 nm) 
TR = 8.7, 10.2 min 
                                                 
27
 Hexum, J. K.; Tello-Aburto, R.; Struntz, N. B.; Harned, A. M.; Harki, D. A. ACS Med. Chem. Lett. 2012, 
459–464 
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Bicyclic enone 3.63e 
 
Cyclohexadienone 3.62e was cyclized using general method F to give 3.63d after flash 
column chromatography (3:1 hexanes/EtOAc). 
IR (thin film) 2964, 1755, 1689, 1370, 1209, 1175, 1013, 938 cm
-1
 
1
H NMR (500 MHz, CDCl3) δ 6.59 (d, J = 10.4 Hz, 1 H), 6.15 (d, J = 10.4 Hz, 1 H), 
4.29–4.25 (m, 1 H), 4.20 (ddq, J = 13.1, 2.1, 2.1 Hz, 1 H), 3.22 (app t, J = 6.0 Hz, 1 H), 
2.71 (dd, J = 16.5, 6.3 Hz, 1 H), 2.60 (dd, J = 16.5, 6.2 Hz, 1 H), 2.10 (s, 3 H), 2.04 (qq, J 
= 6.9, 6.9 Hz, 1 H), 1.92 (ddd, J = 1.6, 1.6, 1.6 Hz, 3 H), 1.05 (d, J = 6.9 Hz, 3 H), 0.97 
(d, J = 6.9 Hz, 3 H) 
13
C NMR (75 MHz, CDCl3, DEPT) δ 197.7 (C), 168.5 (C), 147.2 (CH), 138.7 (C), 131.4 
(CH), 129.1 (C), 84.8 (C), 67.2 (CH2), 41.3 (CH), 39.16 (CH2), 34.35 (CH), 20.8 (CH3), 
17.6 (CH3), 17.2 (CH3), 17.1 (CH3) 
HRMS (ESI+): Calculated for C15H20O4Na
+
: 287.1252; Observed: 287.1252 
HPLC (CHIRALCEL OJ, 10% isopropanol in hexanes, 1 mL/min, λ = 225 nm) 
TR = 17.7, 25.7 min 
Bicyclic enone 3.63f 
 
Cyclohexadienone 3.62f was cyclized using general method F to give 3.63f after flash 
column chromatography (3:1 hexanes/EtOAc). 
IR (thin film) 2991, 2954, 2925, 2843, 1738 (br), 1688, 1437, 1371, 1209, 1146, 1011, 
944 cm
-1
 
1
H NMR (500 MHz, CDCl3) δ 6.77 (d, J = 10.3 Hz, 1 H), 6.10 (d, J = 10.3 Hz, 1 H), 
4.37–4.33 (m, 1 H), 4.33–4.29 (m, 1 H), 3.70 (s, 3 H), 3.41 (app t, J = 6.6 Hz, 1 H), 2.78 
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(d, J = 14.3 Hz, 1 H), 2.75 (d, J = 14.1 Hz, 1 H), 2.71 (dd, J = 16.2, 7.4 Hz, 1 H), 2.64 
(dd, J = 16.4, 6.0 Hz, 1 H), 2.11 (s, 3 H), 1.94 (ddd, J = 1.1, 1.1, 1.1 Hz, 3 H) 
13
C NMR (75 MHz, CDCl3, DEPT) δ 197.0 (C), 169.8 (C), 168.3 (C), 146.3 (CH), 139.5 
(C), 130.8 (CH), 127.3 (C), 80.0 (C), 67.9 (CH2), 52.2 (CH3), 43.8 (CH), 42.3 (CH2), 
38.3 (CH2), 20.8 (CH3), 17.3 (CH3) 
HRMS (ESI+): Calculated for C15H18O6Na
+
: 317.0996; Observed: 317.1007 
HPLC (CHIRALCEL OD, 10% isopropanol in hexanes, 1 mL/min, λ = 225 nm) 
TR = 17.3, 23.2 min 
Bicyclic enone 3.63g 
 
Cyclohexadienone 3.62g was cyclized using general method F to give 3.63g after flash 
column chromatography. This product has been reported previously.
26 
HPLC (CHIRALCEL AS, 10% isopropanol in hexanes, 1 mL/min, λ = 254 nm) 
TR = 14.0, 23.7 min 
Bicyclic enone 3.63i 
 
Cyclohexadienone 3.62i was cyclized using general method F to give 3.63i after flash 
column chromatography (2:1 hexanes/EtOAc). The configuration of 3.63i was confirmed 
by NOE and HMBC NMR experiments. 
IR (thin film) 3041, 2967, 2925, 1752, 1687, 1337, 1206, 1158, 1096, 731, 674 cm
-1
 
1
H NMR (500 MHz, CDCl3) δ 7.65 (d, J = 8.2 Hz, 2 H), 7.25 (d, J = 7.2 Hz, 2 H), 7.17 
(d, J = 10.3 Hz, 1 H), 6.00 (d, J = 10.3 Hz, 1 H), 4.11 (dq, J = 14.3, 1.7 Hz, 1 H), 3.95–
3.92 (m, 1 H), 2.95 (dd, J = 12.4, 5.1 Hz, 1 H), 2.40 (s, 3 H), 2.32 (dd, J = 16.2, 5.1 Hz, 
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1 H), 2.14 (s, 3 H), 2.13 (dd, J = 16.1, 12.6 Hz, 1 H), 1.86 (t, J = 1.8 Hz, 3 H), 1.51 (s, 
3 H) 
13
C NMR (75 MHz, CDCl3, DEPT) δ 197.2 (C), 168.3 (C), 148.4 (CH), 143.9 (C), 140.8 
(C), 137.3 (C), 129.8 (CH × 2), 128.8 (CH), 127.1 (CH × 2), 122.3 (C), 63.7 (C), 49.2 
(CH), 48.5 (CH2), 38.7 (CH2), 26.1 (CH3), 21.7 (CH3), 20.9 (CH3), 16.8 (CH3) 
HRMS (ESI+): Calculated for C20H23NO5SNa
+
: 412.1189; Observed: 412.1181 
HPLC (CHIRALCEL OD-H, 5% ethanol in hexanes, 1 mL/min, λ = 225 nm) TR = 21.5, 
22.6 min 
Bicyclic enone 3.63j 
 
Cyclohexadienone 3.62j was cyclized using general method F to give 3.63j after flash 
column chromatography (3:1 hexanes/EtOAc). 
IR (thin film) 2960, 2926, 2869, 1755, 1686, 1598, 1339, 1156, 1097, 1066, 762 cm
-1
 
1
H NMR (300 MHz, CDCl3) δ 7.65 (d, J = 8.3 Hz, 2 H), 7.39–7.30 (m, 5 H), 7.27–7.24 
(m, 3 H), 6.20 (d, J = 10.3 Hz, 1 H), 4.31 (dq, J = 14.3, 1.6 Hz, 1H), 4.13–4.07 (m, 1 H), 
3.37 (dd, J = 11.8, 5.0 Hz, 1 H), 2.41 (s, 3 H), 2.32 (dd, J = 16.3, 5.0 Hz, 1 H), 2.12 (s, 
3 H), 1.94 (dd, J = 16.2, 11.8 Hz, 1 H), 1.68 (t, J = 1.7 Hz, 3 H) 
13
C NMR (75 MHz, CDCl3, DEPT) δ 197.0 (C), 168.2 (C), 147.0 (CH), 144.0 (C), 142.3 
(C), 140.6 (C), 137.1 (C), 129.8 (CH × 2), 129.2 (CH), 129.0 (CH × 2), 128.2 (CH), 
127.0 (CH × 2), 126.1 (CH × 2), 121.5 (C), 70.4 (C), 51.6 (CH), 49.8 (CH2), 38.8 (CH2), 
21.7 (CH3), 20.9 (CH3), 16.7 (CH3) 
HRMS (ESI+): Calculated for C25H25NO5SNa
+
: 474.1346; Observed: 474.1351 
HPLC (CHIRALCEL OD, 10% isopropanol in hexanes, 1 mL/min, λ = 254 nm) 
TR = 17.6, 24.7 min 
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Bicyclic enones 3.63k and 3.89k 
 
Cyclohexadienone 3.62k was cyclized using the general method to give a mixture of 
3.63k and 3.90k after flash column chromatography (5:1 hexanes/EtOAc). Products 
3.63k and 3.90k were not separable. The 
1
H NMR data for the mixture of major (3.63k) 
and minor (3.90k) product is listed below. The listed proton count is with respect to the 
individual molecules. For multiplets that cannot be distinguished, the total proton count 
(major & minor) from the spectrum is given. 
1
H NMR (300 MHz, CDCl3) δ 6.86 (d, J = 10.4 Hz, 1 H, major), 6.79 (d, J = 10.3 Hz, 
1 H, minor), 6.08 (dd, J = 10.3, 0.9 Hz, 1 H, minor), 6.05 (dd, J = 10.4, 1.0 Hz, 1 H, 
major), 3.34 (dd, J = 12.8, 6.1 Hz, 1 H, major), 3.25 (s, 3 H, minor), 3.23 (s, 3 H, 
major), 2.90–2.79 (m, 2 H, minor), 2.67 (ddd, J = 16.7, 6.2, 1.0 Hz, 1 H, major), 2.57–
2.35 (m, 2.1 H total, major & minor), 2.34 (dd, J = 16.6, 12.8 Hz, 1 H, major), 2.28 (dd, 
J = 17.5, 13.6 Hz, 1 H, minor), 2.14 (s, 3 H, minor), 2.11 (s, 3 H, major), 2.10–1.85 (m, 
5.9 H total, major & minor) 
Bicyclic enones 3.63l and 3.89l, and vinyl acetate 3.90 
 
Cyclohexadienone 3.62l was cyclized using the general method to give 3.63l, 3.89l, and 
3.91 after flash column chromatography (3:1 hexanes/EtOAc). Products 3.89l and 3.90 
were not separable, but the 
1
H NMR resonances were resolved enough to assign. Product 
3.63l could not be purified enough to obtain a reliable NMR spectrum. The diagnostic 
peaks are listed below. 
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3.63l (diagnostic peaks): 
1
H NMR (300 MHz) δ 6.88 (d, J = 10.4 Hz, 1 H), 6.07 (dd, J = 10.4, 0.8 Hz, 1 H), 2.28 
(ddd, J = 16.8, 6.3, 0.8 Hz, 1 H), 2.28 (dd, J = 16.7, 13.1 Hz, 1 H), 1.20 (t, J = 7.0 Hz, 
3 H) 
3.89l: 
1
H NMR (300 MHz, CDCl3) δ 6.81 (d, J = 10.3 Hz, 1 H), 6.10 (d, J = 10.3 Hz, 1 H), 3.98 
(d, J = 12.0 Hz, 1 H), 3.84 (d, J = 12.0 Hz, 1 H), 3.50–3.30 (m, 2 H), 3.25 (s, 3 H), 2.91 
(dd, J = 16.9, 4.8 Hz, 1 H), 2.57–2.45 (m, 1 H), 2.28 (dd, J = 16.9, 13.0 Hz, 1 H), 2.25–
2.10 (m, 2 H), 2.16 (s, 3 H), 2.05–1.85 (m, 2 H), 1.17 (t, J = 7.0 Hz, 3H) 
3.90: 
1
H NMR (300 MHz, CDCl3) δ 6.71 (d, J = 10.3 Hz, 2 H), 6.37 (d, J = 10.3 Hz, 2 H), 5.21 
(t, J = 6.5 Hz, 1 H), 3.87–3.81 (m, 2 H), 3.50–3.30 (m, 2 H), 3.20 (s, 3 H), 2.25–2.10 (m, 
2 H), 2.14 (s, 3 H), 2.05–1.85 (m, 2 H), 1.17 (t, J = 7.0 Hz, 3 H) 
Bicyclic enones 3.63m and 3.89m 
 
Cyclohexadienone 3.62m was cyclized using the general method to give a mixture of 
3.63m and 3.89m after flash column chromatography (2:1 hexanes/EtOAc). Product 
3.63m was not completely separable from 3.89m, but the 
1
H NMR resonances were 
resolved enough to assign. The resonances listed for 3.63m were present in the spectrum 
of the mixture and could be attributed to the minor component. Other resonances were 
not distinguishable from the baseline or were coincidental with the resonances for 3.89m. 
The configuration of 3.89m was confirmed by NOE and HMBC NMR experiments. 
3.63m: 
1
H NMR (300 MHz, CDCl3) δ 6.87 (d, J = 10.4 Hz, 1 H), 4.82 (d, J = 13.1 Hz, 1 H), 3.66 
(dd, J = 13.0, 6.3 Hz, 1 H), 3.24 (s, 3 H), 2.15 (s, 3 H), 2.06 (s, 3 H) 
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13
C NMR (75 MHz, CDCl3) δ 151.2, 130.9, 110.2, 61.1, 51.4, 44.2, 42.3, 34.9, 29.8, 
27.2, 20.8 
3.89l: 
1
H NMR (500 MHz, CDCl3) δ 6.81 (d, J = 10.3 Hz, 1 H), 6.11 (dd, J = 10.3, 0.7 Hz, 
1 H), 4.57 (d, J = 12.5 Hz, 1 H), 4.54 (d, J = 12.4 Hz, 1H), 3.25 (s, 3 H), 3.17 (dd, J = 
12.8, 4.2 Hz, 1 H), 2.88 (ddd, J = 16.9, 4.6, 0.7 Hz, 1 H), 2.56–2.49 (m, 1 H), 2.32 (dd, J 
= 16.9, 13.0 Hz, 1 H), 2.26–2.21 (m, 1 H), 2.17 (s, 3 H), 2.04 (s, 3 H), 1.98–1.93 (m, 
2 H); 
13
C NMR (75 MHz, CDCl3, DEPT) δ 197.4 (C), 170.8 (C), 168.9 (C), 154.4 (CH), 148.0 
(C), 131.3 (CH), 118.9 (C), 73.9 (C), 59.4 (CH2), 50.8 (CH3), 42.0 (CH2), 37.2 (CH), 
27.8 (CH2), 24.2 (CH2), 21.0 (CH3), 20.9 (CH3) 
Bicyclic enones 3.63n and 3.89n 
 
Cyclohexadienone 3.62n was cyclized using general method F to give a mixture of 3.63n 
and 3.89n after flash column chromatography (195:5 hexanes/acetone). Products 3.63n 
and 3.89n were not separable. The 
1
H NMR data for the mixture of major (3.63n) and 
minor (3.89n) product is listed below. The listed proton count is with respect to the 
individual molecules. For multiplets that cannot be distinguished the total proton count 
(major & minor) from the spectrum is given. 
1
H NMR (300 MHz, CDCl3) δ 6.68 (d, J = 10.2 Hz, 1 H, major), 6.61 (d, J = 10.1 Hz, 
1 H, minor), 5.91 (d, J = 10.1 Hz, 1 H, minor), 5.89 (d, J = 10.2 Hz, 1 H, major), 2.82 
(dd, J = 11.0, 6.1 Hz, 1 H, major), 2.72–2.23 (m, 6.4 H total, major & minor), 2.14 (s, 
3 H, minor), 2.11 (s, 3 H, major), 1.95–1.78 (m, 4.5 H total, major & minor), 1.70–1.60 
(m, 2 H, minor), 1.60–1.50 (m, 2 H, major), 1.20 (s, 3 H, minor), 1.16 (s, 3 H, major) 
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Alkynoate-tethered cyclohexadienone 3.67 
 
2-Octynoic acid (100 μL, 0.686 mmol) and DMF (1 drop) were dissolved in CH2Cl2 and 
cooled to 0 ºC. Oxalyl chloride (59 μL, 0.687 mmol) was added and the solution was 
stirred for 2 h at rt. MgO (55.3 mg, 1.37 mmol) and quinol 2.17a (46 mg, 0.37 mmol) 
were added and the mixture was heated to reflux and stirred overnight. The reaction 
mixture was concentrated under reduced pressure and the remaining residue was purified 
by flash-column chromatography (3:1 hexanes/EtOAc) to provide 3.67 (68.4 mg, 75% 
yield) as a tan solid. 
1
H NMR (300 MHz, CDCl3) δ 6.91 (d, J = 9.8 Hz, 2 H), 6.25 (d, J = 10.2 Hz, 2 H), 2.33 
(t, J = 7.1 Hz, 2 H), 1.60 (s, 3 H), 1.59–1.55 (m, 2 H), 1.41–1.29 (m, 4 H), 0.91 (t, 
J = 6.9 Hz, 3 H) 
Cyclohexadienone 3.70i 
 
Quinone imine acetal 3.69
28
 (804 mg, 2.62 mmol) was dissolved in THF and cooled to –
78 ºC. MeLi (1.6 M in diethyl ether, 1.96 mL, 3.14 mmol) was added and the solution 
was stirred for 1.5 h. The reaction was monitored by TLC using alumina plates and, when 
no starting material remained, 10% aq. HCl (20 mL) was added and the reaction mixture 
was allowed to warm to rt while stirring overnight. The THF was removed under reduced 
pressure and the resulting solids were dissolved in diethyl ether; washed with saturated 
aq. NaHCO3, water, and brine; dried over MgSO4; filtered; and concentrated under 
                                                 
28
 Banfield S. C.; Kerr, M. A. Can. J. Chem. 2004, 82, 131–138. 
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reduced pressure. The resulting residue was purified by flash column chromatography 
(gradient 1:1 hexanes/EtOAc to 100% EtOAc) to give cyclohexadienone 3.70i (480 mg, 
66% yield) as a white powder. 
IR (thin film) 3129, 1662, 1617, 1335, 1160, 1094, 1047, 866 cm
-1
 
1
H NMR (400 MHz, CDCl3) δ 7.68 (d, J = 8.2 Hz, 2 H), 7.27 (d, J = 8.0 Hz, 2 H), 6.66 
(d, J = 10.0 Hz, 2 H), 6.02 (d, J = 10.1 Hz, 2 H), 5.64–5.61 (m, 1 H), 2.42 (s, 3 H), 1.43 
(s, 3 H) 
13
C NMR (75 MHz, CDCl3, DEPT) δ 150.7 (CH × 2), 144.4 (C), 137.4 (C), 129.8 (CH × 
2), 128.2 (CH × 2), 127.9 (CH × 2), 54.6 (C), 27.8 (CH3), 21.7 (CH3) 
HRMS (ESI+): Calculated for C14H15NO3SNa
+
: 300.0665; Observed: 300.0663 
Cyclohexadienone 3.70j 
 
Magnesium turnings (139 mg, 5.72 mmol) were activated by flame drying under vacuum. 
THF (5 mL) was added, followed by bromobenzene (0.49 mL, 4.66 mmol). The mixture 
was stirred for 30 min, and then transferred via cannula to a solution of quinone imine 
acetal 3.69
28
 (292 mg, 0.950 mmol) in THF (5 mL) at –78 ºC. The reaction was 
monitored by TLC using alumina plates and, after 20 min, 10% aq. HCl was added and 
the reaction mixture was allowed to warm to rt over 1 h. The mixture was then extracted 
with diethyl ether and EtOAc. The combined organic layers were dried over MgSO4, 
filtered, and concentrated under reduced pressure. The resulting solid was recrystallized 
from hexanes/EtOAc to give cyclohexadienone 3.70j (250 mg, 78% yield) as a white 
solid. Alternatively, the crude material was of sufficient purity to use without further 
purification.  
IR (thin film) 3089, 2878, 1657, 1611, 1489, 1399, 1334, 1156, 968, 750 cm
-1 
Appendix I: Experimental Procedures and Data | 181 
 
 
1
H NMR (300 MHz, CDCl3) δ 7.66 (d, J = 8.3 Hz, 2 H), 7.45–7.42 (m, 2 H), 7.37–7.33 
(m, 3 H), 7.28–7.25 (m, 2 H), 6.78 (d, J = 10.2 Hz, 2 H), 6.07 (d, J = 10.2 Hz, 2 H), 5.45 
(s, 1 H), 2.43 (s, 3 H) 
13
C NMR (75 MHz, CDCl3, DEPT) δ 185.0 (C), 148.8 (CH × 2), 144.4 (C), 137.9 (C), 
137.4 (C), 129.8 (CH × 2), 129.6 (CH × 2), 129.3 (CH), 128.03 (CH × 2), 127.99 (CH × 
2), 125.9 (CH × 2), 59.9 (C), 21.8 (CH3) 
HRMS (ESI+): Calculated for C19H17NO3SNa
+
: 362.0821; Observed: 362.0823 
Benzyl alcohol 3.71 
 
Activated zinc
29
 (830 mg, 12.7 mmol) was suspended in THF (20 mL) and cooled to 
0 ºC. Propargyl bromide (80% w/w in toluene, 1.88 mL, 12.7 mmol) was added, followed 
by TiCl4 (1 M in CH2Cl2, 0.21 mL, 0.21 mmol). The reaction mixture was stirred for 
5 min before a solution of benzaldehyde 3.70
30
 (1.0 g, 4.2 mmol) in THF (20 mL) was 
added. The mixture was stirred for an additional 1 h before the reaction was quenched 
with saturated aq. NH4Cl (20 mL). The reaction mixture was then extracted with diethyl 
ether. The combined organic layers were dried over MgSO4, filtered, and concentrated 
under reduced pressure. The resulting residue was purified by flash column 
chromatography (5:1 hexanes/EtOAc) to give benzyl alcohol 3.71 (1.08 g, 93% yield). 
IR (thin film) 3386, 3307, 2956, 2933, 2858, 1608, 1511, 1258, 914, 839 cm
-1 
1
H NMR (300 MHz, CDCl3) δ 7.25 (d, J = 8.4 Hz, 2 H), 6.82 (d, J = 8.6 Hz, 2 H), 4.82 
(t, J = 6.4 Hz, 1 H), 2.63–2.60 (m, 2 H), 2.38 (bs, 1 H), 2.07 (t, J = 2.6 Hz, 1 H), 0.98 (s, 
9 H), 0.19 (s, 6 H) 
                                                 
29
 Prepared as described in: Armarego W. L. F.; Chai, C. L. L. Purification of Laboratory Chemicals, 
Butterworth Heinemann, Sydney, 2003, p. 497. 
30
 Kwong, C. K.-W.; Huang, R.; Zhang, M.; Shi M.; Toy, P. H. Chem. Eur. J. 2007, 13, 2369–2376. 
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13
C NMR (75 MHz, CDCl3, DEPT) δ 155.6 (C), 135.3 (C), 127.1 (CH × 2), 120.1 (CH × 
2), 81.0 (C), 72.2 (CH), 70.9 (CH
31
), 29.5 (CH2), 25.8 (CH3 × 3), 18.3 (C), −4.3 (CH3 × 
2) 
HRMS (ESI+): Calculated for C16H24O2SiNa
+
: 299.1438; Observed: 299.1426 
Alkyne 3.72 
 
A solution of alcohol 3.71 (1.0 g, 3.6 mmol) and Et3SiH (1.7 mL, 11 mmol) in CH2Cl2 
(30 mL) was cooled to 0 ºC and BF3·OEt2 (1.4 mL, 11 mmol) was added dropwise. The 
mixture was stirred for 2 h before the reaction was quenched with saturated aq. NaHCO3 
(10 mL). After stirring for an additional 20 min, the reaction mixture was extracted with 
CH2Cl2. The combined organic layers were dried over Na2SO4, filtered through a plug of 
silica gel, and concentrated under reduced pressure to give alkyne 3.72 (853 mg, 91% 
yield). 
IR (thin film) 3309, 3027, 2959, 2935, 2858, 1609, 1510, 1510, 1256, 915, 838, 780 cm
-1
 
1
H NMR (300 MHz, CDCl3) δ 7.07 (d, J = 8.3 Hz, 2 H), 6.77 (d, J = 8.5 Hz, 2 H), 2.78 
(t, J = 7.6 Hz, 2 H), 2.44 (td, J = 7.6, 2.6 Hz, 2 H), 1.97 (t, J = 2.6 Hz, 1 H), 0.98 (s, 9 H), 
0.19 (s, 5 H) 
13
C NMR (75 MHz, CDCl3, DEPT) δ 154.2 (C), 133.3 (C), 129.4 (CH × 2), 120.0 (CH × 
2), 84.2 (C), 68.9 (CH
31
), 34.2 (CH2), 25.8 (CH3 × 3), 21.0 (CH2), 18.3 (C), −4.3 (CH3 × 
2) 
HRMS (ESI+): Calculated for C16H24OSiNa
+
: 283.1489; Observed: 283.1490 
                                                 
31
 While the size of the 
13
C peak suggests an attached proton, this peak does not appear in the DEPT 
spectra. This is expected for a terminal alkyne CH: Simpson, J. H. Organic Structure 
Determination Using 2-D NMR Spectroscopy: A Problem-Based Approach, Academic Press, 
Boston, 2008, ch. 6, p. 115. 
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Phenol 3.73k 
 
TBS ether S14 (400 mg, 1.45 mmol) was dissolved in DMF (14 mL, not anhydrous) and 
treated with LiOH·H2O (183 mg, 4.36 mmol). The reaction mixture was stirred overnight 
and then diluted with EtOAc and washed with brine. The aqueous layer was acidified 
with 2% aq. HCl and extracted with EtOAc. The combined organic extracted were dried 
over Na2SO4, filtered, and concentrated under reduced pressure. The resulting residue 
was purified by flash column chromatography (5:1 hexanes/EtOAc) to give phenol 3.73k 
(200 mg, 86% yield). 
IR (thin film) 3375, 3021, 2919, 2857, 1656, 1612, 1514, 1445, 1235, 825 cm
-1 
1
H NMR (300 MHz, CDCl3) δ 7.07 (d, J = 8.5 Hz, 2 H), 6.79 (d, J = 8.5 Hz, 2 H), 6.22 
(s, 1 H), 2.73 (t, J = 7.6 Hz, 2 H), 2.39 (tq, J = 7.6, 2.5 Hz, 2 H), 1.79 (t, J = 2.5 Hz, 3 H) 
13
C NMR (75 MHz, CDCl3, DEPT) δ 154.0 (C), 133.2 (C), 129.6 (CH × 2), 115.3 (CH × 
2), 79.0 (CH), 76.4 (C), 34.7 (CH2), 21.3 (CH2), 3.54 (CH3) 
HRMS (ESI-): Calculated for C11H11O
-
: 159.0815; Observed: 159.0819 
Phenol 3.73l 
 
TBS ether S15 (230 mg, 0.722 mmol) was dissolved in DMF (7 mL, not anhydrous). 
LiOH·H2O (91 mg, 2.2 mmol) was added and the mixture was stirred overnight. It was 
then diluted with EtOAc; washed with water, 10% aq. HCl, and brine; dried over 
Na2SO4; filtered; and concentrated under reduced pressure. The resulting residue was 
purified by flash column chromatography (5:1 hexanes/EtOAc) to give phenol 3.73l 
(135 mg, 92% yield) as a colorless oil. 
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IR (thin film) 3376, 3014, 2974, 2924, 2860, 2222, 1612, 1595, 1514, 1442, 1226, 1065, 
1007, 824 cm
-1 
1
H NMR (300 MHz, CDCl3) δ 7.06 (d, J = 8.5 Hz, 2 H), 6.76 (d, J = 8.6 Hz, 2 H), 5.70–
5.67 (m, 1 H), 4.13 (t, J = 2.1 Hz, 2 H), 3.55 (q, J = 7.0 Hz, 2 H), 2.74 (t, J = 7.5 Hz, 
2 H), 2.45 (tt, J = 7.4, 2.0 Hz, 2 H), 1.22 (t, J = 7.0 Hz, 3 H) 
13
C NMR (75 MHz, CDCl3, DEPT) δ 154.4 (C), 132.6 (C), 129.6 (CH × 2), 115.4 (CH × 
2), 86.6 (C), 76.5 (C), 65.5 (CH2), 58.4 (CH2), 34.2 (CH2), 25.7 (CH2), 21.3 (CH2), 15.0 
(CH3) 
HRMS (ESI+): Calculated for C13H16O2Na
+
: 227.1043; Observed: 227.1039 
Phenol 3.73m 
 
TBS ether S17 (108 mg, 0.325 mmol) was dissolved in THF (3 mL) and cooled to 0 ºC. 
Acetic acid (28 µL, 0.49 mmol) and TBAF (1 M in THF, 0.48 mL, 0.48 mmol) were 
added and the mixture was stirred for 2 h. The reaction was quenched with saturated aq. 
NaHCO3 (10 mL) and the mixture was extracted with CH2Cl2. The combined organic 
layers were washed with brine, dried over Na2SO4, filtered, and concentrated under 
reduced pressure. The resulting residue was purified by flash column chromatography 
(3:1 hexanes/EtOAc) to give phenol 3.73m (60 mg, 86% yield) as a colorless oil. 
IR (thin film) 3427, 3024, 2937, 2860, 1749, 1719, 1614, 1515, 1223, 1025, 926, 
826 cm
-1
 
1
H NMR (300 MHz, CDCl3) δ 7.06 (d, J = 8.4 Hz, 2 H), 6.77 (d, J = 8.5 Hz, 2 H), 5.31 
(s, 1 H), 4.66 (t, J = 2.1 Hz, 2 H), 2.75 (t, J = 7.5 Hz, 2 H), 2.46 (tt, J = 7.5, 2.1 Hz, 2 H), 
2.10 (s, 3 H) 
13
C NMR (75 MHz, CDCl3, DEPT) δ 171.4 (C), 154.4 (C), 132.2 (C), 129.5 (CH × 2), 
115.3 (CH × 2), 87.2 (C), 74.4 (C), 53.1 (CH2), 33.8 (CH2), 21.2 (CH2), 20.8 (CH3) 
HRMS (ESI+): Calculated for C13H14O3Na
+
: 241.0835; Observed: 241.0833 
Appendix I: Experimental Procedures and Data | 185 
 
 
TMS alkyne 3.76 
 
Diisopropyl amine (0.11 mL, 0.78 mmol) was dissolved in THF (2 mL), cooled to 0 ºC, 
and treated with n-BuLi (2.4 M in hexanes, 0.34 mL, 0.82 mmol). The solution was then 
cooled to –78 ºC and a solution of enone 3.7432 (84 mg, 0.60 mmol) in THF (2 mL) was 
added dropwise. The solution was stirred for 30 min, at which point alkyl iodide 3.75
33
 
(334 mg, 1.25 mmol) was added as a solution in THF (2 mL). The reaction mixture was 
allowed to warm to rt overnight while stirring. The reaction was quenched with saturated 
aq. NH4Cl (3 mL), the phases were separated, and the aqueous layer was extracted with 
CH2Cl2. The combined organic layers were dried over Na2SO4, filtered, and concentrated 
under reduced pressure. The resulting residue was purified by flash column 
chromatography (3:1 hexanes/EtOAc) to give alkyne 3.76 (137 mg, 82% yield) as a pale 
yellow oil. 
IR (thin film) 2953, 2172, 1655, 1613, 1373, 1248, 1194, 841, 759 cm
-1
 
1
H NMR (300 MHz, CDCl3) δ 5.25 (s, 1 H), 3.66 (s, 3 H), 2.52–2.32 (m, 2 H), 2.18 (t, J 
= 6.8 Hz, 2 H), 1.90 (dt, J = 13.2, 6.4 Hz, 1 H), 1.73 (ddd, J = 13.6, 7.8, 5.7 Hz, 1 H), 
1.67–1.38 (m, 4 H), 1.07 (s, 3 H), 0.12 (s, 9 H) 
13
C NMR (75 MHz, CDCl3, DEPT) δ 203.9 (C), 176.5 (C), 107.4 (C), 101.0 (CH), 84.8 
(C), 55.7 (CH3), 43.3 (C), 36.1 (CH2), 32.3 (CH2), 25.9 (CH2), 23.6 (CH2), 22.3 (CH3), 
20.5 (CH2), 0.3 (CH3 × 3) 
HRMS (ESI+): Calculated for C16H26O2SiNa
+
: 301.1594; Observed: 301.1598 
                                                 
32
 Miyaoka, H.; Kajiwara, Y.; Hara, M.; Suma A.; Yamada, Y. Tetrahedron: Asymmetry, 1999, 10, 3189–
3196. 
33
 Baldwin, J. E.; Adlington R. M.; Singh, R. Tetrahedron, 1992, 48, 3385–3412. 
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Internal alkyne 3.7734 
 
Terminal alkyne S18 (516 mg, 2.48 mmol) was dissolved in DMSO (16 mL). In a 
separate flask, t-BuOK (834 mg, 7.43 mmol) was also dissolved in DMSO (8 mL). Both 
solutions were degassed via argon bubbling for 10 min before the t-BuOK solution was 
transferred via syringe to the alkyne solution. The mixture was stirred for 40 min and 
then cooled to 0 ºC before the reaction was quenched with saturated aq. NH4Cl (20 mL). 
The mixture was diluted with brine and extracted with diethyl ether and CH2Cl2. The 
combined organic layers were concentrated under reduced pressure. Residual DMSO was 
removed by dissolving the residue in CH2Cl2 and washing with water and brine. The 
organic layer was then dried over Na2SO4, filtered, and concentrated under reduced 
pressure. The resulting residue was purified by flash column chromatography (3:1 
hexanes/EtOAc) to give internal alkyne 3.77 (434 mg, 84% yield). 
IR (thin film) 2918, 2850, 1651, 1611, 1453, 1374, 1194, 1040, 985, 841 cm
-1 
1
H NMR (300 MHz, CDCl3) δ 5.24 (s, 1 H), 3.66 (s, 3 H), 2.52–2.32 (m, 2 H), 2.17–1.97 
(m, 2 H), 1.91 (dt, J = 13.3, 6.5 Hz, 1 H), 1.73 (t, J = 2.5 Hz, 3 H), 1.82–1.63 (m, 3 H), 
1.06 (s, 3 H) 
13
C NMR (75 MHz, CDCl3, DEPT) δ 203.2 (C), 176.5 (C), 101.0 (CH), 79.3 (C), 75.7 
(C), 55.7 (CH3), 43.2 (C), 36.4 (CH2), 32.3 (CH2), 25.8 (CH2), 22.1 (CH3), 14.0 (CH2), 
3.6 (CH3) 
HRMS (ESI+): Calculated for C13H18O2Na
+
: 229.1199; Observed: 229.1198 
                                                 
34
 Internal alkyne 3.77 could also be synthesized by sequentially alkylating the methyl enol ether of 1,3-
cyclohexadione with methyl iodide and 5-iodopent-2-yne. However, we found this route to be 
unreliable and low yielding, regardless of the order of alkylation. 
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Enone 3.78 
 
Vinylogous ester 3.77 (149 mg, 0.715 mmol) was dissolved in toluene (1.5 mL) and 
cooled to –78 ºC. DIBAL-H (0.14 mL, 0.79 mmol) was added slowly, and then the 
mixture was allowed to warm to –20 ºC over 1.5 h before the reaction was quenched with 
methanol (0.5 mL). The reaction mixture was warmed to rt and 10% aq. HCl (0.5 mL) 
was added. After stirring for 30 min, additional 10% aq. HCl (1 mL) was added. The 
mixture was stirred for another 2 h, and then diluted with EtOAc, washed with brine, 
dried over Na2SO4, filtered, and concentrated under reduced pressure. The resulting 
residue was purified by flash column chromatography (5:1 hexanes/EtOAc) to give enone 
3.78 (125 mg, 99% yield) as a colorless oil. 
IR (thin film) 3021, 2958, 2933, 2864, 1681, 1451, 1389, 1375, 1239, 1116, 805 cm
-1
 
1
H NMR (300 MHz, CDCl3) δ 6.65 (d, J = 10.2 Hz, 1 H), 5.84 (d, J = 10.2 Hz, 1 H), 2.42 
(t, J = 6.8 Hz, 2 H), 2.18–2.09 (m, 2 H), 1.95 (dt, J = 13.8, 7.1 Hz, 1 H), 1.72 (t, J = 
2.4 Hz, 3 H), 1.76–1.63 (m, 3 H), 1.11 (s, 3 H) 
13
C NMR (75 MHz, CDCl3, DEPT) δ 199.4 (C), 158.3 (CH), 127.7 (CH), 78.7 (C), 76.2 
(C), 40.1 (CH2), 35.6 (C), 34.1 (CH2), 33.3 (CH2), 24.8 (CH3), 14.1 (CH2), 3.5 (CH3) 
HRMS (ESI+): Calculated for C12H16ONa
+
: 199.1093; Observed: 199.1090 
Vinyl acetate 3.86 
 
Cyclohexadienone 3.67 was cyclized using a modification of general method F, where 
the temperature was 50 ºC, to give 3.86 after flash column chromatography (10:1 
hexanes/EtOAc). 
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1
H NMR (500 MHz, CDCl3) δ 6.88 (d, J = 10.2 Hz, 2 H), 6.22 (d, J = 10.2 Hz, 2 H), 5.57 
(t, J = 0.9 Hz), 2.27–2.23 (m, 2 H), 2.20 (s, 3 H), 1.33–1.30 (m, 4 H), 0.91–0.88 (m, 3 H) 
Alkyne-tethered cyclohexadienone 3.87 
 
Mesitol (409 mg, 3.00 mmol) was dissolved in 2-butyn-1-ol (3 mL) and cooled to 0 ºC. 
PIFA (1.54 g, 3.58 mmol) was added in small portions. The mixture was stirred for 
30 min, and then diluted with water and extracted with CH2Cl2. The combined organic 
layers were dried over Na2SO4, filtered, and concentrated under reduced pressure. The 
resulting residue was purified by flash column chromatography (95:5 hexanes/EtOAc) to 
give cyclohexadienone 3.87 (436 mg, 71% yield). 
IR (thin film) 2979, 2924, 2858, 2302, 1673, 1644, 1443, 1370, 1073, 1036, 906 cm
-1 
1
H NMR (300 MHz, CDCl3) δ 6.50 (s, 2 H), 3.86 (q, J = 2.4 Hz, 2 H), 1.86 (s, 6 H), 1.79 
(t, J = 2.4 Hz, 3 H), 1.37 (s, 3 H) 
13
C NMR (75 MHz, CDCl3, DEPT) δ 186.5 (C), 146.1 (CH × 2), 136.7 (C × 2), 82.8 (C), 
75.9 (C), 72.8 (C), 53.7 (CH2), 26.6 (CH3), 16.0 (CH3 × 2), 3.8 (CH3) 
HRMS (ESI+): Calculated for C13H16O2Na
+
: 227.1043; Observed: 227.1041 
Vinyl acetate 3.88 
 
Cyclohexadienone 3.87 was subjected to the conditions in general method F for 2 days to 
give a crude product containing 3.88. Purification was attempted by flash column 
chromatography (9:1 hexanes/EtOAc); however, while olefin 3.88 was clearly 
identifiable in the recovered material, it could not be completely separated from 
impurities. 
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1
H NMR (300 MHz, CDCl3) δ 6.50 (s, 2 H), 5.17 (td, J = 6.9, 0.9 Hz, 1 H), 3.70 (dd, J = 
6.9, 0.9 Hz, 2 H), 2.09 (s, 3 H), 1.90 (s, 6 H), 1.89–1.87 (m, 3 H), 1.36 (s, 3 H) 
Internal alkyne S14 
 
Alkyne 3.72 (490 mg, 1.88 mmol) was dissolved in THF (18 mL), cooled to –78 ºC, and 
treated with n-BuLi (2.5 M in hexanes, 1.12 mL, 2.82 mmol). The reaction mixture was 
stirred for 30 min, and then MeI (0.17 mL, 2.7 mmol) was added. The mixture was then 
allowed to gradually warm to rt and the reaction was monitored by GC.
35
 After no 
starting material remained, the reaction was quenched with saturated aq. NH4Cl (5 mL) 
and the mixture was extracted with diethyl ether. The combined organic layers were dried 
over MgSO4, filtered, and concentrated under reduced pressure. The resulting residue was 
purified by flash column chromatography (95:5 hexanes/EtOAc) to give alkyne S14 
(401 mg, 78% yield). 
IR (thin film) 2963, 2927, 2858, 1609, 1510, 1257, 916, 837, 781 cm
-1 
1
H NMR (300 MHz, CDCl3) δ 7.05 (d, J = 8.6 Hz, 2 H), 6.76 (d, J = 8.5 Hz, 2 H), 2.73 
(t, J = 7.7 Hz, 2 H), 2.37 (tq, J = 7.7, 2.5 Hz, 2 H), 1.78 (t, J = 2.5 Hz, 3 H), 0.98 (s, 9 H), 
0.18 (s, 6 H) 
13
C NMR (75 MHz, CDCl3, DEPT) δ 154.0 (C), 133.9 (C), 129.4 (CH × 2), 120.9 (CH × 
2), 78.9 (CH × 2), 76.2 (C), 34.9 (CH2), 25.8 (CH3 × 3), 21.3 (CH2), 18.3 (C), 3.6 (CH3), 
−4.3 (CH3 × 2) 
HRMS (ESI+): Calculated for C17H26OSiNa
+
: 297.1645; Observed: 297.1639 
                                                 
35
 Gas chromatography was performed with a 30 m OPTIMA 5 fused-silica column with a 0.25 µm inner 
diameter. 
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Internal alkyne S15 
 
Terminal alkyne 3.72 (265 mg, 1.02 mmol) was dissolved in THF (10 mL), cooled to 
–78 ºC, and treated with n-BuLi (2.4 M in hexanes, 0.46 mL, 1.1 mmol). The reaction 
mixture was stirred for 30 min, and then chloromethyl ethyl ether (80% purity, 0.14 mL, 
1.2 mmol) was added. The mixture was allowed to warm to rt over 2 h, at which point the 
reaction was quenched with saturated aq. NH4Cl (10 mL) and extracted with diethyl 
ether. The combined organic layers were dried over MgSO4, filtered, and concentrated 
under reduced pressure. The resulting residue was purified by flash column 
chromatography (95:5 hexanes/EtOAc) to give ethyl ether S15 (230 mg, 71% yield) as a 
colorless oil. 
IR (thin film) 3028, 2927, 2855, 1608, 1509, 1471, 1254, 1092, 915, 838, 780 cm
-1 
1
H NMR (300 MHz, CDCl3) δ 7.05 (d, J = 8.5 Hz, 2 H), 6.75 (d, J = 8.4 Hz, 2 H), 4.10 
(t, J = 2.0 Hz, 2 H), 3.51 (q, J = 7.0 Hz, 2 H), 2.76 (t, J = 7.6 Hz, 2 H), 2.47 (tt, J = 7.6, 
2.0 Hz, 2 H), 1.21 (t, J = 7.0 Hz, 3 H), 0.97 (s, 9 H), 0.18 (s, 6 H) 
13
C NMR (75 MHz, CDCl3, DEPT) δ 154.1 (C), 133.5 (C), 129.4 (CH × 2), 120.0 (CH × 
2), 86.1 (C), 76.9 (C), 65.3 (CH2), 58.4 (CH2), 34.4 (CH2), 25.8.3 (CH3 × 3), 21.3 (CH2), 
18.3 (C), 15.2 (CH3), −4.29 (CH3 × 2) 
HRMS (ESI+): Calculated for C19H30O2SiNa
+
: 341.1907; Observed: 341.1902 
Propargylic alcohol S16 
 
Terminal alkyne 3.72 (240 mg, 0.921 mmol) was dissolved in THF (6 mL) and cooled to 
–78 ºC. n-BuLi (2.4 M in hexanes, 0.42 mL, 1.0 mmol) was added, the solution was 
Appendix I: Experimental Procedures and Data | 191 
 
 
stirred for 30 min. Paraformaldehyde (83 mg, 2.8 mmol) was added and the mixture was 
allowed to warm to rt while stirring overnight. The reaction was then quenched with 
saturated aq. NH4Cl (20 mL) and the mixture was extracted with diethyl ether. The 
combined organic layers were dried over MgSO4, filtered, and concentrated under 
reduced pressure. The resulting residue was purified by flash column chromatography 
(4:1 hexanes/EtOAc) to give propargylic alcohol S16 (180 mg, 67% yield) as a colorless 
oil. 
IR (thin film) 3290, 3027, 2855, 1608, 1509, 1470, 1169, 1012, 839, 781 cm
-1 
1
H NMR (300 MHz, CDCl3) δ 7.06 (d, J = 8.5 Hz, 2 H), 6.76 (d, J = 8.4 Hz, 2 H), 4.23 
(dt, J = 6.0, 2.1 Hz, 2 H), 2.76 (t, J = 7.6 Hz, 2 H), 2.47 (tt, J = 7.6, 2.1 Hz, 2 H), 1.49–
1.45 (m, 1 H), 0.98 (s, 9 H), 0.18 (s, 6 H) 
13
C NMR (75 MHz, CDCl3, DEPT) δ 154.0 (C), 133.3 (C), 129.2 (CH × 2), 119.9 (CH × 
2), 85.5 (C), 79.1 (C), 50.9 (CH2), 34.2 (CH2), 25.7 (CH3 × 3), 21.1 (CH2), 18.1 (C), 
−4.45 (CH3 × 2) 
HRMS (ESI+): Calculated for C17H26O2SiNa
+
: 313.1594; Observed: 313.1586 
Propargylic acetate S17 
 
Propargylic alcohol S16 (99 mg, 0.34 mmol) and triethylamine (0.23 mL, 1.7 mmol) 
were dissolved in CH2Cl2 and cooled to 0 ºC. Acetyl chloride (73 µL, 1.0 mmol) was 
added and the mixture was stirred for 2 h. The reaction was quenched with saturated aq. 
NaHCO3 and the mixture was extracted with CH2Cl2. The combined organic layers were 
dried over Na2SO4, filtered, and concentrated under reduced pressure. The resulting 
residue was purified by flash column chromatography (95:5 hexanes/EtOAc) to give 
propargylic acetate S17 (108 mg, 96% yield) as a colorless oil. 
IR (thin film) 3028, 2949, 2930, 2857, 1746, 1608, 1509, 1257, 1024, 915, 837, 781 cm
-1 
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1
H NMR (300 MHz, CDCl3) δ 7.05 (d, J = 8.6 Hz, 2 H), 6.76 (d, J = 8.5 Hz, 2 H), 4.65 
(t, J = 2.2 Hz, 2 H), 2.76 (t, J = 7.6 Hz, 2 H), 2.47 (tt, J = 7.7, 2.1 Hz, 2 H), 2.09 (s, 3 H), 
0.98 (s, 9 H), 0.19 (s, 6 H) 
13
C NMR (75 MHz, CDCl3, DEPT) δ 170.5 (C), 154.2 (C), 133.3 (C), 129.4 (CH × 2), 
120.0 (CH × 2), 87.1 (C), 74.7 (C), 52.9 (CH2), 34.1 (CH2), 25.8 (CH3 × 3), 21.3 (CH2), 
20.9 (CH3), 18.3 (C), −4.3 (CH3 × 2) 
HRMS (ESI+): Calculated for C19H28O3SiNa
+
: 355.1700; Observed: 355.169 
Terminal alkyne S18 
 
K2CO3 (102 mg, 0.738 mmol) was added to a solution of alkyne 3.76 (137 mg, 
0.492 mmol) in methanol (1 mL). The reaction mixture was stirred for 2 h, and then 
diluted with CH2Cl2, filtered through Celite, and concentrated under reduced pressure. 
The resulting residue was purified by flash column chromatography (3:1 hexanes/EtOAc) 
to give terminal alkyne S18 (92 mg, 91% yield) as a colorless oil. 
IR (thin film) 3289, 3252, 2937, 2866, 2113, 1650, 1612, 1455, 1377, 1192, 985, 
842 cm
-1 
1
H NMR (300 MHz, CDCl3) δ 5.24 (s, 1 H), 3.66 (s, 3 H), 2.49–2.32 (m, 2 H), 2.15 (td, J 
= 6.7, 2.6 Hz, 2 H), 1.94–1.86 (m, 2 H), 1.77–1.40 (m, 5 H), 1.07 (s, 3 H) 
13
C NMR (75 MHz, CDCl3, DEPT) δ 203.8 (C), 176.5 (C), 101.05 (CH), 84.40 (C), 68.5 
(CH),
31
 55.7 (CH3), 43.2 (C), 36.2 (CH2), 32.2 (CH2), 25.9 (CH2), 23.4 (CH2), 22.4 
(CH3), 19.1 (CH2) 
HRMS (ESI+): Calculated for C13H18O2Na
+
: 229.1199; Observed: 229.1190 
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 Experimental Details – Chapter 4 
β-Ketoester 4.78 
 
Compound 2.13a (20 mg, 0.075 mmol) was added to a suspension of NaH (60% in 
mineral oil, 7.2 mg, 1.8 mmol) in THF (0.75 mL) at 0 °C. After 15 min, acetyl chloride 
(11 µL, 0.15 mmol) was added. The mixture was allowed to warm to rt and stirred for 16 
h, at which point the THF was removed under reduced pressure. The remaining residue
36
 
was cooled to 0 °C and TFA (2 mL) was added. The solution was allowed to warm to rt 
and stirred for 4 h. It was then quenched with saturated aq. NaHCO3, extracted with 
CH2Cl2, dried over Na2SO4, and concentrated under reduced pressure. The crude material 
was purified by flash-column chromatography (3:1 hexanes/EtOAc) to give 4.78 (7.3 mg, 
46% yield). 
IR (thin film) 2980, 2925, 1769, 1715, 1685, 1372, 1237, 1095, 957 cm
-1
 
1
H NMR (300 MHz, CDCl3) δ 6.68 (dd, J = 10.4, 2.1 Hz, 1 H), 6.08 (d, 10.4 Hz, 1 H), 
3.52 (d, 12.0 Hz, 1 H), 3.38 (dddd, J = 12.0, 5.5, 2.1, 2.1 Hz, 1 H), 2.73 (dd, J = 17.7, 
5.5 Hz, 1 H), 2.55 (d, J = 17.7 Hz, 1 H), 2.46 (s, 3 H), 1.71 (s, 3 H) 
13
C NMR (75 MHz, CDCl3, DEPT) δ 199.3 (C), 195.0 (C), 169.5 (C), 147.0 (CH), 129.7 
(CH), 80.4 (C), 57.8 (CH), 41.9 (CH), 36.3 (CH2), 30.3 (CH3), 24.0 (CH3) 
HRMS (ESI–) 207.0663 calcd for C11H11O4, found 207.0684 
                                                 
36
 The crude residue was identified as intermediate 4.77 by 
1
H NMR. 
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Bis-deuterated enone 4.82 
 
Hexamethydisilazane (34 μL, 0.16 mmol) was dissolved in THF (0.5 mL) and cooled to 
0 ºC. n-BuLi (2.5 M in hexanes, 66 μL, 0.17 mmol) was added and the solution was 
stirred for 30 min before being cooled to –78 ºC. In a separate flask, enone 2.13a (20 mg, 
0.075 mmol) was dissolved in THF (0.5 mL) and cooled to –78 ºC. This solution was 
added to the LHMDS solution and stirred for 30 min. D2O (0.5 mL) was added and the 
mixture was allowed to warm to rt. It was then quenched with saturated aq. NH4Cl, 
diluted with Et2O, washed with water and brine, dried over MgSO4, filtered, and 
concentrated under reduced pressure. The crude material was identified by 
1
H NMR as 
4.82. 
1
H NMR (300 MHz, CDCl3) δ 6.68 (dd, J = 10.3, 1.8 Hz, 1 H), 6.09 (d, J = 10.4 Hz, 
1 H), 3.35 (d, J = 12.4 Hz, 1 H), 3.32–3.27 (m, 1 H), 1.73 (s, 3 H), 1.50 (s, 9 H) 
TBS enol ether 4.85 
 
Enone 2.13a (35 mg, 0.13 mmol) was dissolved in CH2Cl2 (0.45 mL) and cooled to 0 ºC. 
TBSOTf (90 μL, 0.39 mmol) and Et3N (109 μL, 0.782 mmol) were added and the 
mixture was stirred until the reaction was complete by TLC (5 h). The mixture was then 
diluted with CH2Cl2, washed with 10% aq. HCl and water, dried over MgSO4, and 
concentrated under reduced pressure. The crude material was used immediately. 
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TMS enol ether 4.86 
 
Diisopropylamide (10.6 μL, 0.075 mmol) was dissolved in THF (0.25 mL) and cooled to 
0 ºC. n-BuLi (2.5 M in hexanes, 30 μL, 0.075 mmol) was added and the solution was 
stirred for 30 min before being cooled to –78 ºC. Cyclohexadienone 2.8a (20 mg, 
0.075 mmol) was added as a solution in THF (0.5 mL). The reaction mixture was allowed 
to warm to rt over 2 h, at which point it was quenched with saturated aq. NH4Cl. The 
mixture was diluted with Et2O, washed with water and brine, and dried over MgSO4. The 
crude material was used immediately. 
Aldol product 4.88 
 
Cyclopropane 2.23r (20.2 mg, 0.0764 mmol) and hexanal (9.5 μL, 0.077 mmol) were 
dissolved in THF (0.75 mL) and cooled to –78 ºC. SmI2 (0.035 M in THF, 4.5 mL, 0.16 
mmol) was added dropwise. The solution was stirred for 2 h at –78 ºC and 2 h at 0 ºC. 
The mixture was quenched with 10% aq. HCl, extracted with CH2Cl2, washed with 
saturated aq. Na2SO3 and water, dried over MgSO4, filtered, and concentrated under 
reduced pressure. The crude material was purified by flash-column chromatography 
(5:1→3:1 hexanes/EtOAc) to provide 4.88 (6.4 mg, 23% yield). 
1
H NMR (300 MHz, CDCl3) δ 6.69 (dd, J = 10.3, 1.8 Hz, 1 H), 6.11 (d, J = 10.4 Hz, 
1 H), 3.89–3.84 (m, 1 H), 3.37 (d, J = 11.6 Hz, 1 H), 3.28 (ddd, J = 11.6, 1.9, 1.9 Hz, 
1 H), 2.51 (dd, J = 5.9, 2.0 Hz, 1 H), 2.03 (d, J = 4.7 Hz, 1 H), 1.78 (s, 3 H), 1.78–1.72 
(m, 2 H), 1.64–1.60 (m, 2 H), 1.51 (s, 9 H), 1.34–1.30 (m, 4 H), 0.92–0.89 (m, 3 H) 
Appendix I: Experimental Procedures and Data | 196 
 
 
Decarboxylated bicyclic lactone 4.90 
 
Enone 2.13a (496 mg, 1.86 mmol) was dissolved in TFA (5 mL). The reaction mixture 
was stirred for 2 h and then the TFA was removed under reduced pressure. The remaining 
residue was dissolved in THF (5 mL). Et3N (0.26 mL, 1.9 mmol) was added and the 
mixture was heated to 50 ºC. After 2 h the reaction mixture was concentrated under 
reduced pressure. The remaining residue was dissolved in EtOAc; washed with saturated 
aq. NH4Cl, water, and brine; and dried over Na2SO4 to give 4.90 (284.6 mg, 92% yield) 
as a tan solid. The crude material was of sufficient purity for use without further 
purification. 
1
H NMR (300 MHz, CDCl3) δ 6.66 (dd, J = 10.3, 1.8 Hz, 1 H), 6.10 (d, J = 10.3, 1 H), 
2.99–2.89 (m, 1 H), 2.73 (dd, J = 17.5, 8.1 Hz, 1 H), 2.73–2.64 (m, 2 H), 2.43 (dd, 
J = 17.5, 11.8 Hz), 1.69 (s, 3 H) 
Methylated bicyclic lactone 4.91 
 
Enone 4.90 (284 mg, 1.71 mmol) was dissolved in 10:1 THF/HMPA (17 mL) and cooled 
to –98 ºC. LDA (1 M in THF, 1.9 mL, 1.9 mmol) was added and the reaction mixture was 
stirred for 30 min. MeI (0.32 μL, 5.1 mmol) was added and the mixture was allowed to 
warm to rt overnight. The mixture was quenched with saturated aq. NH4Cl and 
concentrated under reduced pressure. The remaining material was diluted with EtOAc, 
washed with water and brine, and dried over Na2SO4. The crude material was purified by 
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flash-column chromatography (2:1 hexanes/EtOAc) to provide 4.91 (85.8 mg, 28% 
yield). 
1
H NMR (500 MHz, CDCl3) δ 6.66 (d, J = 10.2 Hz, 1 H), 6.09 (d, J = 10.3 Hz, 1 H), 2.93 
(dd, J = 17.3, 7.4 Hz, 1 H), 2.57–2.46 (m, 3 H), 1.64 (s, 3 H), 1.24 (d, J = 6.5 Hz, 3 H)
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 Bicyclic enones 3.63l and 3.89l, and vinyl acetate 3.90 – crude –  1H NMR 
 
  
A
p
p
en
d
ix II: N
M
R
 S
p
ectra
 | 3
8
8 
 Bicyclic enone 3.63l –1H NMR 
 
  
A
p
p
en
d
ix II: N
M
R
 S
p
ectra
 | 3
8
9 
 Bicyclic enones 3.63m and 3.89m – crude –  1H NMR 
 
  
A
p
p
en
d
ix II: N
M
R
 S
p
ectra
 | 3
9
0 
 Bicyclic enones 3.63n and 3.89n – crude – 1H NMR 
 
  
A
p
p
en
d
ix II: N
M
R
 S
p
ectra
 | 3
9
1 
 Bicyclic enones 3.63n and 3.89n – purified – 1H NMR 
 
  
A
p
p
en
d
ix II: N
M
R
 S
p
ectra
 | 3
9
2 
 Alkynoate-tethered cyclohexadienone 3.67 – 1H NMR 
 
  
A
p
p
en
d
ix II: N
M
R
 S
p
ectra
 | 3
9
3 
 Cyclohexadienone 3.70i – 1H NMR 
 
  
A
p
p
en
d
ix II: N
M
R
 S
p
ectra
 | 3
9
4 
 Cyclohexadienone 3.70i – 13C NMR 
 
  
A
p
p
en
d
ix II: N
M
R
 S
p
ectra
 | 3
9
5 
 Cyclohexadienone 3.70j – 1H NMR 
 
  
A
p
p
en
d
ix II: N
M
R
 S
p
ectra
 | 3
9
6 
 Cyclohexadienone 3.70j – 13C NMR 
 
  
A
p
p
en
d
ix II: N
M
R
 S
p
ectra
 | 3
9
7 
 Benzyl alcohol 3.71 – 1H NMR 
 
  
A
p
p
en
d
ix II: N
M
R
 S
p
ectra
 | 3
9
8 
 Benzyl alcohol 3.71 – 13C NMR 
 
  
A
p
p
en
d
ix II: N
M
R
 S
p
ectra
 | 3
9
9 
 Alkyne 3.72 – 1H NMR 
 
  
A
p
p
en
d
ix II: N
M
R
 S
p
ectra
 | 4
0
0 
 Alkyne 3.72 – 13C NMR 
 
  
A
p
p
en
d
ix II: N
M
R
 S
p
ectra
 | 4
0
1 
 Phenol 3.73k – 1H NMR 
 
  
A
p
p
en
d
ix II: N
M
R
 S
p
ectra
 | 4
0
2 
 Phenol 3.73k – 13C NMR 
 
  
A
p
p
en
d
ix II: N
M
R
 S
p
ectra
 | 4
0
3 
 Phenol 3.73l – 1H NMR 
 
  
A
p
p
en
d
ix II: N
M
R
 S
p
ectra
 | 4
0
4 
 Phenol 3.73l – 13C NMR 
 
  
A
p
p
en
d
ix II: N
M
R
 S
p
ectra
 | 4
0
5 
 Phenol 3.73m – 1H NMR 
 
  
A
p
p
en
d
ix II: N
M
R
 S
p
ectra
 | 4
0
6 
 Phenol 3.73m – 13C NMR 
 
  
A
p
p
en
d
ix II: N
M
R
 S
p
ectra
 | 4
0
7 
 TMS alkyne 3.76 – 1H NMR 
 
  
A
p
p
en
d
ix II: N
M
R
 S
p
ectra
 | 4
0
8 
 TMS alkyne 3.76 – 13C NMR 
 
  
A
p
p
en
d
ix II: N
M
R
 S
p
ectra
 | 4
0
9 
 Internal alkyne 3.77 – 1H NMR 
 
  
A
p
p
en
d
ix II: N
M
R
 S
p
ectra
 | 4
1
0 
 Internal alkyne 3.77 – 13C NMR 
 
  
A
p
p
en
d
ix II: N
M
R
 S
p
ectra
 | 4
1
1 
 Enone 3.78 – 1H NMR 
 
  
A
p
p
en
d
ix II: N
M
R
 S
p
ectra
 | 4
1
2 
 Enone 3.78 – 13C NMR 
 
  
A
p
p
en
d
ix II: N
M
R
 S
p
ectra
 | 4
1
3 
 Vinyl acetate 3.86 – 1H NMR 
 
  
A
p
p
en
d
ix II: N
M
R
 S
p
ectra
 | 4
1
4 
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 Propargyl acetate S17 – 13C NMR 
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 Terminal alkyne S18 – 1H NMR 
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 Terminal alkyne S18 – 13C NMR 
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 β-Ketoester 4.78 – 1H NMR 
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 Bis-deuterated enone 4.82 – 1H NMR 
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 Aldol product 4.88 – 1H NMR 
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 Decarboxylated bicyclic lactone 4.90 – 1H NMR 
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 Methylated bicyclic lactone 4.91 – 1H NMR 
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 Methylated bicyclic lactone 4.91 – NOE 
 
